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11.
s U M M A R Y
1. The concentrations Of 5*“hydroxytryptamine in the rat brain have 
been shown to vary with clock hour. Highest concentrations were 
observed at 13.00 h» and lowest concentrations at 01.00 h.
2. The twenty-four hour variation in brain tryptophan concentrations, 
tryptophan uptake, 5-hydroxytryptophan concentrations and uptake, 
5-hydroxyindole-3-acetic acid concentrations and the activities of 
tryptophan-5-hydroxylase, 5-hydroxytryptophan decarboxylase and 
monoamine oxidase have been determined. The effects of inhibitors of 
catecholamine synthesis on the twenty-four hour rhythm of 5-hydroxy­
tryptamine concentrations, and the effects of drugs which alter brain 
5-hydroxytryptamine concentrations on locomotor activity were determined.
3. Brain and serum (free and bound) tryptophan concentrations vary with 
clock hour, but the rhythm is 180 degrees out of phase with that of
5-hydroxytryptamine. The uptake of ^^C-tryptophan into synaptosomes 
also varies with clock hour.
4. The rate of conversion of 5-hydroxytryptophan to 5-hydroxytryptamine 
was greater during the hours of light than during the hours of darkness, 
although the activity of the enzyme did not vary and substrate and 
pyridoxal phosphate availability were not limiting factors.
Ill.
5. 5-hydroxyindole-3-acetic acid concentrations exhibit a . 
twenty-four hour rhythm which follows the rhythm of 5-hydroxytryptamine 
concentrations.
6. Monoamine oxidase inhibitors, eC-methyl-p-tyrosine and
6-hydroxydopamine abolish the twenty-four hour rhythm of 
5-hydroxytryptamine concentrations and elevate brain levels of the 
amine «
7o It is proposed that the twenty-four hour variation of 
5-hydroxytryptamine concentrations in the rat brain are controlled, 
at least in part, by the twenty-four hour variation of 
5-hydroxytryptophan decarboxylase activity, which in turn is 
significantly influenced by the concentration of catecholamines in 
the brain.
C H A P T E R  O N E
1.
INTRODUCTION
5-hydroxytryptamine is widely distributed in the central 
nervous system (CNS) of mammals, where it probably functions as 
a neurotransmitter. This indoleamine has been postulated to be 
involved in many and varied functions e.g. sleep, pain perception, 
and is noted for displaying a marked circadian rhythm in the CNS.
It is hoped that the results presented in this thesis will 
shed some light upon biochemical aspects of the control of the 
twenty-four hour variation of 5-hydroxytryptamine concentrations 
in the rat brain, and will perhaps help to integrate this apparently 
functionally distinct unit into the recognised patterns of brain 
function as we now know them.
It is the purpose of this introduction to give a resume of the 
work involved with the discovery, distribution, metabolism, regulation 
and function of 5-hydroxytryptamine in the CNS and to explain those 
characteristics of circadian rhythms which are of particular relevance 
to the amine.
1 o1 Discovery, Isolation and Characterisation of 5-hydroxytryptamine
For more than a century mammalian physiologists have been aware 
of a vasoconstrictor substance which appears in the serum after blood 
has been allowed to clot. This substance, which they termed vasotonin, 
could be inactivated by first passing the blood through the lungs.
It was not until 1948 that this compound was isolated. Rapport, 
Green and Page, working at the Cleveland Clinic in America, crystallised 
a complex with vasoconstrictor activity, and gave it the name serotonin, 
a term still very much in vogue. The following year Rapport (1949) 
characterised the active moiety as 5-hydroxytryptamine. When this 
compound was prepared synthetically by Hamlin and Fischer in 1951, it 
was found to behave exactly as the naturally occurring "serotonin".
At approximately the same time Erspamer and his co-workers in 
Italy were investigating the substance that imparts peculiar histochemical 
properties to the enterochromaffin cells of the gastro-intestinal mucosa. 
They found a basic compound, which they called enteramine, in the gastric 
mucosa, and subsequently in other tissues. This compound had the ability 
to stimulate the gastro-intestinal tract. By 1946 Erspamer had suggested 
that the active component was an indolealkylamine,but was not able to 
make further progress until 5-hydroxytryptamine had been discovered in 
the blood. Erspamer and Asero (1952) then established that this was the 
chemical nature of Erspamer's "enteramine".
1.2 The Occurrence of 5-hydroxytryptamine
5-hydroxytryptamine occurs abundantly in animals including mammals, 
birds, reptiles, amphibians, fish, tunicates, molluses, arthropods and 
coelenterates, and in fruits such as pineapple, banana and plum and in 
various nuts. Man has probably been made most aware of the presence of 
5-hydroxytryptamine by its occurrence in stings and venoms e.g. common 
stinging nettle, cowhage, wasps and scorpions.
1.3 5-hydroxytryptamine in the Central Nervous System (CNS)
Many earlier workèrs were unable to establish the presence of 
5-hydroxytryptamine in the CNS, and therefore disputed its existence. 
Eventually Amin, Crawford and Gaddum (1954) assayed appreciable amounts 
of the amine in the brains of dogs.
Since these workers had demonstrated the existence of
5-hydroxytryptamine in the brain, it was essential to man * s endeavour 
to propose a role for the amine. Not unnaturally, considering its 
situation, it was proposed to be a neurotransmitter, but this proposition 
necessitated the localisation of the amine into a specific neuronal network. 
Evidence has accumulated to support the belief that 5-hydroxytryptamine 
found in the brain is derived from specific neurones. This evidence may 
be summarised:
1) Information from the Falck-Hillarp technique of fluorescence 
histochemistry applied to the brain (Fuxe 1965).
2) Subcellular fractionation studies showing 5-hydroxytryptamine 
to be associated with nerve ending particles (Zieher and
De Robertis 1963) .
3) The loss of brain 5-hydroxytryptamine related to the 
degeneration of nerve fibres following lateral hypothalamic 
lesions (Heller and Moore 1968).
Of these findings, perhaps the use of the fluorescent histochemical 
technique has achieved most in associating the amine with specific neurones. 
Barter and Pearse (Pearse 1960) originally developed a fluorescent 
jp-carboline complex (6-hydroxy-3,4-dihydroxy-p-carboline) from thé addition 
of one molecule of formaldehyde to the 5-hydroxytrÿptamine molecule. The 
method was adapted for the mapping of neurones containing 5-hydroxytryptamine 
in the brain by the Swedish group of workers (for summary see Fuxe, Hokfelt
and Ungerstedt 1968). It is pertinent to note that the fluorescence 
produced from this method is very weak for this amine, particularly 
in the small nerve terminals. The majority of studies have therefore 
been conducted with the use of monoamine oxidase inhibitors and 
reserpine, or from large scale ablations of the forebrain to enhance 
fluorescence in the cell bodies. This is clearly not a sound basis 
for drawing conclusions about physiological mechanisms. However,
Bedard, Carlsson and Lindqvist (1972) and Delorme, Froment and 
Jouvet (1966) studied the loss of brain 5-hydroxytryptamine following 
lesions placed according to data obtained from fluorescent techniques, 
and the results were compatible with the neuronal networks proposed.
More recent methods to increase the intensity of fluorescence 
include:-
1) Preloading with high doses of the amino acid precursor
tryptophan (Aghajanian and Asher 1971), thus increasing
the concentration of 5-hydroxytryptamine in the neurones, 
and consequently increasing the fluorescence, and
2) incubating slices of brain with 6-hydroxytryptamine and
developing the fluorescent product, which is more intense
than that of the natural amine. Unfortunately
6-hydroxytryptamine may be taken up into catecholaminergic 
neurones, and is therefore non specific. However, 
pre-incubation of brain slices with 6-hydroxydopamine 
selectively destroys catecholaminergic neurones, and 
subsequent perfusion with 6-hydroxytryptamine produces an 
increased fluorescence which is specific to 5-hydroxytryptamine 
neurones, although smaller nerve endings may still remain 
invisible (Famebo 1971) .
5.
5-hydroxytryptamine has therefore been identified in the brain of 
mammals by methods which lack absolute definition, and therefore cannot 
provide final proof that the amine is a neurotransmitter, although it 
satisfies most of the criteria which are normally considered essential 
(Van Praag 1970).
1) 5-hydroxytryptamine shows a distinct predilection for the 
terminal ramifications of the axons, where it is located in 
synaptic vesicles.
2) The enzymes required for synthesis and degradation of the 
amine are present in the brain.
3) The turnover rate of the amine in nerve terminals is high.
4) 5-hydroxytryptamine introduced to functioning neurones by 
micro-electrophoresis influences their electrical activity.
5) Stimulation of nerves containing 5-hydroxytryptamine reduces 
the concentration of the amine in the terminal axonal 
ramifications, especially when re-synthesis is inhibited.
There are two very important omissions from this list. First, there 
is a lack of evidence to show that the micro-iontophoretic application of 
5-hydroxytryptamine to post-synaptic structures, anywhere in the CNS, 
corresponds to the effect of stimulation of 5-hydroxytryptamine containing 
neurones. Secondly, if the amine is a neurotransmitter it must be available 
for release onto extraneuronal structures, from where it can be collected 
and identified. There is no evidence that this has been achieved.
Micro-iontophoretic application of 5-hydroxytryptamine to pre-synaptic 
structures produces responses which vary according to brain region, Most 
telencephalic neurones are depressed, while spinal and ponto-medullary 
neurones are excited (Bloom, Hoffer, Nelson, Sheu and Siggins 1973).
6,
1.4 Distribution of 5-hydroxytryptamine in the CNS
The nerve cell bodies of the 5-hydroxytryptamine containing 
neurones are situated in the raphe nuclei in the brain stem and 
mesencephalon, with others in the reticular formation. Ascending 
and descending axons project to the more rostral parts of the brain 
(Fig, 1) and to the spinal cord, with nerve terminals apparently
present in most regions of the CNS,
Descending bulbo-spinal neurones have their origin mainly in 
the raphe nuclei of the medulla oblongata i.e. nucleus raphe pallidus
(Bl), nucleus raphe obscurus (B2) and the cells around the pyramidal
tracts (B3), from whence they descend in the white matter of the Spinal 
cord (anterior and lateral funicles) giving off projections into the 
grey matter, probably partly as collaterals, at different levels.
The greatest density of 5-hydroxytryptamine containing nerve terminals 
occurs in the lumbar and sacral regions.
The B3 group of cells lateral and dorsal to the pyramidal tract
and trapezoid body, and the B5 group in the nucleus raphe pontis of the
lower brain stem, provide neuronal innervation of the cerebellum and
lower brain stem by short neurones.
The mesencephalic cell groups B7 (nucleus raphe dorsalis),B8 
(nucleus raphe medianus) and the B9 region, provide the neurones for the 
ascending pathways to the diencephalon and telencephalon. The majority 
of 5-hydroxytryptamine-containing fibres ascend alongside noradrenergic 
neurones in the septum, and end in the cingulum and cerebral cortex in 
fine nerve terminals. The rostral areas of the brain are reached by 
this system, thus innervating the limbic forebrain, hypothalamus and 
neo-cortex. The concentration of 5-hydroxytryptamine in brain regions, 
measured biochemically, correlates well with the number of nerve terminals 
detected by the fluorescent histochemical technique. Particularly high 
concentrations are found in the nucleus suprachiasmaticus and septal regions 
and low concentrations are found in the cerebellum.
7.




Figure 1 . The network of 5-hydroxytryptamine-containing neurones
in the rat brain (after Fuxe, Hokfelt and Ungerstedt 1971) , 
ascending pathways to the prosencephalon originating from 
mesencephalic cell b o d i e s d e s c e n d i n g  pathways 
from cell bodies in the medulla oblongata. (— • —  • —  
5-hydroxytryptamine neurones innervating the lower 
brain stem. (....... ).
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The ultrastructure of the nerve terminal is similar to that of 
catecholaminergic neurones. Both large and small dense-core vesicles 
are present and the synapse is of the Type 1 variety, at least in the
hypothalamus. (Aghajanian, Bloom and Sheard 1969). Amine storage
granules appear to be of more than one type (Thierry, Fekete and 
Glowinski1968; Shields and Eccleston 1972), and may exist in two 
forms :
1) "Young" granules storirig endogenous amine, which have 
undergone proximo-distal transport, possibly by the 
micro tubule system (Dahlstrom 1970) and have recently 
arrived at the nerve terminal.
2) Older granules resident at the nerve terminal.
The former may be important for the release and re-uptake
of transmitter, while the main purpose of the latter is storage of 
the monoamine.
1.5 The Metabolism of 5-hydroxytryptamine
It has been classically established that 5-hydroxytryptamine 
is synthesised from the amino acid tryptophan, by hydroxylation to 
5-hydroxytryptophan and decarboxylation to the amine. It is 
catabolised by monoamine oxidase to 5-hydroxyindole acetaldehyde 
and dehydrogenation to the major excretory product 5-hydroxyindole-3-acetic 
acid (Udenfriend 1959) (Fig.2.), All the necessary components of the 
synthesis and breakdown of 5-hydroxytryptamine are located in, or are 
associated with nerve endings, axons and cell bodies which have been 
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Figure 2 The major route of metabolism of 5—hydroxytryptamine.
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This pathway, which constitutes the major metabolic pathway of 
5-hydroxytryptamine will not be enlarged upon in this introduction, since 
investigation into the components of this pathway make up a large 
proportion of the work presented in this thesis, and will be discussed 
in much greater detail in Chapters 4-9. This introduction will be 
concerned with alternative metabolic processes which may affect the 
concentration of 5-hydroxytryptamine in the brain.
1.6 Alternative Routes of Metabolism
Some alternative routes of metabolism are shown in Figure 3.
The metabolism of 5-hydroxytryptamine relies on the availability 
of its dietary amino acid precursor tryptophan. Since the synthesis 
of the amine is only a minor pathway of tryptophan metabolism, it is 
apparent that some degree of control may be effected by the alternative 
pathways. It is conceivable that the removal of tryptophan for other 
purposes e.g. protein biosynthesis, excretion, could result in a 
decreased production of 5-hydroxytryptamine.
Peripherally, the major route of tryptophan metabolism starts 
with its oxidation, by liver tryptophan pyrrolase, to formylkynurenine, 
and by formamidation to kynurenine - the principal metabolite. Liver 
tryptophan pyrrolase is substrate inducible and is controlled, at least 
in part, by circulating corticosteroids (Curzon and Green 1971), and 
can thus regulate the concentrations of tryptophan in the circulation. 
There is no evidence to suggest the presence of the pyrrolase in the 
CNS, and none to suggest the existence of kynurenine. However, 
since the CNS relies on the circulation for its supply of tryptophan, 
the activity of liver pyrrolase may participate in the control of 
the amino acid levels in the CNS.
11.
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FIG, 3o The Metabolism of Indoleamines in the brain,
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Tryptophan may be decarboxylated directly to tryptamine, and 
although this may occur readily in the periphery, very little 
tryptamine has been found in the CNS (Saavedra and Axelrod 1971) .
Perhaps more important is the discovery (Saavedra and Axelrod 1972) 
of an enzyme able to catalyse the conversion of tryptamine to 
N, N-dimethyltryptamine, and the detection of a compound resembling 
the tertiary amine (Heller, Fischer and Spatz 197 3) in rat brain.
N, N-dimethyltryptamine is a known psychotomimetic and has been 
postulated to be involved in the production of the symptoms of schizo­
phrenia and in dream mechanisms (Heller, Fischer and Spatz 1973).
This supposition would depend on the conversion of tryptophan to 
tryptamine in the CNS. This may be possible if the subsequent 
conversion of tryptamine to the methylated derivatives were so rapid 
as to make any increase in tryptamine undetectable, following loading 
with tryptophan. A second possibility is the conversion of tryptophan 
to N, N-dimethyltryptophan and decarboxylation to N, N-dimethyltryptamine. 
These pathways may be feasible,and perhaps important, if monoamine oxidase 
activity or the activity of endogenous inhibitors is altered.
5-hydroxytryptophan may be decarboxylated directly and rapidly to
5-hydroxytryptamine, or transaminated to the pharmacologically interesting
5-hydroxyindole pyruvic acid. The aminotransferase system is located in
the mitochondria of neurones in the rat brain (Miller and Litwack 1969).
Interest in the pathway has developed due to its ability to bypass the
production of 5-hydroxytryptamine and monoamine oxidase activity, and
provide an alternative source of 5-hydroxyindole acetaldehyde, which has
been suggested to be functionally active in the CNS (Sabelli, Giardina,,
Alivisatos, Seth and Ungar 1969). ^^C-5-hydroxyindole pyruvic acid has
been detected in the CNS following the intravenous injection of 
14
C-5-hydroxytryptophan (Millard and Gal 1971) . The transamination was
14.
inhibited by increased cerebral concentrations of 5-hydroxytryptamine 
and by IDPN (p, p ’ iminodipropionitrile succinate). The aminotransferase 
system is freely reversible, thus providing a regulatory site for the 
synthesis of 5-hydroxytryptamine and 5-hydroxyindole acetaldéhyde.
The aldehyde may be oxidised to 5-hydroxyindole-3-acetic acid, or 
reduced to form the alcoholic metabolite 5-hydroxytryptophol, which may 
also play an active role in the brain (Alivisatos 1973). The 
reduction is readily reversible. Small quantities of 5-hydroxytryptophol 
appear in the urine of man, but it is usually conjugated with sulphate or 
glucuronide.
Small amounts of 5-hydroxytryptamine may be excreted in the urine, 
but several other routes are available for the inactivation of the amine, 
apart from the major route to 5-hydroxindole-3-acetic acid. Initial 
acétylation yields an #xdretable metabolite, but particularly in the 
mammalian pineal gland, acétylation followed by 0-methylation by hydroxy-o- 
methyl transferase produces the biologically active melatonin. Both the 
activity of the enzyme and the concentration of its product show a marked 
circadian variation. The latter depends on the former which is itself 
controlled by sympathetic innervation (Snyder, Axelrod and Zweig 1967) .
The role of melatonin, and the importance of its localisation in the 
pineal glgnd of mammals, is rather obscure. A general inhibitory effect 
on the gonads decelerates sexual maturation in females, and reduces the 
weight of seminal vesicles in male rats (Wurtman and Axelrod 1968). 
Melatonin has no effect on the melanocytes of mammalian skin, but has the 
ability to lighten the skin of amphibians.
N, N-dimethy1 ation of 5-hydroxytryptamine produces the psychoaCtive 
compound bufotenine (5-hydroxy-N, N-dimethyltryptamine), a hallucinogen, 
which is naturally occurring in some mushrooms, seeds of Piptodenia
15
peregrina, and the skin of some toads. Since the enzymes which could 
convert 5-hydroxytryptamine to bufotenine are present in the CNS, it 
has been suggested that this compound may play a role in the production 
of the symptoms of schizophrenia^
It is possible that a hallucinogen may also result from the 
abnormal degradation of melatonin. Normally melatonin is hydroxylated 
in the liver on the sixth C atom, and excreted as the conjugated 
sulphate or glucuronide. Mclsaac (1961) proposed that under certain 
unspecified conditions, melatonin may be converted to 10-methoxyharmalan, 
a hallucinogenic alkaloid, by the simple loss of a molecule of water and 
the closing of the side chain to form a tricyclic alkaloid.
A further route of inactivation of 5-hydroxytryptemine is by 
conjugation with sulphates. A sulphotransferase with this ability has 
been found in the brain ( Gal 1972). Although the sulphotransferase 
normally plays a minor part in the inactivation of the amine, this 
system may be important following monoamine oxidase inhibition.
1.7 The Regulation of 5-hydroxytryptamine Concentrations in the CNS 
It is apparent from the foregoing survey, and it will become more 
apparent in subsequent chapters, that many factors may be expected to 
affect the concentrations of 5-hydroxytryptamine in the CNS. It is 
equally clear that this concentration is rigidly controlled at any given 
time of day, but varies equally consistently throughout the twenty four 
hours of that day. Several workers have concluded that the regulation 
of the amine concentration is a function of the activity of tryptophan-5- 
hydroxylase (Green and Sawyer 1966). However, the enzyme is not 
saturated with its substrate (Jequier, Robinson, Lovenberg and 
Sjoerdsma 1969), and Grahame-Smith (1973) doubted the validity of the
16.
widely held belief that this enzyme is the rate limiting step:-
"I find it very difficult to conceive that the regulation of a 
crucial functional pool of neuronal 5-^hydroxytryptamine can depend upon 
the fine regulation of tryptophan hydroxylation, when this enzymic 
activity is so dependent upon the brain tryptophan concentration, which
is not finely controlled. r-------  compartmentation with regard to
storage in granular binding sites and elsewhere, and a controlled 
intraneuronal metabolism of synthesised,, in excess of needs, amounts 
of 5-hydroxytryptamine seems more likely mechanisms, regulating the size 
and activity of those pools of 5-hydroxytryptamine which are of such 
crucial functional importance.*'
Renson (1973) found it difficult to believe that the concentration 
of tryptophan was the single controlling factor, and Aghajanian (1973) 
found no increase in tryptophan levels following an increased 
5-hydroxytryptamine turnover after stimulation of the raphe nuclei. 
However Glowinski, Hamon and Hery (1972) suggested that the^available* 
concentration of tryptophan, was important, that this may be regulated by 
cyclic adenosine 3*,5'monophosphate (AMP), and in addition, that the 
intraneuronal levels of the transmitter play a part in its own rate 
of synthesis. Schubert (1973) suggested that, the size of the 
5-hydroxytryptamine pools limits the synthesis of the transmitter.
A  summary of some of the controlling factors of 5-hydroxytryptamine 
concentrations in the brain of the rat can be seen in Figure 4.
17.
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Figure 4.
A  model to suggest the possible regulating
factors of 5-hydroxytryptamine synthesis in 
the rat brain.
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1.8 Alterations of 5-hydroxytryptamine Metabolism by Drugs
A  large number of drugs have been shown to alter the metabolism 
of 5-hydroxytryptamine in the CNS. A  few of the more important of 
these will be considered.
The methyl xanthines, caffeine, theophylline and theobromine are 
probably the most widely consumed group of drugs, and have been shown 
to markedly influence the disposition of brain 5-hydroxytryptamine 
(Berkowitz and Spector 1971). These compounds produce increased 
levels of 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in 
the brain, and have been used therapeutically alone, or in combination 
with other drugs, to control migraine headache, hyperthermia and to 
induce sedation and sleep. Abnormal 5-hydroxytryptamine metabolism 
has been implicated with all these maladies.
The benzodiazepines are a class of compounds widely preferred as 
minor tranquillisers (chlordiazepoxide, diazepam) and hypnotics 
(nitrazepam, flurazepam) . Chase, Katz and Kopin (1970) recorded a 
decreased efflux of 5-hydroxyindole-3-acetic acid following 
administration of the drugs, while Dominic (1973) found a depression of 
the 5-hydfoxytryptamine biosynthetic and metabolic pathway in the brain.
These compounds do have a marked effect on the diencephalic and 
telencephalic regions, whilst having little affect on the brain stem.
It has been concluded by some that behavioural suppression induced by 
anxiety may be mediated by 5-hydroxtryptamine, nevertheless the site of 
action of the benzodiazepines has not been elucidated.
Two groups of drugs are commonly used in the management of patients 
with psychotic depressions. These are the monoamine oxidase inhibitors 
ego iproniazid, isocarboxazid, nialamide, phenylzine, tranylcypromine 
and the aminodibenzyl derivatives (tricyclic antidepressants), e.g. imipramine.
19.
amitryptyline, dèsmethylimipramine. Most patients are helped by
the administration of one of these drugs. The biochemical action 
of these compounds serves to increase the concentrations of nor^ 
adrenaline and 5-hydroxytryptamine in the brain, either by inhibition 
of monoainine oxidase in the former group, or by inhibition of the 
aminergic reuptake mechanisms in the nerve terminal in the latter group. 
The behavioural stimulation of animals can occur not only by mechanisms 
involving noradrenaline, the concentrations of which are certainly 
increased in the brain, but also by the selective increase of 5-hydroxy­
tryptamine concentrations (Bueno, Pscheidt and Himwich 1968). Indeed 
increased concentrations of 5-hydroxytryptamine, with normal noradrenaline 
concentrations, seem to assure behavioural stimulation. Coppen (1967) 
concluded that a dearth of 5-hydroxytryptamine may be involved in the 
mechanism of the endogenous depressions in some patients. Conversely 
an excess of 5-hydroxytryptamine has been implicated in manic episodes. 
This is evident from work with methysergide, which has been shown to 
reduce 5-hydroxytryptamine in the CNS (Oswald, Ashcroft, Beger, Ecclèston, 
Evans and Thacore 1966), whilst : relieving manic episodes (Verster 1963). 
The drug may even induce a subsequent depression (Serry 1969). Lithium, 
another drug which has been used in the treatment of manic episodes, has 
been shown to decrease 5-hydroxytryptamine turnover in rat brain.
(Corrodi, Fuxe and Schou 1969).
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1.9 The Role of 5-hydroxytryptamine in the CNS.
Many theories have suggested a role for 5-hydroxytryptamine in 
the CNS. Among those most popular are the involvement of the amine 
in maintaining a balance of the general behaviour of the animal, in 
pain recognition, in hypothermia, sleep, learning and memory, male 
sexual behaviour and stress, while a lack of the amine has been 
considered to cause symptoms of depression* schizophrenia and 
convulsive disorders including Parkinson's disease. The presence 
of the amine in the CNS is not essential to life, but to the 
quality of life, and perhaps to mood.
To suggest that 5-hydroxytryptamine, in isolation, has a 
specific role in the CNS is probably an oversimplification. It 
appears more likely that the amine is part of an interacting system, 
and it is the balance of the components of the system which produces 
the observed behavioural pattern. I intend to present only the data 
which is relevant to 5-hydroxytryptamine. The possible involvement 
of other systems will be borne in mind and will figure in the final 
discussion.
During the last few years Jouvet et al. and other workers have 
accumulated a large amount of evidence to suggest that 5-hydroxytrypt^ 
amine is involved in, and may be responsible for slow wave sleep, and 
for the priming of paradoxical sleep. There seems little doubt that 
the axonal system emanating from the raphe nuclei is involved, to a 
large extent, in this basic physiological response.
Much of the evidence which supports a role for 5-hydroxytryptamine 
in determining an animal's sensitivity to painful stimuli has been 
obtained by placing lesions in the ascending axonal system from the 
raphe nuclei, and demonstrating a decrease in brain concentrations 
of 5-hydroxytryptamine (Lorens, Sorensen and Harvey 1970) and a
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concomitant increased sensitivity to painful stimuli, especially foot 
shock (Evans 1961). Lesions in other regions of the brain do not 
produce either of these effects. It is important to note, at this 
point, that workers who have attempted to establish a biochemical 
correlate of learning and memory, often used a foot shock technique. 
Woolley and Van der Hoeven (1963) found that animals l e a m  more 
quickly when 5-hydroxytryptamine has been depleted, but it is not 
possible to exclude the suggestion of an increased sensitivity to 
pain producing the observed response.
p-Chlorophenylalanine (p-CPA) is a specific depletor of brain 
5-hydroxytryptamine* and manifests its action by inhibiting tryptophan- 
5-hydroxylase (Koe and Weissman 1966). Evidence that p-CPA acts as 
an aphrodisiac in males is somewhat equivocal, but the work of Cessa 
and Tagliamonte (1974) in rats and rabbits would support the hypothesis. 
Many workers have found an enhancement of mounting behaviour in male 
rats treated with p-CPA or p-CPA plus a monoamine oxidase inhibitor* 
although a decrease, increase or no change in ejaculation frequency 
has been recorded by different groups of workers. The suggestion 
remains that 5-hydroxytryptamine participates in the regulation of 
male sexual behaviour.
Feldberg and Myers (1964) proposed the monoamine theory of 
thermoregulation, whereby hypothalamic release of 5-hydroxytryptamine 
and noradrenaline in a balanced situation could regulate the temperature 
of a mammal around a, fixed reference temperature of approximately 37°C. 
5-hydroxytryptamine evokes hyperthermia when injected into the anterior 
hypothalamic pre^optic area of monkeys and cats. In these animals, 
the amine may be a transmitter activating the central heat conservation 
and production pathways (Myers 1973).
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An increase in alerting has been recorded following the 
stimulation of the cell bodies of 5-hydroxytryptamine containing 
neurones in the raphe nuclei (Sheard and Aghajanian 1968). Thierry, 
Fekete and Glowinski (1968) showed that stress activates the 
indoleamine system, whereas isolation depresses it. An increase 
in 5-hydroxytryptamine metabolism following stress may last for 
many days if the animals are maintained in an unfavourable environment, 
such as being intermittently shocked on a grid (Bliss 1973) .
5-hydroxyindole-3-acetic acid concentrations in the brain remain 
increased several hours after the presentation of a single stressful 
stimulus.
Altered metabolism of 5-hydroxytryptamine in psychiatric and 
neurological disorders has been suspected or demonstrated. The 
amine has been implicated in phenylketonuria, mongolism, Hartnup’s 
disease, migraine, Parkinson’s disease, depression and schizophrenia 
to a greater or lesser degree.
1.10 Interactions of 5-hydroxytryptamine with Catecholamines and Cyclic■ 
AMP in the CNS
Although this thesis deals mainly with 5-hydroxytryptamine and the 
indoleamine pathways in the brain, it is not possible tô consider this 
system in isolation, but rather as a part of an integrated and highly 
complex unit in which actions of other systems may modify, or even 
control, the physiological manifestations of this particular system,
a) Catecholamines
Several physiological aspects of catecholamine and 
5-hydroxytryptamine interaction can be readily recognised.
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Jouvet (1969) has demonstrated a classical example 
of the way in which the two systems interact to produce 
the characteristic signs of normal sleep,
5-hydroxytryptamine induces slow wave sleep and possibly 
prepares for the noradrenaline-induced paradoxical sleep, 
which cannot be induced in the absence of slow wave sleep.
Bliss (1973) has found an interaction between dopamine and 
5-hydroxytryptamine which is manisfested in stress reactions. 
Both aminergic systems are activated during gross behavioural 
disturbances. While muscular activity and fear activate 
dopaminergic neurones "something related to gender" activates 
5-hydroxytryptamine neurones. Both systems are required to 
produce the normal reactions to stress.
Of clinical importance is the suggested interaction between 
dopamine and 5-hydroxytryptamine systems in Parkinson's 
disease, following Homykiewicz's (1966) finding that the 
concentration of both of the amines was decreased in the 
substantia nigra of patients suffering from the disease.
The caudate nucleus is also implicated in Parkinson's disease, 
and dopamine has been suggested to be a neurot ransmitter in 
this region where the balance of the two amines is crucial 
(Van der Wende and Johnson 1970). Dopamine is located in 
the soluble fraction of homogenates, and 5-hydroxytryptamine 
in the bound form (Laverty, Michael son, Sharman and Whittaker, 
1963). Van der Wende and Johnson (1970) have suggested that 
5-hydroxytryptamine might be released to complex with the 
dopamine to modulate its action, and thus regulate catecholamine 
activity on a purely molecular level. This complex can occur
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between all catecholamines and 5-hydroxytryptamine, 
and appears to inhibit the oxidation of the catecholamines. 
The diurnal variation of 5-hydroxytryptamine may, in part, 
be controlled by catecholamine neurones in the CNS 
(Hery, Rouer and Glowinski 197 3), although Bobillier 
and Mouret (1971) found the rhythms of the two amines to 
be independent. The diurnal variation of 5-hydroxytrypt­
amine in the mammalian pineal gland is controlled by a 
noradrenergic system, since sympathectomy abolishes the 
rhythm (Zweig and Axelrod 1969) . Although the activity 
of the pineal gland cannot be related to brain activity, 
there does appear to be some evidence for an interaction 
between these amines in the brain.
Asano (1971) compared the maturation of the circadian 
rhythms of noradrenaline and 5-hydroxytryptamine in the 
rat. Animals up to 17 days post natal showed a similar 
pattern for both amines, with highest concentrations during 
the dark period. From day 21 until day 66 these rhythms 
reached maturity with maximum concentrations of 
5-hydroxytryptamine in the light period, and highest 
concentrations of noradrenaline in the dark period. The 
maturation of these rhythms was closely associated with 
those of locomotor activity and the sleep/wake mechanism,
b) Cyclic 3*,5* Adenosine Mono Phosphate (AMP)
Increased concentrations of cyclic AMP have been detected 
in pharmacological (Cramer, Ng and Chase 1972) and 
physiological situations (Hamadah, Holmes, Barker, Hartman 
and Parke 1972) which stimulate 5-hydroxytryptamine synthesis
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Tagliamonte et al (1971(a)) increased the rate of 
synthesis of 5-hydroxytryptamine, without altering 
the concentration of the amine in the brain, following 
cyclic AMP or dibutyryl cyclic AMP injection into the 
lateral ventricles. There was a marked increase in the 
concentration of the amino acid precursor tryptophan, and 
an increased uptake of labelled tryptophan into slices of 
brain. Since tryptophan-5-hydroxylase is probably not 
saturated with its substrate, the increase in synthesis 
of 5-hydroxytryptamine is probably secondary to the 
increased concentrations of tryptophan in the brain.
Brain a deny1 cyclase and phosphodiesterase, enzymes 
which catalyse the fomation and degradation of cyclic 
AMP, are concentrated in the synaptosomal fraction of 
tissue homogenates (De Robertis, Rodriguez de Lores Arnaiz, 
Alberici, Butcher and Sutherland 1967). It is therefore 
conceivable that cyclic AMP is closely associated with 
5-hydroxytryptamine-containing nerve terminals, and may 
play an integral part in the control of the synthesis of 
the amine in the CNS.
1.11 Circadian Rhythms
Biological rhythms have been detected throughout the plant and 
animal kin gdcms, vary in g in frequency from many cycles per second e.g. 
heart beat, to one cycle in many years e.g. the flowering cycle of 
several large cacti. Biological rhythms have been recently well 
reviewed (Mills 1973), and further details will not be presented here.
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When the frequency of a rhythm is approximately one cycle per 
d ^ ,  the rhythm is termed circadian, and may be recognised by certain 
cha racteristi cs.
1) The rhythm has a frequency of approximately one day, and
may be entrained to exactly twenty-four hours.
2) The oscillation often conforms to the mathematical shape
of a sine curve.
3) The rhythm maintains its frequency independently of the
rhythms for habit or environment.
4) If the rhythm is entrained to a n e w  period, it will undergo
a period of disruption before entrainment; similarly it will 
not immediately revert to the former period when it is 
re-presented.
5) Circadian rhythms are nearly always nycthemeral.
5-hydroxytryptamine displays a circadian rhythm. In this thesis
I have investigated the rhythm of 5-hydroxytryptamine following its 
entrainment to twenty-four hours. Hence in the title and throughout 
this thesis, the term "twenty-four hour rhythm" has been used instead 
of the often incorrectly applied term " circadian rhythm".
The origins of circadian rhythms are not known, although several 
theories have been proposed, mainly conceltning endogenous biochemical 
fluctuations (Molchanov 1971). Ehret and Trucco (1967) suggested 
the "Chrcnon Concept", whereby the rhythms are based on the recycling 
of a mechanism regulating the transcription of template RNA (ribonucleic 
acid) from DNA (deoxyribonucleic acid). Even on these bases it is not 
clear what is causing the rhythm, whether it relates to the synthesis 
of inhibitors and/or substrate, or perhaps to some form of compart­
mentation (Hastings 1970).
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Many workers have envisaged the controlling centre of circadian 
variations as a biological clock. The location of this "clock" has 
nearly always been the brain, and more specifically the thalamus 
(Strughold 1965) or hypothalamus (Mills and Conroy 1970) . This 
work has not attempted to locate a "clock"* but has looked for a 
controlling influence in one or more factors in the metabolism of 
5-hydroxytryptamine, or in an association with other brain 
constituents capable of regulating the circadian rhythm of the amine 
This influence may itself subsequently be controlled by a "clock".
1.12 Statistical Analysis of Circadian Data
With the presentation of a series of data, which together 
apparently form a rhythm in a single cycle e.g. a twenty-four hour 
rhythm with a single acrophase, it is desirable to obtain an objective 
estimate of the phase and amplitude of the rhythm. It is not 
satisfactory simply to compare the highest values with the lowest 
values, since one may rightly be accused of "data snooping". The usual 
method is to attempt to fit the observed data to a sine curve, a 
geometric model with a natural, recognised rhythm. It is assumed that 
if the data do not significantly differ from the calculated sine curve, 
then a rhythm is in evidence, whose highest values do differ from lowest 
values. In this thesis only data collected at equal time intervals 
over a twenty-four hour period have been examined. The analysis is 
thus straightforward. (For analysing more complex irregularly collected 
data see Fort and Mills 1970).
In this instance, the best fit sine curve has been calculated using 
the Fourier analysis, and the experimental data compared to the calculated 
data by means of the x2 test.
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C H A P T E R  T W O
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CONTROL OF THE ENVIRONMENT
2.1 INTRODUCTION
The normal environmental conditions in the laboratory or 
animal house vary, particularly with respect to lighting, noise 
and temperature, throughout the seasons. In any animal experiment 
it is necessary to control these parameters, and it is particularly 
vital if circadian variations are being estimated. In addition, 
there is ample evidence to suggest that the concentration and 
metabolism of 5-hydroxytryptamine in the brain is susceptible to 
environmental fluctuations (Hauty and Adams 1966a,b; Schwartz and 
Aghajanian 1969; Thierry, Fekete and Glowinski 1968). In planning 
the experiments presented in this thesis, it was therefore doubly 
important that environmental variability should be controlled.
The possibility that circadian changes in the performance 
of the operator may produce changes in circadian data being assessed, 
is a,criticism which has often been levelled at workers in this field 
In the cabinets described in this chapter, it is possible to arrange 
the lighting cycle, so that samples may be taken during the normal 
working period of the operator. In addition, noise levels, 
temperature and stress could be maintained within acceptable limits 
(Hillier, Davies and Redfern 1973).
2.2 Cabinet Construction
The dimensions of the cabinet, which was made from ^/lO in. 
blockboard, are shown in Figure 5. To ensure light proofing, 
i in. plastic foam strips were sandwiched between adjoining faces 
To increase sound insulation, each cabinet was lined with | in. 














Figure 5. The Dimensions of the environmental cabinet.
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bottom edge, and were closed with a latch fitting. The cabinets were 
lit by 12 in. miniature fluorescent fittings with 8 watt, warm white 
tubes (Thorn L.J. SIOOS.H). To prevent overheating, the choke was 
removed from each fitting and reassembled outside the cabinet. Each 
light was connected through a time switch (Sangamo Type 5254-1-171).
The maintenance of animals under these conditions of light and 
sound insulation, poses the problem of dispensing heat and water 
vapour. This problem was overcome by using domestic extractor fans 
(Xpelair FXC 6) to pull a constant stream of air through the cabinets. 
One fan, which was capable of removing 1,200 cu.ft. of air per hour, 
served two cabinets, to which it was connected through triple gauge 
1| in. bore rubber tubing. The intake was first passed through an 
insulated chamber containing a 300 watt infra red bulb. This was 
activated by a thermostat inside the cabinet, so that in the event 
of a fall in temperature inside the cabinet, the temperature of the 
air input was automatically increased.
The complete apparatus is shown diagrammatically in Figure 6.
A constant watering reservoir was included, and by using extra large 
food hoppers on the cages, animals (in groups of seven or eight) 
could be left undisturbed for up to fourteen days.
2.3 Cabinet Characterisation
The cabinets were shown to be light proof, by leaving a 
photographic plate inside the cabinet, locking the cabinet, and 
exposing the cabinets to the normal lighting of the laboratory. 
The photographic plate was subsequently removed and developed and 










Figure 6 . The Organisation of the controlled environmental 
system.
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The cabinets were tested for sound proofing by exposing them to 
varying frequencies and intensities of sound at a distance of ten 
feet from the cabinets. A portable tape recorder was used to record 
sound within the cabinets. The cabinets were found to be sound 
proofed, under these conditions, below 74 dB, a level considered to 
be well within the normal noise levels of the laboratory, and therefore 
satisfactory for our purposes. The constant background noise 
provided by the extractor fans, provided an additional buffer to 
external auditory cues.
With the thermostat set at 24°C, the temperature inside the 
cabinets varied by t 1.5°C over a seven day trial period. However, 
it must be remembered that since there is no means of lowering the 
temperature inside the cabinets, a large increase in temperature in 
the laboratory could cause a corresponding increase in temperature 
in the cabinets. In this respect therefore, the apparatus is not 
fully independent of the external environment. This could be overcome 
by the provision of some mechanism for cooling the air input, but the 
necessity for such a provision has not yet been encountered.
These cabinets, constructed and set up in groups of four, using 
the extraction and heating systems described, have been used with 
complete satisfaction throughout the period encompassed by this 
thesis a
2.4 Maintenance of Animals
The experiments were performed with the rats maintained as 
follows:
Male Sprague Dawley rats (120 - 140g) were kept in groups of 
seven or eight, with one group per cabinet. Using extra large food
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hoppers and a constant watering reservoir system, the rats had 
access to food (Oxoid Breeding Diet) and water ad libitum, and 
could remain undisturbed for up to fourteen days.
In many experiments, the rats were on a reversed lighting
regimen, and therefore had undergone a phase shift upon entry 
into the cabinets. At least ten days were therefore allowed 
for acclimatisation for all groups of animals (Davies, Navaratnam 
and Redfern 1974). There was no recognisable difference between 
groups of animals maintained on a 'normal' lighting regimen,and 
those on the reversed schedule. Weight gain, weight of food
consumed and volume of fluid intake were all similar.
In all experiments the rats were maintained either on a
06.00 - 18.00 light/dark schedule or a 06.00 - 18.00 dark/light 
schedule, thus giving twelve hours light and twelve hours dark 
per twenty-four hour day. The temperature was maintained at 
24 i 1.5°C throughout.
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C H A P T E R  T H R E E
The twenty-four hour Rhythm of 5-hydroxytryptamine 
in the Rat Brain.
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3.1 INTRODUCTION
A twenty-four hour or circadian fluctuation in the concentration 
of 5-hydroxytryptamine has been demonstrated in the whole brain of the 
rat. (Montanaro, Casoli and Babbini 1964; Dixit and Buckley 1967; 
Montanaro and Graziani 1967; Scheving, Harrison, Gordon and Pauly 1968; 
Schwartz and Aghajanian 1969; Okada 1971; Asano 1971; and 
Davies and Redfern 1970), in the whole brain of the mouse (Albrecht, 
Visscher, Bittner and Halberg 1956; and Morgan and ¥ndo 1973) , the 
whole brain of the hamster (Matussek and Patshke 1963), various brain 
regions in the rat (Quay 1963, 1964, 1965, 1968; Piske 1964; Snyder 
and Axelrod 1964; Snyder, Axelrod, Fischer and Wurtman 1964; Snyder, 
Axelrod and Zweig 1965; Snyder and Axelrod 1965; Snyder, Axelrod, 
Wurtman and Fischer 1965; Axelrod, Snyder, Moore and Heller 1966;
Snyder and Zweig 1966; Snyder, Axelrod and Zweig 1967; Walker and 
Friedman 1967; Friedman and Walker 1968; Snyder 1968; Wurtman,
Axelrod and Kelly 1968; Merritt and Sulkowski 1969; Bobillier and 
Mouret 1971; Scapagnini, Moberg, Van Loon, DeGroot and Geàong 1971; 
Hery, Rouer and Glowinski 1972) in brain regions of the cat (Reis, 
Weinbren and Corvelli 1968; Reis, Corvelli and Conners 1969) and in 
the turtle (Quay 1967).
In the work on whole rat brain, the highest concentration of 
5-hydroxytryptamine was found during the light period, and the lowest 
concentration during the dark period.
In brain regions of the rat, circadian rhythms of 5-hydroxytrypt^ 
amine concentrations have also been found, with highest concentrations 
during the light period and lowest concentrations during the dark period 
e.g. in the pimeal gland (Quay 1963, 1964, 1968; Snyder and Axelrod 
1964; Fiske 1964; Snyder, Axelrod, Fischer and Wurtman 1964; Snyder,
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Zweig and Axelrod 1964; Snyder and Axelrod 1965; Snyder, Axelrod 
and Zweig 1965; Snyder, Zweig, Axelrod and Fischer 1965; Snyder, 
Axelrod, Wurtman and Fischer 1965; Snyder and Zweig 1966; Axelrod. 
Snyder, Moore and Heller 1966; Snyder, Axelrod and Zweig 1967;
Snyder 1968; Wurtman, Axelrod and Kelly 1968; Merritt and 
Sulkowski 1969). In 1964 Quay reported that there was not a 
circadian rhythm of 5-hydroxytryptamine in the anterior or posterior 
hypothalamus I but later (1968) he reported a rhythm in whole 
hypothalamus, a finding which was confirmed by Hery, Rouer and 
Glowinski (1972). Quay (1965) found rhythms in three areas of the 
cortex, with higher concentrations in the dorsal frontopolar regions 
than in more posterior areas, while Hery, Rouer and Glowinski (1972) 
reported a rhythm in whole cortex. Other authors have shown that 
the circadian or twenty-four hour rhythm of 5-hydroxytryptamine exists 
in every brain region in which it has been investigated, e.g. in whole 
brainstem (Hery, Rouer and Glowinski 1972), lateral lower brainstem 
(Quay 1968), mid brain and caudate nucleus (Friedman and Walker 1967), 
amygdala and hippocampus (Scapagnini, Moberg, Van Loon and De Groot 
1971).
It would thus appear that the summation of the circadian effects 
on the concentration of 5-hydroxytryptamine in the brain region is 
responsible for the large fluctuation measured in whole brain, and 
since the rhythm of whole brain 5-hydroxytryptamine concentrations 
is similar to that of every brain region investigated, the whole rat 
brain was mainly used as the tissue of study in this thesis.
Although a large number of workers have reported the circadian 
or twenty-four hour variation of 5-hydroxytryptamine concentrations, 
it was necessary to establish such a rhythm under the conditions 
employed in our own laboratories, and then to investigate the 
regulating factors of this rhythm under these same conditions.
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3.2 METHODS
Male Sprague Dawley rats (120 - 140g) were housed, in groups 
of seven or eight under the constant environmental conditions described 
in Chapter Two, for at least ten days before each experiment. Different 
groups of rats were killed at intervals of four hours commencing at
09.00 ho When those groups housed in a reversed lighting cycle were 
killed, the laboratory was illuminated only by a red photographic 
safety lamp, since red light has been shown to have no significant 
effect on circadian variations (McGuire, Rand and Wurtman 1973).
The rats were killed by decapitation, the pineal gland removed, 
and the whole brain dissected out from a position immediately caudal 
to the cerebellum. The brains were frozen in liquid nitrogen and 
stored at -14°C until assayed. The time taken for the removal of 
the brain never exceeded two minutes.
3.2.1. Extraction
(Shore and Olin 1958). Brains were weighed and subsequently 
homogenised in washed acid n-butan-l-ol (10 ml/g tissue), using an 
MoS.E. high speed rotary cutter (Type 7700) at approximately 9,500 
r.p.m. for three minutes. The homogenate was centrifuged at 4,000 
r.p.m. for five minutes in a bench centrifuge. The whole of the 
organic layer was transferred to 125 ml'medical flats' containing 
15 ml water and 30 ml n-heptane, and shaken for five minutes in a 
mechanical shaker (Gallenkamp super shaker SD-050), after which the 
bottles were centrifuged at 500g for three minutes.
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3o2o2 Assay of 5-hydroxytryptamine
The assay used was a modification of that of Snyder, Axelrod 
and Zweig (1965).
2oO ml of the aqueous phase was shaken for five minutes with
2.0 ml. borate buffer pH 10.0, 10 ml.washed n-butan-l-ol, and 
approximately 2g of sodium chloride in 125 m l ’medical flats’ as 
described before.
The bottles were centrifuged as described previously, and 
5 ml.of the organic phase was transferred to bottles containing 
10 ml. n-heptane and 2.0 ml. phosphate buffer pH 7.0. The bottles 
were shaken for five minutes and centrifuged for three minutes as 
described before.
1.2 ml. of the aqueous phase was heated for thirty minutes at 
70°C with 0.1 ml. 0.1 M  ninhydrin reagent (indane-trione-hydrate) 
in screw top test tubes. After cooling for one hour at 4°C, the 
fluorescence was measured against aqueous standards, and internal and 
external reagent standards at activation wavelength 380 mp. and 
emission wavelength 490 mp. (wavelengths uncorrected) in an Amineo- 
Bowman spectrophotofluorometer.
3.2.3 Characterisation of 5-hydroxytryptamine
The extracted product was shown to have a fluorescence spectrum 
identical to that of pure 5-hydroxytryptamine (Sigma), and may therefore 
be assumed to be 5-hydroxytryptamine (Figure 7)«
The effect of related indoleamines on the fluorescence of 
5-hydroxytryptamine was also measured. Tryptophan, 5-hydroxytryptophan 
and 5-hydroxyindole-3-acetic acid were extracted, and the fluorescence 
developed and measured as described for 5-hydroxytryptamine.
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None of these indoleamines produced a fluorescent product 
which gave a measurement exceeding that of a phosphate buffer 
blank. The results which follow can therefore be taken to be 
a true measure of 5-hydroxytryptamine content of the brain.
3.2.4 Statistical Methods
Statistical significance of the twenty-four hour variation of 
5-hydroxytryptamine concentrations in the rat brain was determined 
by Fourier analysis and the test as described in Chapter One.
3.3 RESULTS
The twenty-four hour rhythm of brain concentrations of 
5-hydroxytryptamine, obtained by the methods described, is shown 
in Figure 8, and is compared with the calculated sine curve in 
Figure 9. Brain 5-hydroxytryptamine concentrations are expressed 
in millimicrograms per gram of brain wet weight t standard error of 
the mean (S.E.M.), and are plotted against clock hour. The twenty- 
four hour rhythm was not significantly different from the calculated 
sine curve. The highest concentration of 5-hydroxytryptamine 
(444.3 - 8.1 mpgo/g) was found in the middle of the light period at
13.00 h., and the lowest concentration (289.1 - 11.0 nyig./g) in the 
middle of the dark period at OltOO h. A forty per cent fluctuation 
was shown, and values at the nadir and zenith of the curve were 
significantly different at the p < 0.001 level by Students' t test 
analysis.
Characteristically the rate of change of 5-hydroxytryptamine 
concentrations slowed during both the ascending and descending 
























































Figure 7 . The fluorescence spectrum of extracted
5-hydroxytryptamine (a) compared with the pure 
product (b) . (□•— " □) excitation 380mfi, scan 
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Figure 8 The twenty-four hour rhythm of 5-hydroxtryptamine 
concentrations in the rat brain. Concentrations 
are expressed in mpg/g brain wet weight, t S.E.M. 
The numbers of animals used at each clock hour 
are shown in parentheses. The solid black bars 
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Figure 9. The twenty-four hour rhythm of 5-hydroxytryptamine
concentrations (•----- ©) compared with the
calculated sine curve (O O) •
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respectively 0 The possible significance of this finding will 
be discussed in Chapter Twelve,
Because seven groups of animals were measured in the full 
twenty-four hours, animals in the first and last group were killed 
at the same clock hour on consecutive days. Since brain 
5-hydroxytryptamine concentrations, determined from these two 
groups, did not show any significant difference, it can be 
concluded that the methods used were consistent. The twenty-four 
hour rhythm recorded is a true reflection of cerebral changes of 
5-hydroxytryptamine, and is not an artifact dependent on 
environmental or operant variation.
The calculation of recovery from the extraction procedure 
was carried out by the use of internal standards and by istopic 
methods. The recovery was 48,4 1 1,6%, In these and all 
subsequent graphs and tables, values have not been corrected for 
recovery.
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3o4 The in vivo and in vitro Uptake of 5-hydroxytryptamine 
into rat brain,
In vitro studies have demonstrated active transport mechanisms 
for the uptake of 5-hydroxytryptamine by blood platelets (Hughes and 
Brodie 1959; Weissbach, Redfield and Titus 1960), and by rat brain 
slices (Blackburn, French and Merrills 1967). Conversely 
Schanberg (1963) using rat brain, and Robinson, Anderson and 
Green (1965) using particulate fractions of rat brain, suggested that, 
in vitro, uptake of 5-hydroxytryptamine was due to passive diffusion and 
non-specific binding, although, in vivo, the uptake of 5-hydroxytrypt­
amine by rat brain is affected by certain drugs (Palaic, Page and 
Khairallah 1967). Robinson, Anderson and Green (1965) indicated a 
non-specific ion-exchange binding of 5-hydroxytryptamine to
synaptosomes and microsomal fractions of brain slices at a
-4
concentration of 1 x 10 M, 5-hydroxytryptamine has also been shown 
to bind to mitochondria and proteins at 0°C (Marchbanks 1966), and to 
interact with lipid components of homogenates (Woolley and 
Campbell 1960),
More recently however, an active transport system has been shown
to be involved in the uptake of 5-hydroxytryptamine into the brain of
rats, mice and rabbits. Ross and Renyi (1969), investigating the
uptake of H-5-hydroxytryptamine into slices of mouse brain, found an
active transport system, with 7 x lO'^M and 0.23 mp mole/g
0 - 1 .
min , which was limited to low concentrations, being masked by passive 
diffusion at higher concentrations (10"^M), The uptake process could 
be blocked by tertiary tricyclic anti-depressants (imipramine, 
amitryptyline), rather less by secondary derivatives (desipramine, 
nortryptyline) and by cocaine both in vitro and in vivo,o<-Alkylated 
tryptamines were equipotent with imipramine in blocking
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5-hydroxytryptamine uptake, Carlsson (1970) calculated 
potency ratios for the blockade of the uptake process, with 
chlorimipramine > imipramine>  desipramine,
Shaskan and Snyder (1970) proposed two processes of 
5-hydroxytryptamine uptake, one of high affinity and one of 
low affinity, yielding Kg 1,7 x 10 and 8 x 10 
respectively in the corpus striatum. They proposed the high 
affinity process to be the uptake of the amine into 
5-hydroxytryptamine-containing nerve endings, consistent with 
the localisation of ^ H-5-hydroxytryptamine in these nerve endings 
following intra-ventricular injection of small doses of the 
^H-amine found by Aghajanian and Bloom (1967) , The low affinity 
process was suggested to be the uptake of 5-hydroxytryptamine into 
catecholaminergic neurones since the for competitive inhibition 
of noradrenaline uptake by 5-hydroxytryptamine approximately equalled 
the for the low affinity uptake process Shaskan and Snyder (1970). 
Iversen (1970) showed that impairment of catecholaminergic function 
by the injection of 6-hydroxydopamine inhibited the low affinity 
process, while the high affinity process was not affected, thus 
supporting the view of Shaskan and Snyder (1970), Wong, Horng 
and Fuller(1973)similarly demonstrated two uptake processes with
1 X 10 and 7,91 x 10 for the high and low affinity processes 
respectively.
Blockade of the uptake mechanisms has been shown by Horn (1973) 
using substituted derivatives of 5-hydroxytryptamine, Acétylation 
of the terminal amino group, méthylation of the 5-hydroxyl group or 
substituting hydroxyl groups onto other positions reduced the 
affinity for the 5-hydroxytryptamine uptake site. Substitution of 
the tryptamine side chain in the oi -position by methyl or ethyl but
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not carboxyl groups * or increasing the side chain by one carbon 
atom increased the affinity for the uptake site. Further work 
by Horn, Baumgarten and Schlossberger (1973) on the substituted 
hydroxyl derivatives showed 5, 6-dihydroxytryptamine to be the 
most potent inhibitor of 5-hydroxytryptamine uptake.
A circadian variation has been shown for the uptake of 
5-hydroxytryptamine in the hippocampus of rat brain (Wirtz-Justice 
and Hackmann 1973), but they were unable to find such a rhythm in 
other brain regions. Highest concentrations of 5-hydroxytryptamine 
were found at 08.00 h. and lowest concentrations at 20.00 h. on a 
lighting regimen 06.00 - 18.00 h.
Schubert (1973) summarised the regulating factors upon which 
5-hydroxytryptamine uptake depends.
"The accumulation of ^H-5-hydroxytryptamine in central neurones 
is dependent on the specific activity of the precursor, the rate of 
5-hydroxytryptamine synthesis and the degree of retention of the 
newly formed amine by the endogenous stores".
48,
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3o5 The Uptake of C-5-hydroXÿtryptamine into Homogenates 
of Rat Whole Brain.
3.5.1 METHODS
Male Sprague Dawley rats (120 - 140g) were housed under 
constant environmental conditions as described in Chapter Two 
for at least ten days before each experiment.
The animals were killed by decapitation, the pineal discarded, 
and the brain removed as previously described in this Chapter.
The brain was immediately weighed and transferred to a glass 
homogeniser tube containing 10 ml. ice-cold 0.32M sucrose, and 
homogenised on ice using six strokes of a teflon pestle 
(0.01" clearance) at mark 4 on a Camlab K41 homogeniser. The 
homogenate was centrifuged at 500g at 4°C for ten minutes. 1.0 ml, 
of the supernatant was added to 3.0 ml. Krebs-Ringer solution 
pH 7.4 of composition, NaCl 6.92, MgS0^.7.H20. 0.144, KH^PO^ 0.162, 
NaHCOg 2.1, KCl 0.354, CaCl2°6.H20 0.28, D-Glucose 2.0 (all values 
expressed as grams/litre distilled water) and pre-incubated at 37°C 
for ten minutes. All solutions were made up in Krebs-Ringer solution 
pH 7.4. 1.0 ml. 5-hydroxytryptamine-3-^^C creatinine sulphate 57 mCi/
m.mole (concentrations of the isotope, and conditions varying from 
those described here, are shown in the legends to the appropriate 
Figures) was added to the homogenate and incubated for varying times 
as indicated, 3.0 ml. ice-cold buffer was added and the homogenate 
centrifuged at 45,OOOg for twenty minutes at 0°C. The supernatant 
was discarded, the pellet washed with buffer and the tube blotted dry. 
After the addition of 1.0 ml. hyamine hydroxide, the pellet was left
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to digest overnight in the dark. 0.5 ml. of the digest was added to
5 ml. Unisolve (Koch Light), and counted in a Phillips PW4510/01 liquid
14
scintillation analyser, thus allowing the uptake of C-5-hydroxytrypt­
amine to be determined.
3.5.2 The twenty-four hour Variation of 5-hydroxytryptamine Uptake
Since the variation of 5-hydroxytryptamine concentrations in the 
rat brain is so consistent with respect to clock hour, and the difference 
between nadir and zenith is so marked, it was considered justified, when 
investigating factors which may contribute to the twenty-four hour 
rhythm, to carry out estimations at the two clock hours when 
5-^hydroxytryptamine concentrations were highest and lowest, namely
01.00 h. and 13.00 h.
The effects of temperature, pH, incubation time, glucose 
concentration and the subcellular distribution and Michaelis constant 
were therefore determined at these two clock hours.
3.5.3 The Effect of Temperature on the Uptake of ^^C-5-hydroxy- 
trypfamine
The method used was as previously described, using a Krebs-Ringer
14 o -7
solution pH 7.4. 1.0 ml. C-5-hydroxytryptamine 1 x 10 M  was added
to the diluted homogenate and incubated for ten minutes at 4°C, 10°C,
22°C, 37°C, 45°C and 60°C.
50
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3o5o4 The Effect of pH on the Uptake of C-5-hydroxytryptamine
The Krebs-Ringer solutions used for the dilution of the homogenate, 
14
and for making up the C-5-hydroxytryptamine solution were altered by 
the use of 2N-hydrochloric acid or 2N-sodium hydroxide to the following
pH:- 5oO, 6.0, 7oO, 7.4, 7.6, 7.9, 9.0. 1.0 ml. of ^^C-5-hydroxy-
-7 . o
tryptamine 5 x 10 M  was added and incubated for ten minutes at 37 C.
3.5.5 The Effect of Incubation time and D-Glucose concentration on
14
the Uptake of C-5-hydroxytryptamine
14 . -7 o
1.0 ml. C-5-hydroxytryptamine 5 x 10 M  was incubated in
Krebs-Ringer solution pH 7.4 at 37°C for the following times :- 15s, 45s,
75s, 1 min.45s, 2 mins.30s, 5 mins., 10 mins., 20 m ins., 30 min s .,
45 m i n s ., 60 mins.,
The experiment was repeated using Krebs-Ringer solutions containing
loOg/1 D-Glucose, 0.25g/l D-Glucose and O.Og/1 D-Glucose instead of the
normal 2.0g/l D-Glucose.
3.5.6 The Subcellular localisation of ^^C-5-hydroxytryptamine 
following Uptake into a homogenate of rat brain 
The procedure for determining the uptake of^^C-5-hydroxytryptamine
was carried out exactly as described previously, using 1.0 ml
14 0 - 7
C-5-hydroxytryptamine 5 x 10 M in Krebs-Ringer solution pH 7.4 at
37°C for ten minutes. The subcellular localisation of^^C-5-hydroxy­
tryptamine which had been taken up into the homogenate was determined 
as follows:
The homogenate was immediately poured onto an ice-cold discontinuous 
sucrose gradient of composition 0.32M, 0.8M, 1.2M sucrose . The gradients
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were centrifuged at 22,500 r.p^mo at 0°C for sixty minutes in a 
Beckman ultracentrifuge with SWo25.1 swing out rofor. The fractions 
were collected by puncturing the bottom of the tube and allowing the 
contents to drip into collecting tubes. 0.5 ml. digested pellet, 
or 0.5 ml. hyamine-treated supernatant fractions were taken for 
liquid scintillation analysis.
3.5.7 Determination of the Michaelis constant (K^)
14 . -7
1.0 ml. C-5-hydroxytryptamine of concentration 10 M to
10 ^M, was incubated with the homogenate for ten minutes at 37°C
in Krebs-Ringer solution pH 7.4. Since some of the isotope was
taken up by facilitated diffusion at low temperatures (Figure 10),
duplicate samples were incubated at 0°C for ten minutes and the
uptake was measured, and subtracted from the uptake recorded at
37°C. This was the procedure for calculating uptake kinetics
throughout this thesis.
The results were plotted according to the method of
Eisenthal and Cornish-Bowden (1974) (Figures 14, 15).
3.5.8 RESULTS AND DISCUSSION .
14
At both clock hours, the uptake of C-5-hydroxytryptamine into 
a homogenate of rat brain increased rapidly from 4°C to a maximum at 









Figure 1 0 . The effect of temperature on the uptake
of ^'^C-S-hydroxytryptamine (1 x into
rat brain homogenates, at 01.00 h ( H  B )
and 13.00 h ( A  A )  at pH 7.4 following
10 minutes incubation.
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A  specific pH requirement was found (Figure 11), reaching
maximum rates of uptake at pH 7.4 in Krebs-Ringer solution, and
decreasing rapidly either side of this optimum. There was no
significant difference between temperature and pH optima at the
two clock hours measured.
The concentration of D-Glucose in the incubation medium
was not critical, since even in a buffer containing no added 
14
D-Glucose, C-5-hydroxytryptamine was readily taken up. At
higher concentrations of glucose (lg/1 and 2g/l), 30% and 32%
increases respectively in the uptake of the amine were recorded.
It would thus appear that while D-Glucose induced an increased 
14
uptake of C-5-hydroxytryptamine when added to the incubation
medium, there was sufficient glucose present in the homogenised
brain to permit a limited uptake process.
The length of incubation time would appear to be important
(Figure 12), since saturation of the uptake system occurred rapidly
within the first two and a half minutes of incubation. The concentration 
14
of C-5-hydroxytryptamine taken up in the homogenate was maintained only
for the first ten minutes of incubation and was reduced after this period, 
possibly due to metabolism by monoamine oxidase, although Kannengiesser, 
Hunt and Raynaud (1973) found that 85% of the amine taken up was not 
metabolised.
The initial rapid accumulation of ^^C-5-hydroxytryptamine indicated 
that the uptake measured was not a single process. Since the method made 
measurement of uptake extremely difficult at times less than 15s., this 
part of the process has not been further investigated» 33% of the amine 
was taken up in this initial 15s. period, a rate more than four times 
greater than that during the following two minutes. It seems unlikely 
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Figure 1 1 . The effect of pH on the uptake of
^^C-5-hydroxytryptamine (5 x 10” ^M) 
into rat brain homogenates at 01.00 h
( B  a  ) and 13.00 h ( A  A )  at














Figure 1 2 . The effects of incubation time and glucose 
concentration on the uptake of 
^^C-5-hydroxytryptamine (5 x 10” ^M) into 
homogenates of rat brain at 13.00 h. Glucose
concentrations Og/1 (0----  0), 0.25 g/l (A-----A),
1.0 g/l ( © ---®), 2.0 g/l ( □ -- □), pH 7.4
and temperature 37°C.
56 0
initial very rapid uptake processo Since passive diffusion accounts
for only a small proportion of the amine taken up, the most plausible
explanation would appear to be that the amine exhibits a high degree
of non specific bindingo This binding apparently occurred in the
nerve ending fraction, since 64% of the total radioactivity was found
in this fraction, with the remainder in the supernatant (Figure 13),
and little associated with other particulate fractions.
The effects of incubation time and D-Glucose concentration were
similar at the two clock hours measured.
14
The rate of uptake of C-5-hydroxytryptamine was not proportional
to the concentration of exogenous substrate. A carrier-mediated
transport process of limited capacity is thus implicated. The
requirement for specific temperature and pH optima and the increase
in uptake with D-Glucose concentration indicated an energy-requiring
process. The K for ^^C-5-hydroxytryptamine uptake was 2.5 x 10
-6
at 13.00 h. and 3.1 x 10 M at 01.00 h. (Figures 14, 15). These two 
estimates were not significantly different. When calculated as c.p.m./g 
5 min., was approximately 15% higher at 01.00 h. than at 13.00 h.
(Figures 14, 15). This calculation does not allow for the difference 
in specific activity at the two clock hours. The implications of this 









Figure 13. The subcellular distribution of the uptake of
 ^ C-5-hydroxytryptamine (5 x 10" M) at 37°C pH 7.4. 
A-myelin component; B-nerve endings; C-mitochondria. 
The percentage uptake in each component is shown in 































































































































































3 o6 The Uptake of C-5-hydroxytryptamine into Homogenates
of Rat Brain Regions
3.6.1 METHODS
The rats were killed and the brains removed as described previously.
The greatest concentrations of 5-hydroxytryptamine-containing nerve
endings are in the septal region and the suprachiasmatic nucleus, and the
cell bodies of these nerve endings are found in the raphe nuclei
(Chapter One). The region containing the septum and the region
containing the raphe nuclei were therefore taken for the estimation of 
14
the uptake of C-5-hydroxytryptamine.
The brain stem area containing the raphe nuclei was dissected out 
(Figure 16) and immediately homogenised in 2.0 ml. ice-cold Krebs-Ringer 
solution pH 7.4. The pestle and tube were washed in a further 2.5 ml. 
ice-cold Krebs-Ringer solution and the washings added to the homogenate. 
The homogenate was diluted to 7.5 mis. with ice-cold Krebs-Ringer 
solution and kept on ice.
The septal region was removed (Figure 17) from two rats and 
homogenised separately in 1.0 ml. ice-cold Krebs-Ringer solution 
pH 7.4. The homogeniser pestle and tube were washed with 2.5 ml. 
ice-cold Krebs-Ringer solution and the washings added to the 
homogenate. The two homogenates were combined and the whole made 
up to 7.5 ml. with ice-cold Krebs-Ringer solution and kept on ice.





Figure 16. Diagrammatic representation of the area removed 
(shaded area) and used as a source of nerve cell 
bodies of 5-hydroxytryptamine-containing neurones 









Figure 17. Diagrammatic representation of the area removed 
(shaded) and used as a source of nerve endings 
from 5-hydroxytryptamine-containing neurones.
(--- represents the lines of cut).
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3o6c2 Estimation of the Michael is Constant (JC )
■ ' ' —  ■ ■   — '   m
The homogenates containing raphe nuclei and septal regions were
incubated for 5 minso at 37°C to equilibrate. 2.5 m i s . of a solution 
14
containing C-5-hydroxytryptamine in Krebs-Ringer solution was added. 
Concentration of the isotope are shown in Figures 18, 19, 20, 21.
1.0 mlc samples of the incubation mixture were taken after 1,2,4,6,8 
and 10 minso and immediately passed through a 0.22p mlllipore-filter. 
The residue was washed with 5 ml. ice-cold Krebs-Ringer solution to 
remove excess isotope. The filters were blotted dry, immersed in 
5 ml. Unisolve and taken for liquid scintillation analysis as before. 
The Michaelis constant was estimated at 01.00 h. and 13.00 h. as 
previously described in this Chapter. The results are the means 
of three determinations.
3.6.3 RESULTS AND DISCUSSION
The Michaelis constant of the septal region was estimated
as 4.9 X  10 ^M at 13.00 h. and 5.8 x 10 ^M at 01.00 h. Figures 18,19,
Since there is no significant difference between these two figures it
can be concluded that there is no twenty-four hour variation in the 
14
for the uptake of C-5-hydroxytryptamine into nerve endings of the
septal region of the brain of rats.
The Michaelis constant of the uptake of ^^C-5-hydroxytrypfamine
into a homogenate of brain stem was estimated as 1.2 x 10 ^M at
-6
01.00 h. and 1.3 x 10 M at 13.00 h. Figures 20, 21. These results 
do not suggest a twenty-four hour variation of the for uptake of 
the amine in this region. These estimations are similar to those for 
whole brain, but are less than those for the septal region, although 
the difference is not sufficiently large to suggest a different 
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Figure 19. Direct linear plot to determine the Michaelis
constant of ^^C-5-hydrpxytryptamine uptake into 
homogenates of the septal region of rat brain 

















































































































































































































Since it has already been shown that there is a twenty-four 
hour rhythm of 5-hydroxytryptamine concentrations in the rat brain, 
it is apparent that there will be different concentrations of
5-hydroxytryptamine in the homogenates taken at different clock hours.
. » . 14
The specific activity of the C-5-hydroxytryptamine in these
homogenates will therefore be different. This will not affect the
K_ values calculated, but it will affect V . The values of V 
™  max max
shown in Figures 14, 15, 18, 19, 20 and 21 have been calculated without
taking the different endogenous concentrations of 5-hydroxytryptamine
into account. When these values are recalculated taking into account
the different endogenous concentrations of 5-hydroxytryptamine, the
samples taken at 13.00 h, which previously showed to be
approximately 14% lower than those taken at 01.00 h, now show V
max
to be approximately 12% higher than those taken at Ol.OOh.
calculated by this method still did not differ significantly between
the two clock hours, so it must be concluded that V does not
max
display rhythmic variations in relation to the twenty-four hour day.
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Tryptophan, an essential amino acid, is the necessary precursor 
of brain 5-hydroxytryptamine (Udenfriend, Clark and Titus 1953; 
Udenfriend, Titus, Weissbach and Peterson 1956). Dalgleish and 
Dutton (1957) proposed that tryptophan must be hydroxylated extra­
cer ebr ally, and that cerebral synthesis of 5-hydroxytryptamine 
depends on the rapid entry of 5-hydroxytryptophan into the brain 
and its subsequent and immediate decarboxylation to 5-hÿdroxytrypt- 
amine. Grahame-Smith (1964) using an in vitro technique, and Gal, 
Poczik and Marshall (1963); Gal, Morgan and Marshall (1965); Gal, 
Morgan, Chatterjee and Marshall (1964); Weber and Horita (1965); and 
Weber (1966) working in vivo showed that cerebral tissue can 
hydroxylate tryptophan, but that the process was too slow to account 
for all cerebral 5-hydroxytryptaniine. It was therefore thought 
that extra-cerebral hydroxylation of tryptophan must complement that 
which occurs in the brain.
In this Introduction I shall describe the details of the 
metabolism and distribution of the amino acid peripherally as well as 
in the CNS, and the relationship between these two systems. The 
effects of diet on tryptophan concentrations, and the effect of 
tryptophan concentration on the synthesis of 5-hydrôxytryptâmine 
will also be considered. Finally, evidence for the twenty-four hour 
variation of tryptophan concentrations, and evidence for a high 
affinity uptake process into nerve endings will be produced.
Further evidence that tryptophan is the necessary precursor of 
5-hydroxytryptamine has been presented by Ashcroft, Eccleston and 
Crawford (1965). Using the technique of tryptophan loading, they 
showed that the intra-peritoneal injection of 800 mg/kg tryptophan 
caused a rapid rise in brain 5-hydroxytryptamine and
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5-hydroxyindole-3-acetic acid concentrations. Wang, Harwalkar, and 
Waisman (1962) and Quay (1963) found increased brain 5-hydroxytrypt­
amine concentrations simply by feeding a tryptophan supplemented diet 
to rats. Conversely Culley, Saunders, Mertz and Jolly (1963) fed a 
tryptophan deficient diet to rats and found plasma tryptophan and 
brain 5-hydroxytryptamine concentrations to be significantly decreased. 
Similar results were obtained by Zbinden and Pletscher 1958; Gal and 
Drewes 1962 and Quay 1963.
Yuwiler (1973) reported a lack of stereospecificity for the 
conversion of tryptophan to 5-hydroxytryptamine, although the 
D-isomer must undergo peripheral deamination and subsequent transamination 
to the L-form. The D-isomer iS therefore slower acting and less potent.
Since it has been widely shown that the synthesis of 
5-hydroxytryptamine in the CNS is dependent on the presence of the 
amino acid tryptophan, and since cerebral tryptophan supplies are 
dependent on circulating tryptophan in the blùod, it is perhaps 
pertinent to examine the role of tryptophan peripherally.
Tryptophan enters the systemic circulation from two main sources 
i.e. overflow from the portal circulation following protein ingestion, 
and efflux from bound and free tryptophan pools in the tissues.
Tryptophan is removed from the circulation by uptake ihto the tissues, 
including the brain, metabolism in the liver by tryptophan pyrrolase 
or by excretion in the urine.
The metabolism of tryptophan via thè 5-hydroxytryptamine pathway 
accounts for only 1% of urinary tryptophan metabolites (Michael,
Drummond, Doeden, Anderson and Good 1964). Curzon and Green (1969) 
confirmed that the major route of tryptophan metabolism starts with 
its oxidation to formyl kynurenine by tryptophan pyrrolase in the 
liver, and only a minor route leads to 5-hydroxytryptamine.
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L-tryptophan is unique among amino acids in that it is bound to 
a non-dialysable plasma component (McMenamy, Lund and Oncley 1957; 
McArthur and Dawkins 1969) which was identified as serum albumin 
(McMenamy and Oncley 1958). Binding is strongest at the indole- 
protein bond, although bonding by the tryptophan carboxyl to protein 
and a ’close fit’ to the protein at the hydrogen of the tryptophan 
which would not permit the amino group to occupy this position 
completes the bound structure. Approximately 20-25% of tryptophan 
remains unbound or free (McMenamy, Lund, van Marcke and Oncley 1961; 
McArthur and Dawkins 1969) although lowered pH releases the amino acid 
from its bound form. Johnson and Bergeim (1951) found a 3 or 4:1
plasma: erythrocyte ratio for tryptophan, although McMenamy, Lund,
V
van. Marcke and Oncley(1961),failed to confirm this ratio and concluded 
that tryptophan is evenly distributed in the blood.
Tryptophan plays a major role in peripheral metabolism other than 
in 5-hydroxytryptamine synthesis. The availability of plasma free 
tryptophan can be a limiting factor in hepatic protein biosynthesis 
(Munro 1968) and tryptophan facilitates the formation of polysomal 
aggregates in liver, and enhances protein synthesis (Sidransky, Sarma, 
Bongiurno and Verney 1968). Under certain conditions, release of 
adrenal corticoids in response to stress induces tryptophan pyrrolase 
which may lower tryptophan levels to such an extent that peripheral 
metabolism would be shifted from protein synthesis to gluconeogenesis 
while simultaneously lowering brain 5-hydroxytryptamine. , Tryptophan 
has been reported to inhibit gluconeogenesis by converting and 
maintaining phosphoenolpyruvate carboxykinase, (EC.4.1.1.32.) in a 
non-functional state (Ray, Foster and Lardy 1966).
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Yuwiler (1973) suggested that brain 5-hydroxytryptamine 
biosynthesis was controlled by its precursor, tryptophan.
Fernstrom and Wurtman (1971) and Fernstrom, Larin and Wurtman (1973) 
proposed that the control of brain 5-hydroxytryptamine synthesis was 
coupled to plasma tryptophan levels. Conversely Curzon, Joseph and 
Knott (1972) found brain and plasma tryptophan levels not to be 
correlated, but Knott and Cur&on (1972) found brain tryptophan and 
plasma free tryptophan to be associated, and Curzon, Friedel and 
Knott (1973) demonstrated that plasma non-esterified fatty acid 
changes have a role in determining the availability of tryptophan 
to the brain. This latter finding is in agreement with Fernstrom, 
Larin, and Wurtman (1973), who showed that brain tryptophan was 
increased by administering a carbohydrate and fat diet* although not 
when 18 -24% protein was added. The effect of diet was not well 
correlated with plasma tryptophan concentration alone, but did correlate 
with the ratio of plasma tryptophan to individual amino acids (Leucine, 
isoleucine, valine, tyrosine and phenylalanine) or to the sum of the 
concentration of those amino acids. Carbohydrate depressed neutral 
amino aCids while elevating plasma tryptophan. Protein ingestion 
raised neutral amino acid levels and altered the balance for their 
competitive,uptake against tryptophan into the brain (Fernstrom and 
Wurtman 1971). These workers also suggested that the serotonin- 
containing neurones provide the rest of the brain with information 
about a broad range of metabolic states, since a wide variety of 
dietary and hormonal inputs probably can influence the ratio of 
plasma tryptophan to its competitor amino acids.
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The effects of non-esterified fatty acids on the plasma free 
tryptophan concentrations in plasma have been recently investigated by 
Lipsett, Madras, Wurtman and Munro (1973). Oleic acid added to serum 
increased the free tryptophan concentrations, whereas glucose ingestion 
(75 g. to humans) decreased the plasma free tryptophan by 35% with no 
change in total plasma tryptophan concentrations. Munro and 
Thompson (1953) found only a small decrease in total serum tryptophan 
concentrations, following carbohydrate ingestion, compared with the 
larger reduction in other amino acids. This decrease occurred in the 
non-albumin-bound fraction, and may be explained by either an insulin 
mediated increase in the transport of free amino acids into some 
tissues, notably muscle, or a reduction in non-esterified fatty acid 
by glucose administration reducing the availability of free tryptophan 
by increasing its binding to albumin. Albanese, Irby, Frankston and 
Larin (1947) recorded an immediate fall in urinary tryptophan following 
carbohydrate ingestion.
Drugs which increased the concentration of non-esterified fatty 
acids e.g. isoprenaline, aminophylline, heparin (Curzon and Knott 1973), 
also increased plasma free tryptophan concentrations. Aminophylline 
increased brain tryptophan, 5-hydroxytryptamihe and 5-hydroxyindole-3- 
acetic acid in addition. Fatty acids increased free plasma tryptophan, 
while nicotinic acid prevented the increase in plasma free tryptophan 
induced by food deprivation, and also increased plasma non-esterified 
fatty acid concentrations. Insulin decreased non-esterified fatty 
acids and tryptophan concentrations. These results are consistent with 
a positive correlation between changes in tryptophan metabolism and 
adenosine-3',5'-monophosphate (cyclic AMP), as this is known to mediate 
the lipolytic action of the catecholamines. Aminophylline and nicotinic 
acid increased and decreased fat-cell cyclic AMP respectively. This
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suggested that the disposition of plasma tryptophan and brain 
5-hydroxytryptamine metabolism could be influenced by the hormonal 
factors (Robison, Butcher and Sutherland 1971) controlling 
extra-cerebral cyclic AMP and fatty acid production.
Tagliamonte, Tagliamonte, Porn, Perez-Cruet, Krishna and 
Gessa (1971(a) ) demonstrated a marked increase in brain tryptophan 
concentrations induced by cyclic AMP and dibutyryl cyclic AMP. They 
assumed that the cyclic AMP system was located within nerve endings 
where monoamine containing vesicles were also present (De Robertis 
1964). More recently Tagliamonte, Biggio,Vargiu and Gessa (1973(a)) 
concluded that brain tryptophan and serotonin turnover were controlled 
by free serum tryptophan, which is itself independent of total serum 
tryptophan.
Madras, Cohen, Fernstrom, Larin, Munro and Wurtman (1973) lent 
a word of caution to this interpretation of these findings. They 
recognised that the concentration of free tryptophan in serum did not 
regulate the changes in brain tryptophan concentrations that normally 
accompany such physiological occurrences as eating, although free 
tryptophan may be correlated with brain tryptophan after certain 
treatments such as drug administration (Tagliamonte, Biggio and 
Gessa 1971(c); Tagliamonte, Tagliamonte, Perez-Cruet and Gessa 1971(b)) , 
or a prolonged fasting period or immobilisation stress (Knott and 
Curzon 1972) or electro convulsive shock (Tagliamonte, Tagliamonte, 
DiChiara, Gessa and Gessa 1972).
Perhaps of clinical importance is the finding that salicylate 
(McArthur and Dawkins 1969, Tagliamonte, Biggio,Vargiu and Gessa 1973) 
and other anti-inflammatory drugs (McArthur, Dawkins and Smith 1971) 
may be up to 90% bound to the albumin fraction, while tryptophan may 
consequently be virtually absent from the serum of humans being treated
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with these drugs. Tryptophan has been shown to be metabolised via 
the kynurenine pathway under these conditions (McMillan 1960,
Bett 1962, Spiera 1966) due to tryptophan pyrrolase enzyme induction 
(Knox and Mehler 1950). Salicylate displaced non-esterified fatty 
acids from their binding sites on albumin and these fatty acids could 
be taken up into cells and broken down. The production of aceto- 
acetate in this process could play a part in the acidosis which occurs 
during salicylate toxicity (Dawkins, McArthur and Smith 1970). Rather 
unusually since it inhibits most aminotransferases,salicylate stimulates 
L-tryptophan OC-oxoglutarate aminotransferase (Gould and Smith 1965).
Tagliamonte, Tagliamonte, Perez-Cruet and Gessa (1971 (b) ), and 
Tagliamonte, Tagliamonte, Perez-Cruet, Stern and Gessa (1971(d) ) found 
that the concentration of tryptophan in the brain reflected 
5-hydroxytryptamine synthesis. Conversely Korf, Van Praag and Sebens 
(1972) and Van Praag, Flentge, Korf, Dois and Schut (1973) found 
decreased serum tryptophan concentrations, increased brain tryptophan 
concentrations and unchanged brain 5-hydroxytryptamine concentrations 
following the administration of probenecid to rats. However Lewander 
and Sjostrom (1973) recorded increased concentrations of free 
tryptophan in the plasma of humans, following probenecid administration.
Tryptophan concentrations may also be important in pathological 
conditions. Curzon, Kantamaneni. Winch, Rojas-Bueno, Murray-Lyon and 
Williams (1973) posed the question whether increased brain tryptophan 
could have a role in coma. Hartmann, Chung and Chien (1971) found 
hypnotic properties for L-tryptophan in man. A  dose dependent 
reduction in sleep latency with little change in sleep architecture 
was demonstrated in rats, whereas Williams, Lester and Coulter (1968) 
found slow wave sleep increased and sleep-dream cycle length decreased 
at similar doses. Wyatt et al. (1970)showed an increase in slow wave sleep
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and decreased paradoxical sleep following tryptophan administration, 
but reduced 5-hydroxytryptamine levels decreased paradoxical sleep.
He therefore suggested that tryptophan was acting by a different 
mechanism, possibly by the kynurenine route.
Lapin and Oxenkrug (1969) and Curzon (1969) suggested that 
an increased metabolism of tryptophan along the kynurenine pathway, 
thereby reducing the amount of tryptophan available for conversion 
to 5-hydroxytryptamine or tryptamine, might participate in the 
production of the symptoms of mental depression. However, the 
results of Frazer, Pandey and Mendels (1973) did not support this 
suggestion, although the former hypothesis (Lapin and Oxenkrug 1969; 
Curzon 1969)@ would be in agreement with the most consistent 
observation in depressed patients, that they have a lower than normal 
concentration of either 5-hydroxyindoles or 5-hydroxyindole-3-acetic 
acid in lumbar spinal fluid (Ashcroft, Crawford, Eccleston, Sharman, 
MacDougall, Stanton and Binns 1966; Dencker, Malm, Roos and 
Werdinius 1966; Bowers, Heninger and Gerbode 1969; Mendels, Frazer, 
Fitzgerald, Ramsey and Stokes 1972). A substantial review of the role 
of indoleamines in affective disorders and schizophrenia has been 
presented by Himwich (1970).
The regional distribution of tryptophan in the brain of the dog 
has been plotted by Price and West (1960). Hypothalamus, pons and 
cerebellum are rich in tryptophan and poor in 5-hydroxytryptamine 
(approximately a 100 fold difference) whereas cerebral hemispheres 
and spinal cord show a much smaller ratio (10:1). This difference 
between tryptophan and 5-hydroxytryptamine concentrations would 
agree with the view of Morgan and Yndo (1973) that the proportion of 
brain tryptophan in 5-hydroxytryptamine-containing neurones must be 
very small.
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Tryptophan is taken up by 5-hydroxytryptamine-containing neurones in 
the brain, and the intrasynaptosomal concentration of L-tryptophan is 
one factor controlling 5-hydroxytryptamine synthesis (Grahame-Smith and 
Parfitt 1970)o Yuwiler, Wetterberg and Geller (1971) argued against 
the proposal that the activity of tryptophan peroxidase directly affects 
the synthesis of brain 5-hydroxytryptamine by diverting tryptophan from 
the biosynthesis of this monoamine. Tagliamonte, Biggio, Vargiu and 
Gessa (1973(b) ) found indirect evidence indicating that the rate 
limiting step in the synthesis of 5-hydroxytryptamine is the 
concentration of tryptophan present and not the activity of trygtophan- 
5-hydroxylase as suggested by other workers. (Chapter Five).
The synthesis of, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic 
acid from tryptophan has been shown to be partly dependent on substrate 
levels (Moir and Eccleston 1968; Grahame-Smith 1971; Fernstrom and 
Wurtman 1972). Schubert (1973), using a transected spinal cord 
preparation, came to the conclusion that the synthesis of 5-hydroxytrypt­
amine is not directly dependent on neuronal activity or tryptophan levels, 
but seemed to be inversely correlated to endogenous 5-hydroxytryptamine 
concentrations, although the possibility that the uptake and transport 
of tryptophan in 5-hydroxytryptamine neurones may be impaired by spinal 
transection could not be discounted (Carlsson, Kehr, Lindqvist,
Magnusson and Atack 1972). Knott, Joseph and Curzon (1973) postulated 
that a possible regulatory role of increased brain tryptophan could 
involve decreased firing of 5-hydroxytryptamine neurones, as shown when 
tryptophan is injected peripherally (Aghajanian 1972). Moir (1971) 
illustrated the dangers of regarding total plasma or brain concentrations 
of tryptophan as indicative of the quality of the substance available for 
transport or metabolism. "Thus it is naive to relate such concentrations
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to the in vitro determined values of their metabolising enzymes, 
or to imply that alteration in total concentration of substrate in 
whole brain must necessarily alter significantly the rate of subsequent 
neuronal metabolism (Tagliamonte, Tagliamonte, Perez-Cruet and Gessa 
1971(b))".
A  diurnal variation in mammalian tryptophan concentrations has 
been shown (Fernstrom and Wurtman 1971; Wurtman, Rose, Chou and Larin 
1968; Morgan and Yndo 1973; Rapoport, Feigin, Bruton and Beisel 1966), 
and the diurnal variation has been related, in man, to circadian 
periodicity of tryptophan metabolism (Rapoport and Beisel 1968), and 
to tyrosine transaminase activity (Wurtman, Shoemaker and Larin 1968; 
Fuller and Snoddy 1968). Bobillier and Mouret (1971) suggested that 
the diurnal variation of brain tryptophan concentrations may be partly 
a reflection of the variation of tryptophan hydroxylation in the brain. 
In all these instances, both brain and plasma tryptophan concentrations 
show highest levels following feeding and lowest levels during the 
period of fasting. However Morgan and Yndo (1973) proposed that the 
daily rhythm of tryptophan and 5-hydroxytrypCamine in mouse brain may 
be relatively independent of daily variations of food intake or plasma 
tryptophan content.
Hery, Rouer and Glowinski (1972, 1973) found that the decreased 
formation of 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in 
hypothalamic slices during the dark period (21.00 h.)is related to 
changes in the initial accumulation of ^H-hryptophan in tissues, and 
not related to changes in the rate of conversion of tryptophan to 
5-hydroxytryptamine nor was it dependent on plasma tryptophan levels.
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In vivo studies of tryptophan uptake into the brain (Guroff and
Udenfriend 1962) showed an accumulative process, but brain levels
did not reach plasma levels. A marked stereospecificity, with
preference for the L-isomer, was demonstrated. Kiely and Sourkes
(1972) confirmed the accumulation of tryptophan into rat cerebral
cortical slices against its concentration gradient. This
accumulation is an energy requiring process (Joanny, Barbosa and
Corriol 1968; Barbosa, Joanny and Corriol 1970). Grahame-Smith ,
and Parfitt (1970) have elucidated the nature of tryptophan transport
across the synaptosomal membrane, with for the uptake process of
1 X 10 - 0,28 X 10 and V 225 - 39 miimo/g 5 min. in a
max •
saturable system, which utilises a stereospecific carrier-mediated 
process. Karobath, Diaz and Huttunen (1972) found that L-dihydroxyphenyl 
alnine (L-DOPA), L-3-methoxytyrosine and tryptophan shared an uptake 
transport system and that these compounds competitively inhibited the 
uptake of tryptophan into synaptosomes. Catecholamines did not 
interfere with the uptake of tryptophan into synaptosomes, but both 
dopamine and noradrenaline inhibited the synthesis of 5-hydroxytrypt­
amine from tryptophan in this system.
A high affinity uptake process has been reported (Knapp and
Mandell 1972; Knapp and Mandell 1973; Meek and Neff 1972) with a K^ ^
-5
1 X  10 M, as opposed to the low affinity process of Grahame-Smith 
and Parfitt (1970). It has been suggested (Iversen 1970; Shaskan 
and Snyder 1970) that high affinity amino acid qptake in synaptosomes 
is indicative of neurotransmitter function, whereas low affinity uptake 
is related to protein synthesis. The high affinity uptake can be 
inhibited with cocaine and stimulated with lithium (Knapp and 
Mandell 1972). Raphe lesions do not affect this process (Kuhar,
Roth and Aghajanian 1972) although the uptake of 5-hydroxytryptamine 
is reduced by such lesions.
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The,turnover of tryptophan in brain is very rapid (approximately 
ten minutes ) (Tyce, Flock, Owen, Stobie and David 1967), so its 
availability for conversion to 5-hydroxytryptamine depends on its 
transport from blood to neurones. At least two processes complicate 
this transport
1) The high affinity tryptophan uptake system in the nerve 
endings (Mandell, Knapp and Hsu 1974).
2) Transport into glial cells (Henn and Hamberger 1971). ,
Bauman, Bourgoin, Benda, Glowinski and Hamon (1974) suggested 
that variations of plasma free tiyptophan could modify the tryptophan 
carrier activity in glial cells, thence leading to changes in 
5-hydroxytryptamine synthesis.
Grahame-Smith (1973) did not find a specific uptake system for 
tryptophan across the synaptosomal membrane, and suggested that there 
were"mechanisms" for stabilising the intracellular concentration of 
tryptophan in the brain.
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4.2 METHODS
Male Sprague Dawley rats (120 - 140g) were housed and maintained 
exactly as described in Chapter Two.
The animals were killed by neck dislocation. Their throats were 
cut, and blood collected from the wound. Blood was left overnight 
to clot. The brains were immediately removed as described previously, 
and homogenised in 6 ml. 0.4M perchloric acid using a glass tube with 
teflon pestle (0.01 in. clearance), and centrifuged at 3,000g for ten 
minutes. 4.5 ml. of the supernatant .was centrifuged at 25,OOOg for 
20 minutes. 4.0 ml, of the supernatant was taken for assay by the 
aldehyde condensation method of Denckla and Dewey (1967).
0.1 ml. of a solution containing O.OIM ferric chloride in 
85% (^Yv) trichloracetic acid and 0.1 ml.18% formaldehyde were added 
to the sample and boiled together at 100°C for one hour. The reaction 
mixture was cooled to room temperature and the fluorescence measured at 
excitation wavelength 360 mp and emission wavelength 450 nyj (wavelength 
uncorrected).
For the estimation of serum tryptophan, 0LO2 ml. serum was added
to 0.2 ml. 1.8% formaldehyde and lb8 ml. of a solution containing 
-4
3 X 10 M  ferric chloride in 10% (^/v) trichloracetic acid. The 
reactants were boiled for one hour at 100°C, cooled to room temperature, 
centrifuged at 25,OOOg for ten minutes and the fluorescence measured 
as before.
Serum free tryptophan was determined by dialysing 2.0 ml. serum
against 0.5 ml. Krebs-Ringer solution pH 7.4 in a shaking water bath
at 37°C for times indicated in the legends to the Figures. 8/32 in.
Visking tubing was used as the dialysing membrane. This was boiled 
-4 . .
twice in 2 X  10 M  disodium EDTA (ethylenediaminetetracetic acid) and 
twice in distilled water to remove heavy metal ions,notably copper.
The tubes used for the dialysis were flushed with O 2 /CO 2  (95:5) prior
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to incubation. Tryptophan was assayed as for serum total tryptophan, 
using 0.02 ml. Krebs-Ringer dialysate.
The twenty-four hour variation of brain and serum free and total 
tryptophan were determined by measuring the amino acid concentrations 
at four hourly intervals throughout the twenty-four hour period, 
commencing at 09.00 h. The twenty-four hour rhythms were compared 
with the calculated sine curve by means of the Fourier analysis and 
test.
The product of the aldehyde-condensation reaction with 
tryptophan is norharman (Denckla and Dewey 1967). The fluorescence 
spectrum of the product of the assay was compared with that for pure 
norharman (Sigma).
Internal tryptophan standards and norharman standards were used 
for each assay.
4.2.1 RESULTS
The fluorescence spectrum for pure norharman was identical with 
that of the product being assayed (Figure 22)à The results obtained 
can therefore be considered to be a true measurement of the concentrations 
of tryptophan in serum and brain.
Serum samples subjected to dialysis at 37°C were incubated for 
30 mins.,1,2,3,6 and 18 hours. Tryptophan concentrations came 
rapidly to equilibrium at one hour, and were maintained in this state 
throughout the eighteen hours of the experiment, although some 
re-adjustment occurred between two and six hours. A 9% decrease in 
fluorescence was detected after three hours, but this eventually returned 
to the equilibrium state. In Figure 23,time of incubation is plotted 
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Figure 22. The fluorescence spectrum of the condensed tryptophan 
product (a) compared with that of pure norharman (b).
(H h ) excitation 360mp, scan emission; ( ©  O)





















Figure 23. The effect of time on the dialysis of serum 
tryptophan.
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There is a twenty-four hour variation in the concentration of 
tryptophan in the serum (total and free) and brain (Figure 24, Table 1).
The twenty-four hour variation of bound tryptophan in the serum is also 
shown in Figure 24. These figures were calculated as being the difference 
between serum total and free tryptophan concentrations. In all instances 
the highest concentration of tryptophan occurred in the middle of the dark 
period when the animal is most active and consumes the greatest amount of 
food. The lowest concentrations occurred in the middle of the light 
period when the animal is least active. The twenty-four hour variations 
in the tryptophan concentrations have been compared with their calculated 
sine curves (Figures 25, 26, 27 for serum free and total tryptophan and 
brain tryptophan respectively). None of these rhythms was significantly 
différent from their calculated curve when assessed by the test. Brain 
tryptophan concentrations fluctuated by 38% throughout the twenty-four hours, 
serum free tryptophan by 20% and serum total tryptophan by 34%.
In serum and brain, tryptophan concentrations increased rapidly 
following the onset of darkness (18.00 h.) to maximum concentrations at
01.00 h. Concentrations decreased rapidly after this time in serum, 
but rather more slowly in the brain. Tryptophan concentrations were 
at their lowest level by 09.00 h. and remained in this state until 17.00 h. 
immediately preceding the onset of darkness. Tryptophan concentrations 
in the brain and in serum appear to increase only immediately following 
the onset of darkness and maintain a plateau of lower concentrations 
during the light period and the latter part of the dark period.
28% of serum tryptophan existed in the free form at 01.00 h. and 
35% at 13.00 ho The daily mean was 32%. The ratio of free : total 
tryptophan in the serum does not therefore change significantly 




































+ 1 m vO rd" 1—4 m O' 00






O CO o O VO o o1—1 4J 1—1 o O' r-4 o r-~
S
B O r-4 1—4 o 1—4 1—4 O
W) a
a. M + 1 + 1 + 1 + 1 + 1 + 1 + 1
M CO CO o 00 -d" o
O 00 crv T—4 o CO m 1—4
C CM m m 1—4 m•H CM I—1 I—4 1—4 1—4 CM 1—4
Cd
XI
60 m vO rd- T—4 m -d" 00






H 4-1 CM CM 00 <d" 1—4 1—4
< CN r~r 1—4 CM CO CM CM
M
H B o O o O O O o
S a
W f 1 + 1 + t + » + 1 + 1 + 1
U cu
:s CO r—1 C3V VO VO 1—4
o Mj- CO T—4 CO 1—4 1—4 CM
u
VO in m m m vO m
§
(X,
o CM T—4 o CM VO m 00








n m m rd" 00 VO m m
pq O o o o O o O
o o o o O o O
+1 + 1 + 1 + 1 + 1 -t-i + 1
CTi CO CO vO 00 VO m
m CM CM CO CO rH CO
CO CO CM CM CM cn CM
V4
a
o O O O o o o o
X I o o O o o o o
A! r-l m C7\ CO r- 1—4 CO





































































































n  J i
13.00
J C
1 7 .0 0 21.00 01.OO 05.00
— I---




Figure 24. The twenty-four hour variation of tryptophan
concentrations in the rat brain (0---- 0)
and serum'free' (□-----□) ,'bound' (Ô--- ©)
and total (A A) . The solid black bar
represents the period of darkness.
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Figuré 25. The twenty-four hour variation of tryptophan
concentrations in the rat brain ( O  O) compared
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Figure 26
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The twenty-four hour variation of serum free
tryptophan (0--- 0) compared with the calculated

























Figure 27. The twenty-four hour variation of serum total
tryptophan concentrations (A--- A) compared with
the calculated sine curve Ql--- A).
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4o3 The Uptake of ^^C-Tryptophan into nerve endings
METHODS
14
The uptake of C-tryptophan into homogenates of the septal
region of rat brain, was determined exactly as described for the
uptake of ^^C-5-hydroxytrÿptamine in septal regions (Chapter Three),
with the exception that DL-^^C-tryptophan 57 mCi/m mole was used as
the substrates The effects of incubation time, and the Michaelis
constant for the uptake of tryptophan were determined,
14
In addition the uptake of DL- C-tryptophan into a 
synaptosomal fraction was determined as follows°
Male Sprague Dawley rats (120 - 140g) were maintained as 
described previously for ten days before experimentation. The rats 
were killed by decapitation and the brains were rapidly removed, 
weighed and homogenised in 0,32M sucrose (10 ml/g,) and centrifuged 
at l,000g at 4°C for ten minutes. The supernatant was removed and 
centrifuged at 17,000g at 4°C for one hour. The supernatant was 
discarded, and the pellet resuspended in 20 mlSè Krebs-Ringer solution 
pH 7,4,
This fraction was placed on a discontinuous sucrose gradient of 
composition 0,32M, 0,8M, 1,2M sucrose and centrifuged at 100,000g for 
one hour at 0°C in a Beckman ultracentrifuge using a S,W,25,2 swing 
out rotor. The synaptosome fraction was collected at the interface 
of the Oo8M and 1,2M sucrose solutions, 5 mis, of the synaptosome 
fraction were adjusted to 0,4M by slowly adding an equal volume of 
water. To 1,0 ml, of this, 8 ml, of Krebs-Rifiger solution was 
added and this mixture was preincubated at 37°C for five minutes.
1,0 ml, DL-^^C-tryptophan 2 x 10 ^M made up in Krebs-Ringer solution 
pH 7,4 was added, and the effect of incubation time on the uptake
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process was determined. The final concentration of
14 -7
DL- C-tryptophan was 2 x 10 M,
The uptake process, by these two methods, was compared at
two different times of the day, 01,00 h, and 13,00 h, to determine
any variation in the process with clock hour.
The concentrations of isotope used, and the incubation times
are presented in the legends to the Figures, All results given
are the means of three experiments.
4,3,1 RESULTS
14 -7
The uptake of DL- C-tryptophan(2 x 10 M)into a homogenate
of the septal region of rat brain increases with time up to a maximum
after eight minutes, in samples taken at 01,00 h, and 13,00 h,
(Figure 28), Samples taken at both clock hours have equal initial
rates of uptake, and the uptake of DL-^^C-tryptophan with time, does
not therefore display a twenty-four hour variation at this
-7
concentration (2 x 10 M ) , The concentration of amino acid decreased 
following attainment of maximum uptake. The reason for this is 
rather obscure, but two possibilities may be suggested6 First 
tryptophan may be taken up, metabolised and released, and therefore 
becomes unavailable for re-uptake with the result that there is 
insufficient tryptophan available to replenish that which is released^ 
Secondly the stability of the nerve endings in the homogenate may 
decrease with time. Rupture of nerve endings would limit the uptake 
sites available, and if this was a continuous process, it might be 
expected that the amount of amino acid taken up would decrease. The 
former possibility does not seem likely, since even at higher 
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Figure 28. The effects of incubation time on the uptake
of ^^C-tryptophan (2 x 10~^M) into homogenates 
of the septal region of rat brains at 01.00 h.






Figure 29. The effects of incubation time on the
uptake of ^^C-tryptophan (2 x 10“ ^M) into 
a synaptosomal preparation from rat brain
at 01.00 h ( B  ■ )  and 13.00 h ( A  A )
at 37°C and pH 7.4.
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present, there is still a decrease in uptake at incubation greater
than twenty minuteso The second possibility, if true, would mean
that the breakdown of the homogenate must occur throughout the
experiment and the results are not a true estimate of the,uptake
capabilities of the homogenate° However, these results are only
being used to compare the rates of uptake at two clock hours, and
the results remain valid unless one accepts the possibility of a
twenty-four hour rhythm in the rate of breakdown of the homogenate.
It was interesting to note that in each of the three experiments,
of which the mean is shown in Figure 28, the uptake curve for
samples taken at 13cOO ho was always higher than that for 01.00 h,
although there is no statistically significant difference between them,
14
The uptake of DL- C-tryptophan into the prepared synaptosomal
fraction was similar to that for the crude homogenate of the septal
regiona Maximum uptake occurred after eight minutes (Figure 29).
The rate of uptake for samples taken at 01.00 h. was similar in the
two systems. The rate of uptake for samples taken at 13.00 h. was
30% greater in the synaptosomal fraction than in the crude homogenate
and 33% greater than in the synaptosomal fraction taken at 01.00 h.
There was a decline in tryptophan uptake with time after maximum
levels of uptake had been reached.
The Michaelis constant (K^) was plotted for samples taken at
01.00 ho and 13.00 h. (Figures 30, 31). The for the uptake of 
14
DL- C-tryptophan into a homogenate of septal region of rat brain
“5 “5
was 6.2 X 10 M for samples taken at 13.00 h. and 3.0 x 10 M  for
samples taken at 01.00 h. There is no difference in the K values
m
at these clock hours, and consequently it must be concluded that









Figure 3 0 . Direct linear.plot to determine the Michaelis constant
for the uptake of  ^ C-tryptophan into a septal homogenate 






Figure 3 1 . Direct linear plot to determine the Michaelis 
constant for the uptake of ^^C-tryptophan into 
a septal homogenate at 01.00 h. , 37°C, pH 7.4.
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As presented previously (Chapter Three) has been
calculated (Figures 30 and 31) without taking the different
endogenous concentrations of tryptophan into account, and
was approximately 26% lower at OloOO ho than at 13,00 ho under
these conditions. However, when V was recalculated to take
max
the different endogenous concentrations of tryptophan into account,
the level at 01,00 h, was approximately 8% higher than at 13,00 h.
There was no statistically significant difference between the,
values of V measured at 01,00 h, and 13,00 h, and it must 
max '




The twenty-four hour variations in serum free and total 
tryptophan and brain tryptophan are similar, with highest concentrations 
in the dark period and lowest concentrations in the light period, thus 
agreeing with results shown by other workers (Femstrom and Wurtman 
1971), Similarly the characteristics of the high affinity uptake 
process (K^ 6,2 x 10 at 13,00 h; 3,0 x 10 at 01,00 h) agrees
with the findings of other workers (Knapp and Mandell 1972),
The most striking anomaly when these results are compared with 
the twenty-four hour variation of 5-hydroxytryptamine in Chapter Three 
is the twelve hour difference between the highest concentrations 
observed for tryptophan (01,00h)and for 5-hydroxytryptaniine (13,00 h) ,
It is therefore apparent that the twenty-four hour variation of 
5-hydroxytryptamine is not merely a consequence of increased tryptophan 
concentration, Hery, Rouer and Glowinski (1972) related the increase 
in 5-hydroxytryptamine to the increase in initial rate of accumulation
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of tryptophan, I have little evidence to support this; although
a more rapid rate of uptake of tryptophan was seen at 13,00 h,
in synaptosomes. This was not reflected in the V when the ^ max
Michaelis constants were plotted. Indeed the V at both times
^ max
of day were almost identical. From these results one might suggest
that the higher rate of accumulation at 13,00 h. in synaptosomes
might play a part in the establishment of the twenty-four hour
variation of 5-hydroxytryptamine although it would be necessary to
establish a similar variation in V to confirm this,
max
If the other implications of the twenty-four hour variation 
of tryptophan in the brain are considered, it is necessary to find 
a reason for this variation, since it is obviously not to control 
5-hydroxytryptamine concentrations. It may be that the concentration 
of amino acid in the brain simply reflects the concentration in the 
serum, either free or bound, since the ratio between these did not 
change throughout the day. Other authors have suggested that it 
is the serum free tryptophan that regulates the concentration of 
the amino acid in the brain (Knott and Curzon 1972), but whether the 
serum free tryptophan actually regulates brain tryptophan concentrations 
or whether brain tryptophan concentrations are merely a reflection of 
peripheral metabolism is debateable.
It appears from this work that the amount of tryptophan required 
for the synthesis of 5-hydroxytryptamine cannot be determined from the 
measurement of concentrations of tryptophan in the brain, particularly 
by the methods employed, which have only measured gross changes in 
tryptophan concentration.
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If it is true that the synthesis of 5 -hydroxytryptanrLne is 
independent of total brain tryptophan concentration, and this seems 
likely since the highest concentration of 5-hydro2ytryptamine 
coincides with the lowest concentration of tryptophan, then only 
a small proportion of tryptophan can be involved in the synthesis 
of the amine, and the concentrations involved must be very 
carefully controlled. What controls the availability of tryptophan 
for the conversion to 5-hydroxytryptamine? The utilisation of, 
tryptophan in protein biosynthesis is an obvious alternative pathway 
which may limit the availability of tryptophan for the synthesis of 
5-hydroxytryptamine but the complexities involved in the suggestion 
that protein biosynthesis is itself so rigidly controlled make this 
idea unattractive, and certainly no proof is available. It is more 
tempting to suggest that the neuronal uptake of tryptophan is the 
controlling factor, and indeed Hery, Rouer and Glowinski (1972) 
came to this conclusion by indirect means. However I have found 
little evidence to support this, and if the initial accumulation 
of tryptophan were the regulating factor of the twenty-four hour 
rhythm of 5-hydroxytryptamine concentrations, one might expect 
the kinetic studies undertaken in this Chapter to vary with clock 
hour to a degree comparable with the 4 0% fluctuation of 
5-hydroxytryptanrLne concentrations recorded in the rat brain 
(Chapter Three),
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C H A P T E R  F I V E
The Effects of Tryptophan-5-hydroxylase activity on the 
Twenty-four hour variation of 5-hydroxytryptamine.
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5.1 INTRODUCTION
Freedland, Wadzinski and Waisman (1961(a) and (b) ) found an 
enzyme able to convert tryptophan to 5-hydroxytryptophan in the liver. 
Attempts were therefore made to identify the enzyme, tryptophan-5- 
hydroxylase (E.C. 1.99.1.4.) in the brain.
In this introduction I shall provide evidence to demonstrate 
the existence and distribution of tryptophan-5-hydroxylase in the 
CNS, and also the characteristics and regulating factors of the 
enzyme which play an important part in 5-hydroxytryptamine synthesis. 
In addition the role of inhibitors of the enzyme will be discussed 
with respect to the synthesis of the amine.
Initial attempts to demonstrate the presence of tryptophan-5- 
hydroxylase in the CNS proved unsuccessful (Renson, Weissbach and 
Udenfriend 1962), and it was not until 1963 that Gal and his 
co-workers established the presence of the enzyme in vivo (Gal,
Poczik and Marshall 1963). The existence of the enzyme in the CNS 
has since been shown by many workers (Gal, Morgan, Chatterjee and 
Marshall 1964; Weber and Horita 1965; Consolo, Garattini, Ghielmetti, 
Marselli and Valzelli 1965).
Gal, Morgan, Chatterjee and Marshall (1964) were unable to 
demonstrate sufficient enzymic activity to account for all the 
5-hydroxytryptamine in the brain, and they therefore concluded that 
an extra-cerebral source of 5-hydroxytryptophan must complement that 
which is produced in the brain. However, Bertaccini (1960) did not 
find a decrease in brain 5-rhydroxytryptamine concentrations following 
removal of the gastro-intestinal tract, as might have been expected. 
More recent evidence (Garattini and Valzelli 1965; and Grahame-Smith 
1967) has indicated the rate of 5-hydroxytryptamine synthesis to be 
1 pg/g /h and 0.8 fig/g ^/h  ^ respectively, and both Grahame-Smith
(1967) and Jequier, Lovenberg and Sjoerdsma (1967) concluded that
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there may indeed be sufficient enzyme to account for all the 
5-hydroxytryptamine in the brain.
The decrease of brain 5-hydroxytryptamine concentrations 
following electrolytic destruction of the midbrain raphe nuclei 
(Kuhar, Roth and Aghajanian 1971) without a concomitant fall in 
noradrenaline, dopamine and tryptophan concentrations, indicates 
that the tryptophan-5-hydroxylase is predominantly localised in 
5-hydroxytryptamine-containing neurones.
The regional distribution of the enzyme has been studied in 
guinea pig brain (Ichiyama, Nakamura, Nishizuka and Hayaishi 1968), 
cat brain (Peters, McGeer and McGeer 1968) and in rat brain 
(Deguchi and Barchas 1972). Although there is some species 
variation, the highest activity has been generally found in the 
hypothalamus, midbrain, pons and medulla. The activity of 
tryptophan-5-hydroxylase parallels 5-hydroxytryptamine 
concentrations (Deguchi and Barchas 1972; Baumgarten, Victor and 
Lovenberg 1973), 5-hydroxytryptophan decarboxylase activity 
(Grahame-Smith 1967) and synaptosomal uptake of 5-hydroxytryptamine 
(Kuhar, Aghajanian and Roth 1972), suggesting perhaps that 
5-hydroxytryptamine is synthesised and stored (and therefore found) 
at the same site.
Tryptophan-5-hydroxylase was thought to be a cytoplasmic 
enzyme (Lovenberg, Jequier and Sjoerdsma 1968). However Knapp and 
Mandell (1972(a) ) established the presence of both soluble (68%) 
and particulate (32%) forms of the enzyme in the brain. The soluble 
fraction was associated with brain regions containing cell bodies 
e.g. pôns, medulla and ventral midbrain, and the particulate fraction 
with regions containing nerve endings e.g. septum (Grahame-Smith 1967) 
The activity of the enzyme in the particulate fraction is regulated
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by the uptake of substrate, while the activity in the soluble 
fraction is regulated by the activity of the enzyme itself (Knapp 
and Mandell 1972(b) ).
Meek and Neff (1972) found that tryptophan-5-hydroxylase 
was apparently synthesised in cell bodies and was carried to the 
nerve endings by axoplasmic flow at the slow rate of 5 - 7 mm 
per day. The apparent half life of the enzyme was 2.5 days.
Clineschmidt. Pierce and Lovenberg (1971) recorded an 81% reduction 
in tryptophan-5-hydroxylase activity and 86% reduction of 
5-hydroxytryptamine concentrations in the spinal cord following 
spinal transection, and showed that the enzyme was specifically 
associated with 5 -hydroxytryptamine-containing neurones. There was 
a relatively constant ratio of enzyme to amine from cell bodies to 
terminal axons at least in the bulbo-spinal 5-hydroxytryptamine 
containing neurones.
Study of the maturation of tryptophan-5-hydroxylase in the brain 
(Deguchi and Barchas 1972) indicated that adult levels were reached after 
thirty days, and that the maturation of the enzyme paralleled that of 
5-hydroxytryptamine, thus suggesting a rate limiting function for the 
enzyme. Schmidt and Sanders-Bush (1971) found a four-to-five fold 
increase in tryptophan-5-hydroxylase activity in rats between seven 
and twenty-eight days post partum. This increase occurs at the 
same time as dendrite proliferation and increased intraneuronal 
interactions (Eayrs and Goodhead 1959), the appearance of synaptic 
junctions (Aghajanian and Bloom 1967(b) ), the development of many 
enzyme systems (Pitts and Quick 1967; Schmidt, Palmer, Dettborn and 
Robison 1970) and the assumption of adult patterns of electrical 
activity in the brain (Crain 1952). Bennett and Giarman (1965) and 
Schmidt and Sanders-Bush (1971) found that the intraperitoneal
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injection of tryptophan into the developing animal did not increase 
5-hydroxytryptamine concentrations, but 5-hydroxytryptophan injection 
did, again suggesting a rate limiting function for tryptophan-5- 
hydroxylase (Deguchi and Barchas 1972). Substrate concentration was 
not a limiting factor in these experiments.
For many years the dispute as to whether tryptophan-5-hydroxylase 
or other factors e.g. tryptophan availability (Jequier, Lovenberg 
and Sjoerdsma 1967), oxygen concentration (Green and Sawyer 1966; 
Friedman, Kappelman and Kaufman 1972) or a pteridine co-factor (Koe 
and Weissman 1966) are the controlling influence on 5-hydroxytryptamine 
synthesis, has been contested. Lovenberg, Jequier and Sjoerdsma (1967) 
thought that the activity of tryptophan-5-hydroxylase in a neurone, 
probably determines the rate of synthesis of 5-hydroxytryptamine.
Meek and Neff (1972) found that acute changes in the turnover of the 
amine in nerve endings were not likely to be caused by corresponding 
changes in synthesis and transport of new tryptophan-5-hydroxylase, 
but transient changes were probably modulated by other mechanisms 
e.g. allosteric reactions or availability of substrates or co-factors.
In a recent report, Renson (1973(b) ) concluded that "The regulation 
of 5-6ydroxytryptamine synthesis cannot be accomplished, by rapid changes 
of enzyme levels".
Ashcroft, Eccleston and Crawford (1965); Green and Sawyer (1966) 
and Moir and Eccleston (1968) found tryptophan-5-hydroxylase to be rate 
limiting in vivo and in vitro, but Airaksinen, Giacalone and Valzelli
(1968) thought that the enzyme may be partially dependent on the 
availability of its substrate. Azmitia, Algeri and Costa (1970) 
suggested that brain stem concentrations of tryptophan-5-hydroxylase 
exceed the amount required to maintain the steady state concentration 
of 5-hydroxytryptamine, possibly because the brain stem contains
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mainly cell bodies, where the enzyme is presumably synthesised. 
Clineschmidt, Pierce, and Lovenberg (197,1) proposed that the 
concentration of enzyme determines the concentration of amine in 
a given area of the brain, but they could not reconcile this with 
the increase in enzyme without an accompanying rise in amine in the 
brain stem,, following chronic spinal transection. Grahame-Smith 
and Parfitt (1970) were under the impression that if tryptophan-5- 
hydroxylase were the controlling factor in the synthesis of 
5-hydroxytryptamine in the brain, and in the amount available for 
functional activity, it would seem to be excessively vulnerable to 
amino acid inbalance in the plasma. Sheard and Aghajanian (1968);
Kuhar, Roth and Aghajanian (1971); Shields and Eccleston (1972) and 
Carlsson, Lindqvist, Magnusson and Atack (1973) found that nerve 
impulse flow influenced tryptophan-5-hydroxylase activity to some 
extent. Shields and Eccleston (1972) concluded that the rise in 
synthesis of 5-hydroxytryptamine, as a result of electrical stimulation 
in the region of the midbrain raphe nucleus, was not due to the induction 
of the enzyme, but was more likely due to an increase in the activity of 
existing enzyme. Millard, Costa and Gal (1972) found 5-hydroxytryptamine
synthesis to be attuned to circulating corticosteroid via tryptophan-5- 
hydroxylase, and Azmitia and McEwen (1969) found a 75% decrease in the 
activity of the enzyme following adrenalectomy.
Tryptophan-5-hydroxylase displays an affinity constant for 
-4
tryptophan of 5 x 10 M, which when compared to brain concentration of
-5
the substrate of approximately 1 x 10 M, suggests that the enzyme is 
unsaturated with regard to its substrate (Grahame-Smith 1964;
Lovenberg, Jequier and Sjoerdsma 1968; Ichiyama, Nakamura, Nishizuka 
and Hayaishi 1968). Saturation of tryptophan-5-hydroxylase in vivo 
by its substrate seems to be accomplished at 0.09 x 10 ^M, and
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tryptophan concentrations greater than 0.4 x 10 M  may give substrate 
inhibition of tryptophan-5-hydroxylase (Renson 1973(b) ). However in 
experiments using tetrahydropterin (BH^) or 6-methyl-5,6,7,8 tetra- 
hydropteridine (6 MPH^) instead of the more commonly used co-factor
2-amino-4 hydroxy-6,7, dimethyl 5,6,7,8 tetrahydropteridine (DMPH^) 
(Friedman, Kappelman and Kaufman 1972), the affinity of tryptophan-5- 
hydroxylase for tryptophan may be within the range of physiological 
concentrations of tryptophan and therefore the enzyme may not be 
unsaturated in situ.
The possibility that tryptophan-5-hydroxylase activity may be 
modified by a negative feedback system, controlled by 5-hydroxy­
tryptamine concentrations, has been another subject of great debate. 
Macon, Sokoloff and Glowinski (1971) and Hamon Bourgoin and Glowinski 
(1973) found good evidence for a negative feedback system for the 
enzyme but Lin, Neff, Ngai and Costa (1969); Millard and Gal (1971) 
and Millard, Costa and Gal (1972) found no evidence for such an 
action. Lovenberg, Jequier and Sjoerdsma (1968) and Knapp and 
Mandell (1973) showed that 5-hydroxytryptamine inhibits the enzyme 
only in high concentrations (IxlO ^M) and in a non-competitive way.
The high concentrations pf 5-hydroxytryptamine required in vitro 
apparently rule out the possibility of a negative feedback system, 
but experiments in vivo would suggest that a decrease in amine 
synthesis can be achieved by increasing extra-vesicular intra-neuronal 
5-hydroxytryptamine and vice versa. In addition, a moderating 
influence on drug effects has been shown to occur via tryptophan- 5 - 
hydroxylase (Knapp and Mandell 1972(a), 1973) indicating some form of 
feedback control, although it cannot be ruled out that this will occur 
indirectly via other systems. Mandell, Knapp and Hsu (1974) found
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dopamine to inhibit tryptophan- 5 -hydroxylase at concentrations similar 
to those found in the brain.
The nature of tryptophàn-5-hydroxylase co-factors has been 
extensively researched, although the components have not been 
isolated. Nakamura, Ichiyama and Hayaishi (1965) found that solubilised 
fore-brain enzyme was stimulated by a pteridine co-factor. Gal,
Armstrong and Ginsberg (1966) located the enzyme in mitochondria and 
showed a requirement for a pteridine type or reduced biopterin 
co-factor or for NADPH. Green and Sawyer (1966); Davis and Carlsson
(1973) showed an oxygen requirement for tryptophan-5- hydroxylase. 
Grahame-Smith (1967) found no increase in enzyme activity, in intact 
synaptosomes, following the addition of DMPH^, but rupture of the 
synaptosomes, or partial purification of the enzyme, revealed that 
tryptophan-5-hydroxylase was dependent upon DMPH^ for ité activity. 
Friedman, Kappelman and Kaufman (1972), using a partially purified 
enzyme system, showed an absolute requirement for tetrahydropterin.
The enzyme was stimulated by reduced pyridine nucleotide, dihydropteridine
2 +  ^
reductase and catalase. Fe stimulated the enzyme in the absence of
2+
catalase, suggesting that Fe or catalase protects a sensitive component 
of the tryptophan hydroxylation system from inactivation by peroxide. 
Dihydropteridine reductase has been shown to be present in large excess 
(Graine, Hall and Kaufman 1972).
Inhibition of tryptophan-5-hydroxylase decreases the synthesis and 
therefore the concentration of 5-hydroxytryptamine in the CNS. Drugs 
which inl^ibit this enzyme are useful pharmacological tools in that 
they provide another means of determining the role of 5-hydroxytryptamine 
in the CNS. Of these drugs p-chloroamphetamine and p-chlorophenylalanine 
(p-CPA) have been most widely investigated. p-Chloroamphetamine decreases 
5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid concentrations in
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the brain by inhibiting tryptophan-5-hydroxylase activity (Sanders- 
Bush, Bushing and Sulser 1972). The drug is long acting, up to 
four months, and may therefore be used to study the long term effects 
of 5-hydroxytryptamine depletion.
Koe and Weissman (1966) reported that p-CPA depleted 
5-hydroxytryptamine stores in the brain to very low levels, although 
brain noradrenaline and dopamine concentrations were only slightly 
decreased. p-CPA inhibited tryptophan and phenylalanine hydroxylation 
in the liver, but the drug was more specific to tryptophan-5-hydroxylase 
in the brain. The slow onset of action of p-CPA may be due to its 
conversion to an active metabolite, p-chlorophenylpyruvic acid, which 
has virtually the same effect as p-CPA. Jequier, LoVenberg and 
Sjoerdsma (1967) found that p-CPA was a competitive inhibitor of 
tryptophan-5-hydroxylase in vitro» but caused irreversible inactivation 
of the enzyme in vivo in the brain, but not in the pineal (Deguchi and 
Barchas 1972). Gal, Roggeyeen and Millard (1970) suggested that p-CPA 
might be taken up into the enzyme during its synthesis instead of 
phenylalanine, and that the new enzyme, with p-CPA incorporated into it, 
was inactive. Knapp and Mandell (1972 (a) ) produced evidence for three 
mechanisms of p-CPA action.
1) Competition with substrate for entry into the nerve 
ending.
2) Reversible cpmpetitiye inhibition of the enzyme for 
substrate.
3) Irreversible inhibition by incorporation into the enzyme 
during new protein synthesis in the cell body.
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p-CPA produces maximum depletion of brain 5-hydroxytryptamine 
after two or three days and concentrations of the amine return to 
normal after thirteen or fourteen days (Koe and Weissman 1966; Knapp 
and Mandell 1972(a) ).
The twenty-four hour or circadian variation of tryptophan-5- 
hydroxylase has not been widely investigated, but Renson (1973 (b) ) 
was not able to detect a circadian rhythm of tryptophan-5-hydroxylase 
activity.
The methods most widely used for the estimation of tryptophan-5- 
hydroxylase activity in the brain utilise a radioactive isotope of 
tryptophan, a brain or brain region homogenate (particulate or 
supernatant) and one or more co-factors depending on the purity of 
the enzyme extract. Since it is difficult to measure 5-hydroxy­
tryptophan in these samples, a purified 5-hydroxytrophan decarboxylase 
extract is included, and 5-hydroxytryptamine is measured as the end 
product. This assumes that the activity of the decarboxylase and 
its co-factors is consistent, but as will be seen later (Chapter Seven) 
this is not the case. In the methods used here I have therefore 
measured the activity of tryptophan-5-hydroxylase in the presence of 
a decarboxylase inhibitor (NSD.1024), and 5-hydroxytryptophan, as the 
end product, has been measured. Although the sensitivity of the method 
is decreased by this approach, it is hoped that a truer reflection of 
tryptophan-5-hydroxylase activity has been obtained.
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5.2. METHODS
The activity of tryptophan-5-hydroxylase was estimated according 
to the method of Graheme-Smith (1964) with the exclusion of 
5-hydroxytryptophan decarboxylase and the estimation of 5-hydroxytrypt­
amine concentrations. This assay is dependent on the inhibition of 
5-hydroxytryptophan decarboxylase using NSD.1024 (3-hydroxybenzyl- 
oxyamine). 5-hydroxytryptophan concentrations were determined by 
chromatographic methods.
Male Sprague Dawley rats (120 - 140g) were maintained for ten 
days as described in Chapter Two. The rats were sacrificed at 01.00 h. 
and 13.00 h. and the brains removed, weighed and homogenised in ice-cold 
Krebs-Ringer solution pH 7.4 (10 ml./g.) as described previously. The 
homogenate was centrifuged at 500g. at 4°C for ten minutes. 0.8 ml. of 
the supernatant was pre-incubated for ten minutes in a shaking water 
bath at 37°C. with 0.1 ml. NSD.1024 2.5 x lo'^M. 0.1 ml. DL-3-^^C
-4
tryptophan 57mCi/m.mole 1 x 10 M was added, the tubes flushed/with 
: CO^ (95:5) and stoppered, and incubated in a shaking water bath 
for one hour at 37°C. Control homogenates were first boiled for 
five minutes at 1 0 0 °C and were then carried through the rest of the 
procedure.
At the end of incubation 0.1 ml. non-radioactive DL-5-hydroxy-
_2
tryptophan (Sigma) 2 x 10 M  was added to each tube, and the samples 
deproteinised by boiling for 5 mins. at 100°C. The samples were 
centrifuged at 3,000g. to remove the protein precipitate. The 
supernatant was adjusted to pH 4.0 with O.IN HCl and 0.25g. of charcoal 
deactivated with 4% stearic acid (Asatoor and Dalgleish 1956) was added. 
The samples were shaken for thirty minutes and left to stand for ten 
minutes. The charcoal was washed with 10 ml. water and the indoles 
eluted with 10 mis. 7.2% phenol solution, and the eluate evaporated to
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drynesso The residue was dissolved in 0.1 ml. water and subjected 
to two dimensional ascending paper chromatography on Whatmann 3 mm* 
chromatography paper, the first solvent being propan- 2 -ol: ammonia 
(spogro O 0 8 8 O): water (200:10:20 v/v), the second solvent was 
butan-l-ol: glacial acetic acid: water (120:30:50 v/v). The sample 
chromatograms were compared to a standard chromatogram of tryptophan 
and 5-hydroxytryptophan stained with Ehrlich’s reagent (10 ml, of a 
solution containing 1 0 % (^/v) p-dimethylaminobenzaldehyde in cone,
HCl plus 40 ml, acetone). The area containing 5-hydroxytryptophan 
was cut from the chromatogram and slowly eluted with 1 0  ml, water.
The eluate was evaporated to dryness, redissolved in 0,5 ml, water, 
and 0,4 ml, of this solution was added to 5 ml Unisolve and taken for 
liquid scintillation analysis.
In other experiments attempts were made to find a soluble enzyme 
fraction which gave more reproducible results. The initial homogenate 
was centrifuged at 12,500 g, for thirty minutes and 0,8 ml, of the
supernatant was taken for incubation as described previously. After
incubation, the incubation mixture was deproteinised by heating to 
100°C for five minutes. The mixture was centrifuged for ten minutes 
at 5,000g, and the supernatant subjected to two dimensional chromatography 
as described previously,
-4
The effects of DMPH^ (2,7 x 10 M) on the activity of tryptophan-5-
hydroxylase were assessed using this latter system.
The effects of the inhibition of tryptophan-5-hydroxylase, by p-CPA, 
on the twenty-four hour rhythm of 5-hydroxytryptamine was assessed as 
follows :
Male Sprague-Dawley rats (120-140g) were maintained as described 
previously. Following ten days of acclimatisation, groups of rats 
were taken at 01,00 h, and 13,00 h, and injected orally either with
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p-CPA (316 mg/kgo) or with 0,9% saline. These latter groups served 
as controls. Rats in groups of seven or eight were sacrificed after 
1,2,3,4,7 and 14 days at each clock hour, and the concentration of 
5-hydroxytryptamine in the brains was determined for control and 
experimental groups as described previously.
5,3, RESULTS AND DISCUSSION
The accumulation of ^^C-5-hydroxytryptophan after incubation for 
one hour at 37°C was measured, and calculated as c,p.m, per gram of 
brain wet weight. The results can be seen in Table 2, The results 
for the soluble enzyme extract and the effects of DMPH^ on the system 
are shown in Table 3, The inhibition of tryptophan-5-hydroxylase by 
p-CPA at 01,00 h, is shown in Figure 32, and at 13,00 h, in Figure 33, 
and the maximum effects of p-CPA after 3 days is compared with the 
twenty-four hour rhythm of 5-hydroxytryptamine in the brain in Figure 34
A typical chromatogram from the assay of 5-hydroxytryptophan is 
shown in Figure 35, Other indoleamine standards and a mixture of 
these standards are included to demonstrate the separation of 
5-hydroxytryptophan from other indoleamines which may be involved in 
the assay.
Where Rf are the values obtained from the propan-2-ol; 
anmonia:water solvent, and Rf^^) the values obtained from the 
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0 1 . oo 873.2 - 28.4 
(15)
1 1 1 0 0 2 0.79
13.00 926.9 - 36.4 
(15)
109989 0.84
Table 2 . ^^e conversion of DL- C-tryptophan to
C-5-hydroxytryptophan in a crude enzyme 
preparation. The number of determinations is shown 
in parentheses.
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Figure 3 2 . The effects of one injection of p-CPA (316 mg/kg.p.o.)
( ® ---- @) on 5-hydroxytryptamine concentrations in the
rat brain, at 13.00 h. plotted against time (days) 
Saline control ( A  A),
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Figure 33. The effects of one injection of p-CPA (316 mg/kg.p.o.)
( O  O) on 5-hydroxytryptamine concentrations in the
rat brain at 0 1 . 0 0  h. plotted against time (days). 







Figure 3 4 . The effects of p-CPA (316 mg/kg.p.o.)
on the twenty-four hour variation of 
5-hydroxytryptamine concentrations in 






5 H I M
5 HIAA
5 HTP 5 HTP
5-hydroxy- Tryptophan 5-hydroxy- Mixture 5-hydroxyindole
tryptamine (Try) tryptophan -3-acetic acid
(5-HT) C5-HTP) (5-HlAA)
Figure 3 5 . Two dimensional chromatographic separation of Indoles 
isolated from the rat brain. 1 st p h a s e tpropan- 2 -ol:
ammonia: water (2 0 0 :1 0 :2 0 ) 2 nd phase ---► butan-l-ol:
acetic acid:water (120:30:50).
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acetic acid 0.842 0.320
It is quite clear that 5-hydroxytryptophan is well separated 
from other indoleamines by this method and that the tryptophan substrate 
did not interfere with the 5-hydroxytryptophan samples taken..
The conversion of DL-^^C-tryptophan to ^^C-5-hydroxytryptophan was 
similar in the two methods used* There was no significant difference 
between the conversion rates at the two clock hours measured, and DMPH^ 
was ineffective in increasing the activity of tryptophan- 5 -hydroxylase 
in these systemso It must be added that I had difficulty in assaying 
this enzyme, no matter which of the currently popular methods I 
attemptedo Indeed the methods presented here, although apparently 
crude, were the only methods which showed any degree of reproducibility, 
but as can be seen from the standard errors of the mean presented in 
Tables 2 and 3, even these were not smallo
From these measurements there appears no doubt that tryptophan-5- 
hydroxylase is present in the brain of the rat, although the conversion 
of DL-^^C-tryptophan to ^^C-5-hydroxytryptophan was slow (Oo79 - lol 6 %
per hour), and that the enzyme does not display a twenty—four hour
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rhythm. Since the addition of DMPH^ did not increase the activity 
of the enzyme, it is assumed that there was already sufficient co-factor 
present in the homogenate, and that the enzyme was saturated with 
co-factor.
It has already been shown that a significant twenty-four hour
variation of the uptake of tryptophan into a homogenate does not exist.
The specific activity of the ^^C-tryptophan available for conversion 
14
to C-5-hydroxytryptophan by tryptophan-5-hydroxylase will therefore
be the same at the two clock hours measured. A slightly faster rate 
14
of C-5-hydroxytryptophan formation was indicated at 13.00 h. in both 
forms of homogenate, but there was no statistically significant 
difference between the activities of tryptophan- 5 -hydroxylase at the 
two clock hours.
p-Chlorophenylalanine inhibited the synthesis of 5-hydroxytryptamine 
at the two clock hours with a maximum inhibition after three days and 
returning to control concentrations after fourteen days. The inhibition 
was apparently ineffective in reducing 5-hydroxytryptamine concentrations 
below 170 n^g/g. at this dose of p-CPA. This may either be due to 
insufficient p-CPA being available for the complete inactivation of 
tryptophan-5-hydroxylase, or one might suggest the presence of a stable 
pool of 5-hydroxytryptamine in nerve endings, which cannot be depleted 
by inhibition of synthesis of the amine. Alternatively 5-hydroxytrypt­
ophan taken up from the periphery may account for this low concentration.
p-CPA abolished- the twenty-four rhythm of 5-hydroxytryptamine 
concentrations. Since this inhibition of synthesis was much greater 
(61%) at 13.00 h. than at 01.00 h. (33%), it is proposed that the 
twenty-four hour rhythm of 5-hydroxytryptamine concentrations in the 
rat brain is controlled at some stage in the synthesis of the amine.
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Tryptophan-5-hydroxylase has often been considered to be the 
limiting factor in 5-hydroxytryptamine synthesis. These results 
suggest that the enzyme is not the regulating factor in the control 
of the twenty-^four hour rhythm of 5-hydroxytryptamine.
If one looks collectively at the results produced in this thesis 
so far, it is apparent that the total concentration of tryptophan in 
the brain does not regulate the concentration of 5-hydroxytryptamine, 
since their respective twenty-four hour rhythms are twelve hours (180°) 
out of phase. The measurement of the uptake of tryptophan into a 
synaptosomal fraction showed that this process was independent of 
total tryptophan concentrations in the brain, but may be dependent 
on the concentration of tryptophan which is immediately available for 
uptake into the nerve endings or nerve cell body. It is now apparent 
that the conversion of tryptophan to 5-hydroxytryptophan is also 
independent of tryptophan concentration. From these data it is 
possible to speculate that at different clock hours, the concentrations 
of 5-hydroxytryptophan in the brain are equal, and should show no 
twenty-four hour variation unless the concentration is affected by 
the uptake of the 5-hydroxy amino acid from peripheral sources. At 
this stage one must conclude that these initial steps in the synthesis 
of 5-hydroxytryptamine play no direct role in the production of the 
twenty-four hour rhythm of 5-hydroxytryptamine concentrations. However, 
a contribution to the establishment of the rhythm is apparent i.e. if 
one now looks at the twenty-four hour rhythm of 5-hydroxytryptamine 
concentrations in the brain with highest concentrations at 13.00 h . , 
it is no longer necessary to propose a system whereby tryptophan 
concentrations, which are twelve hours out of phase with 
5-hydroxytryptamine concentrations, might participate in the control
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of the twenty-four hour rhythm of 5-hydroxytryptamine concentrations, 
since the concentration of 5-hydroxytryptophan produced by tryptophan- 
5-hydroxylase activity is the same at both clock hours.
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C H A P T E R  S I X
The Role of 5-hydroxytryptophan in the Twenty-four hour 
rhythm of 5-hydroxytryptamine in the rat brain.
126.
6.1 INTRODUCTION
The conversion of tryptophan to 5-hydroxytryptamine requires 
aromatic ring hydroxylation in the 5 position and decarboxylation of 
the side chain. This may occur by either the initial decarboxylation 
to tryptamine followed by hydroxylation, or hydroxylation to 
5-hydroxytryptophan followed by decarboxylation. Udenfriend, 
Creveling, Posner, Redfield, Daly and Witkop (1959) found no evidence 
for tryptamine as a precursor of 5-hydroxytryptamine, while the 
injection of 5-hydroxytryptophan increased brain 5-hydroxytryptamine 
concentrations (Udenfriepd, Titus, Weissbach and Peterson 1956).
5-hydroxytryptophan is normally undetectable in the rat brain, 
and assay is thus non-productive unless the amino acid is allowed to 
accumulate following the administration of a 5-hydroxytryptophan 
decarboxylase inhibitor (Carlsson and Lindqvist 1970). These workers 
then found that 5-hydroxytryptophan and 5-hydroxytryptamine were 
similarly distributed, and that the precursor was located in nerve cell 
bodies and nerve terminals in areas normally containing 5-hydroxytrypt­
amine in the rat brain. Fuxe (1965) and Corrodi, Fuxe and Hokfelt
(1967) demonstrated that 5-hydroxytryptophan was specifically taken up 
and decarboxylated in 5-hydroxytryptamine-containing neurones in the 
rat brain, while catecholamine-containing neurones were little 
affected by the amino acid.
L-5-hydroxytryptophan is the active isomer although the D -form 
may be oxidised and transaminated to the L-isomer (Oates and 
Sjoerdsma 1961) and may then be taken up into the brain. This 
uptake was much more rapid in rats between one and twenty-one days 
of age than in older animals (Kellogg and Lundborg 1972).
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The in vitro uptake of 5-hydroxytryptophan into nerve endings 
or cell bodies is an active process requiring glucose and is 
inhibited by dinitro phenol (Schanberg 1962, Smith 1963). Only a 
small proportion of the 5-hydroxytryptophan taken up was decarboxylated 
to 5-hydroxytryptamine. The uptake process was inhibited by 
L-phenylalanine and ot-methyl dopa, and was not linked to decarboxylation 
(Smith 1963).
The behavioural responses of rats which have been injected with 
high doses of 5-hydroxytryptophan are very marked, characteristically 
producing an overt stimulation (piloerection, panting increased motor 
activity) (Brodie, Comer, Costa and Dlabac 1966). These authors 
suggested that this was due to the release of noradrenaline by 
5-hydroxytryptophan since one large dose of the amino acid reduced 
brain noradrenaline concentrations by 50%. Johnson, Kim and Boukma
(1968) demonstrated the inhibition of the synthesis of noradrenaline 
by 5-hydroxytryptophan (600 mg/kg i.p.) and in addition showed that the 
incorporation of ^^C-tyrosine into rat brain noradrenaline and the 
specific activity of the isolated noradrenaline were reduced. They 
found no evidence that 5-hydroxytryptophan mediated the release of 
noradrenaline.
5-hydroxytryptophan has been used in clinical trials to alleviate 
the symptoms of schizophrenia and depression, although the results are 
rarely encouraging (Wyatt, Vaughan, Kaplan, Galanter and Green 1973; 
Brodie, Sack and Siever 1973). 5-hydroxytryptophan has however been 
shown to increase slow wave sleep and to delay paradoxical sleep in 
rabbits (Tabushi, Kaoru and Himwich 1970), so might therefore be 
expected to aid schizophrenic and depressed patients.
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Weiss, Wurtman and Munro (1973) showed that 5-hydroxytryptophan 
was able to disaggregate brain polysomes, and they therefore postulated 
that intracellular aittines may normally participate in the control of 
brain protein synthesis.
In this Chapter the concentrations of 5-hydroxytryptophan have 
been estimated over a twenty-four hour period in the rat brain, and 
characteristics of the uptake of DL-^^C-5-hydroxytryptophan into 
homogenates of the septal region of rat brain have been determined.
The effects of the results obtained on the twenty-four hour rhythm 
of 5-hydroxytryptamine are discussed.
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6.2 METHODS
Male Sprague Dawley rats (120 - 140g) were maintained for 
ten days under constant environmental conditions (Chapter Two),
6.2.1 Determination of the Twenty-four hour rhythm of
5-hydroxytryptophan concentrations in the rat brain.
Following acclimatisation, rats in groups of seven or eight 
were killed by decapitation at four-hourly intervals commencing 
at 09.00 h. The pineal glands were discarded and the brains were 
immediately removed and 5-hydroxytryptophan was isolated by the 
chromotographic methods described in Chapter Five. No 5-hydroxy­
tryptophan was added to brain homogenates, only to standard 
chromatograms. The areas containing 5-hydroxytryptophan were cut 
out and the amino acid was eluted from the paper with 1 0  ml.distilled 
water evaporated to dryness under reduced pressure at 55°C and made up 
to 2 . 0  ml. with distilled water. 1 . 0  ml. was acidified with 0.3 ml. 
conc. HCl and the native fluorescence of 5-hydroxytryptophan was 
measured at excitation wavelength 280 mji and emission wavelength 540 m|i 
(wavelengths uncorrected). The fluorescence spectrum of the amino acid 
was determined.
6.2.2. Determination of the Uptake of DL-^^C-5-hydroxytryptophan
into homogenates of the Septal Region of rat brain.
The method was exactly the same as that described in Chapter Three 
14
for the uptake of DL- C-5-hydroxytryptamine into homogenates of the 
septal region of rat brain with the exception that DL-^C-5-hydroxy- 
tryptophan (51 mCi/mmole) was used as the substrate. The Michaelis
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constant and the effects of time, temperature and pH on the uptake 
of DL-^^C-5-hydroxytryptophan were determined at 01.00 h. and 13.00 h, 
by the methods described previously in Chapter Three. All results 
are the means of three experiments.
6.3 RESULTS and DISCUSSIONS
The fluorescence spectrum of 5-hydroxytryptophan exibited two 
peaks (Figure 36) when measured by the native fluorescence method. 
The first, at excitation wavelength 280 m^, emission wavelength 
540 nyi, and the second at excitation wavelength 300 mji and emission 
wavelength 580 nyi. When fluorescence intensity was plotted against 
the concentration of 5-hydroxytryptophan (Figure 37) a linear plot 
was obtained only at the former wavelengths which were therefore 
selected to measure the concentrations of 5 -hydroxytryptophan from 
the chromatograms.
The effects of the related indoleamines, tryptophan, 
5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid, on the native 
fluorescence of 5-hydroxytryptophan were determined (Table 4).














Table 4. The effects of related indoleamines on the native fluorescence 










































Figure 36. The fluorescence spectrum of extracted
5-hydroxytryptophan (a) compared with the 
pure compound (b) . (a — — — A) excitation 280 mp 
scan emission; (□— — □) emission 540 mp scan 
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Figure 37. Standard curves of 5-hydroxytryptophan fluorescence
at wavelengths 280 mp, 540 nyi ( © ---  ©) and 300 mp,
580 mp (0   0) .
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It was found that although tryptophan has no effect, both 
5-hydroxytryptamine and 5-hydroxyihdole-3-acetic acid fluroresce 
at least as much as 5 -hydroxytryptophan at these wavelengths.
It was therefore found to be essential to separate the indoleamines 
before measurement, and this has already been shown to be 
accomplished by the chromatographic method employed (Chapter Five).
The concentrations of 5-hydroxytryptophan determined over a 
twenty-four hour period can be seen in Table 5. The results shown are 
those calculated from the total 5 -hydroxytryptophan measured with the 
water blank substracted, and are expressed as mpg. 5 -hydroxytryptophan 
per g. brain wet weight.




13.00 72 + 3.9 (8 )
17.00 55 + 5.1 , (7)
2 1  < > 0 0 77 + 6 . 1 (7)
0 1 . 0 0 62
+
3.6 (8 )
05.00 52 + 3.6 (7)
09.00 59 + 4.1 (8 )
Table 5. The twenty-four hour variation of 5-hydroxytryptophan
concentrations in the rat brain. Numbers of animals used 
in each group are,shown in brackets.
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These results can only be regarded as estimates of 
5-hydroxytryptophan concentrations since the fluorimetric 
measurements obtained were only marginally greater than readings 
secured for the water blank. From the results obtained, the twenty- 
four hour variation of 5-hydroxytryptophan concentrations in the rat 
brain did not correspond to a sine curve when calculated by Fourier 
analysis 9 and it must therefore be concluded that there was no 
twentyvfour hour rhythm of 5 -hydroxytryptophan concentrations in the 
rat brains However, a method providing better resolution of the 
extracted product might indicate differences not detected here. 
Alternatively, the use of decarboxylase inhibitors may give an 
indication of endogenous concentrations of the amino acid, although 
it was felt that a method which measured endogenous concentrations 
directly was essential to this project. In any event the very low 
concentrations of 5-hydroxytryptophan recorded led to the inevitable 
conclusion that there is no store of the amino acid in the rat brain, 
but that it must be rapidly broken down to 5-hydroxytryptamine or 
via other routes.
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The uptake of DL- C-5-hydroxytryptophan into septal homogenates 
increased with time to a maximum after six minutes, remained stable up 
to twenty minutes and slowly declined after this period when incubated 
at 37^C at pH 8.0 (Figure 38).
The uptake process was temperature (Figure 39) and pH (Figure 40) 
dependent and there was no significant difference between the uptake 
process subjected to these variables at 01.00 h. and 13.00 h.
Maximum uptake was obtained at 37°C and pH 8.0 at both clock hours.
Since the endogenous concentrations of 5-hydroxytryptophan are
apparently the same at 01.00 h. and 13.00 h . , it can be assumed that
lA

















The uptake of C-5-hydroxytryptophan 
(5 X 10 M) into a septal homogenate plotted 
against incubation time at 37 C, pH 8.0. 13.00 h,
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Figure 3 9 . The uptake of C-5—hydroxytryptophan
(5 X 1 0 ~ % )  into a septal homogenate plotted 
against temperature at pH 8.0. 13.00 h
( A  A )  and 01.00 h. ( A  A ) .











6 73 8 9 10
pH
Figure 40. The uptake of C-5-hydroxytryptophan
(5 X 10 ^M) into a septal homogenate plotted 
against pH at 37°G. Incubation time was
6  minutes. 13.00 h. ( A  A )  and 01.00 h.
( ^ ^  ) •
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same at these clock hours. The Michaelis constant for 5-hydroxy-
- 6
tryptophan uptake was 8,3 x 10 M at 01.00 h. (Figure 41) and 
-6
9o3 X 10 M  at 13.00 h. (Figure 42). There was no significant
difference between these values, and there was no significant
difference in V at these clock hours. It was therefore 
max
concluded that there was no twenty-four hour rhythm of the uptake 
of 5-hydroxytryptophan in the rat brain.
It was concluded from these results that neither the 
endogenous concentrations of 5-hydroxytryptophan nor the uptake 
of 5-hydroxytryptophan into 5-hydroxytryptamine-containing neurones 
in the brain play a controlling part in the production of the twenty- 
















































































































































































































C H A P T E R  S E  V E N
The Involvement of 5-hydroxytryptophan decarboxylase in the production 
of the Twenty-four Hour Rhythm of 5-hydroxytryptamine in the rat brain.
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7.1 INTRODUCTION
5-hydroxytryptophan decarboxylase (EC.4.1.1.28) (M.wt.112,000) 
catalyses the synthesis of 5-hydroxytryptamine from 5-hydroxytryptophan 
in the CNS, and the localisation of the enzyme parallels that of 
5-hydroxytryptamine (Gaddum and Giarman 1956). There is good 
evidence that most of the 5-hydroxytryptophan decarboxylase in the 
rat brain is present in monoamine neurones and is highly active there 
(Anden, Magnusson and Rosengren 1965).
The trivial name L-aromatic amino acid decarboxylase has been 
adopted to describe both 5-hydroxytryptophan decarboxylase and 
3,4-dihydroxy-L-phenylalanine decarboxylase (EC.4.1.1.26) activities, 
and there remains some dispute as to whether these enzymes are different, 
Clark Weissbach and Udenfriend (1954) found two distinct enzymes, 
although Lovenberg, Weissbach and Udenfriend (1962); Christenson,
Dairman and Udenfriend (1970) and Hokfelt, Fuxe and Goldstein (1973) 
could only find one enzyme, but this had the ability to decarboxylate 
both 5-hydroxytryptophan and 3,4-dihydroxyphenylalanineo (DOPA).
Coulson, Bender and Jepson (1969) found four peaks of decarboxylase 
activity following separation of the protein fraction one of these 
was more specific towards the 5-hydroxyttyptophan substrate while two 
others were more specific for 3 ,4-dihydroxyphenylalanine. Yuwiler, 
Geller and Eiduson (1960) proposed one enzymic site involved in the 
decarboxylation of 5-hydroxytryptophan and DOPA and they suggested 
that DOPA may combine irreversibly at a 5-hydroxytryptophan site 
while reacting at a different site but 5-hydroxytryptophan probably 
could not bind irreversibly at DOPA sites.
5-hydroxytryptophan and DOPA show widely different pH optima 
for the enzyme but they are mutually competitive, and there is 
apparently no relation between the probable ionisation states of
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the substrates and the pH dependence of the enzyme (Bender and 
Coulson 1972). These authors proposed that the enzyme has a complex 
active site with separate affinity sites for the two substrates 
adjacent to a single catalytic site. The decarboxylase enzyme(s) 
has a pyridoxal phosphate co-factor requirement, and evidence of 
only one catalytic site has been presented by the finding of only 
one molecule of pyridoxal phosphate per molecule of enzyme (Christenson, 
Dairman and Udenfriend 1970).
Aromatic-L-amino acid decarboxylase is a soluble enzy&e in most 
tissues, but in brain preparations a part of the activity is apparently 
bound or enclosed in vesicles (Arnaiz and DeRobertis 1964).Sims 
Davis and Bloom (1973) found 5-hydroxytryptophan decarboxylase activity 
almost equally distributed between soluble and particulate fractions, 
and there was a definite association of the enzyme with fractions 
containing large numbers of nerve endings.
Maturation studies of 5-hydroxytryptophan decarboxylase have shown 
that in all brain regions the enzyme and 5-hydroxytryptamine concentrations 
mature differently (Baker, Hoff and Smith 1973) thus indicating that the 
enzyme is not a regulating factor in the synthesis of 5-hydroxytryptamiiie 
during maturation. Conversely Hakanson, Lombard, Des Gouttes and 
Owman (1967) found 5-hydroxytryptophan decarboxylase to be a controlling 
step in the maturation of 5-hydroxytryptamine concentrations in the 
pineal gland.
Yuwiler, Geller and Eiduson (1971) were unable to demonstrate a 
circadian variation for 5-hydroxytryptophan decarboxylase in liver 
extracts.
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In this Chapter 5-hydroxytryptophan decarboxylase activity has 
been assessed and characteristics of the enzyme have been determined 
in rat brain homogenates. The activity of the enzyme was also 
determined in a purified enzyme preparationj and the twenty-four hour 
variation of enzymic activity was measured in both enzyme preparations
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7.2 METHODS
Male Sprague Dawley rats (120 - 140g) were maintained for ten days 
under constant environmental conditions before each experiment as 
described in Chapter Two.
7.2.1 Assay of 5-hydroxytryptophan decarboxylase activity
Rats were killed by decapitation, the pineal glands discarded, 
and the brains removed immediately weighed and homogenised in ice-cold
0.25M sucrose (4 ml./brain). The homogenates were centrifuged at
o 0 -3
l,500g. for ten minutes at 4 C. 0.1 ml. pargyline (10 M  made up in
pH 8.0 phosphate buffer 94.5 m l .) Na^ HPO^ (1.780g/100 ml) + 5.5 ml
KH^PO^ (1.361g/100 ml) ), and 0.1 ml. pyridoxal phosphate 
-4
(4 X 10 M made up in pH 8.0 phosphate buffer) were added to 1.0 ml. 
of the supernatant. The mixture was pre-incubated at 37°C for ten 
minutes. 1.0 ml. DL-5-hydroxytryptophan (5 x 10 ^M made up in 
pH 8.0 phosphate buffer) was added and these reactants were incubated 
together for varying time intervals. The reaction was stopped by the 
addition of 0.1 ml. 4N.H2S0^. The 5-hydroxytryptamine formed from the 
reaction was assayed by the method of Snyder, Axelrod and Zweig(1965) 
as described in Chapter Three with the exception that the borate 
buffer pH 10.0 washing was repeated three times.
In later experiments DL-^^C-5-hydroxytryptophan (2.5 x 10 ^M) 
was used as the substrate. The incubation was carried out as already 
described but the assay of 5-hydroxytryptamine was modified as follows: 
The incubation mixture was shaken for five minutes with 10 ml. acid
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n-butan-l-olo 15 ml. water and 30 m l . n-heptane were added and the 
mixture was shaken for five minutes and centrifuged at 500g. for five 
minutes. 10 ml. of the aqueous phase was added to 5 ml. borate buffer 
pE 10.0 10 ml. butan-l-ol and 4 gm. sodium chloride, shaken for five 
minutes and centrifuged at 500g. for five minutes. All the butan-l-ol 
phase was shaken twice more with 2.0 ml. borate buffer pH 10.0 and 2g. 
NaCl. 5 ml. of the butan-l-ol phase was added to 2.0 ml. phosphate 
buffer pH 7.0 and 10 ml. n-heptane and was shaken for five minutes 
and centrifuged at 500g. for five minutes. 0.5 ml. phosphate buffer 
phase was added to 5 ml. Unisolve and taken for liquid scintillation 
analysis.
The effects of pH, temperature, incubation time and pyridoxal 
phosphate concentration were determined following one or other of these 
assay procedures. The conditions for the different experiments presented 
in this Chapter will be described in the legends to the Figures.
7.2.2 The twenty-four hour variations of 5-hydroxytryptophan- 
decarboxylase activity.
The twenty-four hour variation of 5-hydroxytryptophan decarboxylase 
activity wâs determined using the isotopic method described above. Rats 
were killed at four-hourly intervals commencing at 09.00 h.
7.2.3 Investigation of factors affecting 5-hydroxytryptophan- 
decarboxylase activity.
In order to determine whether the activity of the enzyme was a 
consequence of tryptophan-5-hydroxylase activity or endogenous 
5-hydroxytryptophan productions, groups of rats were pre-treated with
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p-chlorophenylalanine (316 mg/kg p.o) and killed three days later at 
varying clock h o u r s a n d  the activity of 5-hydroxytryptophan 
decarboxylase was determined isotopically as described before.
In order to determine whether the variation of the activity of 
the enzyme was dependent.upon its co-factor requirements, the enzyme 
was isolated by the method of Clark, Udenfriend and Weissbach (1954) 
and its activity was measured as follows:
Rats were killed by decapitation at 01.00 h. and 13.00 h® The 
pineal glands were discarded and the brains were immediately removed 
and homogenised in ice-cold distilled water (8 ml./brain). The 
homogenates from four brains were pooled and centrifuged at 1500 rpm 
for twenty minutes at 0°C. 14 ml. saturated ammonium sulphate pH 8.1
was added to the supernatant. The mixture was shaken, allowed to stand 
for twenty minutes at 0°C, and was then centrifuged at 1500 rpm for 
twenty minutes at 0°C. 14 ml. saturated ammonium sulphate pH 8.1
was added to the supernatant, shaken and allowed to stand for twenty 
minutes at 0°C. The mixture was centrifuged at 3000 rpm for thirty 
minutes at 0°C and the precipitate was dissolved in 5 ml. water and 
dialysed against ice-cold distilled water for three hours. The pH 
was rapidly adjusted to pH 5.8 with 0.02N acetic acid, an equal 
amount (^Vv) of alumina was added and the mixture was allowed to 
stand for thirty minutes on ice stirring occasionally. The alumina 
wâs washed once with 5 ml. water and the washings discarded, and then 
four times with 5 ml. O.IM phosphate.buffer pH 6.3 and the washings 
were collected on ice. The activity of the enzyme was assayed ascfollows 
all solutions were made up in O.IM phosphate buffer pH 8.0.
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0.1 ml. pyridoxal phosphate (4 x 10 M) and 1.3 ml. O.IM
phosphate buffer pH 8.0 were added to 2.0 ml. of the enzyme preparation
and the mixture was pre-incubated for ten minutes at 37°C. 0.1 ml
-5
DL-5-hydroxytryptophan (1 x 10 M) was added and the reactants were 
incubated for 15, 30 and 45 mins. at 37°C. In some tubes 0.1 ml.
O.lM phosphate buffer pH 8.0 replaced 0.1ml DL-5-hydroxytryptophan in 
order to measure the unreacted blank. The reaction was stopped with 
0.1 ml. 4N.H2S0^. The 5-hydroxytryptamine formed during the reaction 
was assayed as follows:
The reaction mixture was adjusted to pH 10.0 with N.NaOH, saturated 
with NaCl and shaken for five minutes with 10 ml. washed butan-l-ol.
8.5 ml. of the butan-l-ol phase was washed three times with 2.0 ml. salt 
saturated borate buffer pH 10.0. 7.5 ml. of the organic phase was
added to 10 ml. n-heptane and 2.0 ml. phosphate buffer pH.7.0 and shaken 
for five minutes. 1.2 ml. phosphate buffer was heated at 70°C for 
thirty minutes with 0.1 ml. O.IM ninhydrih reagent. The mixture was 
cooled to 4°C for one hour; and the fluorescence measured at excitation 
wavelength 380 mji, emission wavelength 490 vaji (wavelengths uncorrected).
7.3 RESULTS AND DISCUSSION
The rate of synthesis of 5-hydroxytryptamine from 5-hydroxytryptophan 
in a crude homogenate (method 7.2.1) varied at the two clock hours measured 
(Figure 43). The rate of formation of 5-hydroxytryptamine was 0.875 ^  moles/ 
h ^/g ^ brain (wet weight) at 13.00 h. and 0.70 p moles/h ^/g  ^ at 01.00 h.
At 13.00 h synthesis was linear over a three hour period but synthesis 
remained linear only over a two hour period in samples taken at 01.00 h. 
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Figure 4 3 . The effects of incubation time on 5-hydroxytryptophan
decarboxylase activity at 01.00 h ( #  O) and 13.00 h,
( A  A )  in a homogenate of whole rat brain.
5-hydroxytryptophan 5 x 10 % ;  pH 8.0; 37°C.
Results are the mean of five experiments.
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At OloOO h and 13«00 ho the optimum temperature of incubation for 
5“hydroxytryptôphan decarboxylase was 37°C (Figure 44) and the pH 
optimum was 8 «0 (Figure 45)o Activity was very low at high (60°C) 
and low (4°C) temperatures and in acid (pH 5oO) conditions»
The rate of 5-hydroxytryptamine synthesis was 0o430 p moles/
-1 -1 -1 -1 
h /g at 13o00 ho and 0.320 p moles/h /g at 01,00 h, in samples
pre-incubated without added pyridoxal phosphate (Figure 46), The
rate of synthesis increased with added pyridoxal phosphate concentration
in the pre-incubation mixture to a maximum at a concentration of 
-4
4 X 10 Mo The increased rate of synthesis was approximately 100% 
at both clock hours.
As has already been stated, one molecule of enzyme receives only 
one molecule of co-factor (Christenson, Dairman and Udenfriend 1970) and 
it is therefore assumed that the enzyme is, at least in part, maintained 
in an inactive form since addition of pyridoxal phosphate was able to 
increase the amount of product formed in a given time. The activity of 
the enzyme increased proportionally in samples taken at 01,00 h, and
13,00 h, when pyridoxal phosphate was added. As a result it can be 
concluded that the twenty-four hour variation in enzyme activity is 
probably not due to different amounts of 5-hydroxytryptophan decarboxylase 
being present.
In order to determine whether the variation of 5-hydroxytryptophan 
activity was a consequence of pyridoxal phosphate availability or 
whether there was a change in the activity of the enzyme at different 
clock hours, the enzyme was isolated and assayed as described in the 
Methods in this Chapter (Methods 7,2,3), The rate of 5-hydroxytryptamine 
synthesis using the purified enzyme extract was maximal after thirty 
minutes of incubation under the conditions employed, and the rate did 



























Figure 4 4 . The effects of temperature on the activity of 
5-hydroxytryptophan decarboxylase at 01.00 h
( O  •) and 13.00 h. ( A ----A )  in a
homogenate of whole brain. pH 8.0, incubation 
time Ih. 5-hydroxytryptophan 5 x 10~^M.
Results are the mean of three experiments.
152.




















Figure 4 5 . The effects of pH on the activity of 5-hydroxytrypt-
phan decarboxylase at 01.00 h ( ® --- ©) and 13.00 h.
 A )  in a homogenate of whole brain. Incubated
for Ih. at 37°C. 5-hydroxytryptophan 5 x 10”3m . 































Figure 4 6 . The effects of pyridoxal phosphate concentration on 
the activity of 5-hydroxytryptophan decarboxylase at
01.00 h ( ©  O )  and 13.00 h. ( A  A) in a
homogenate of whole brain. Incubated for 1 h, at 
37°C and pH 8.0. 5-hydroxytryptophan 5 x 10“3m . 










Figure 4 7 . The activity of a purified preparation of
5-hydroxytryptophan decarboxylase at 01.00 h.
( 9 ---- ©) and 13.00 h. ( O ---- O) . Incubated at
pH 8.0 for 1 h. at 37°C with 4 x 10”^M pyridoxal 
phosphate. Results are the mean of ten experiments
155.
It was therefore concluded that there was no twenty-four hour variation 
in the activity of the enzymeo
Since no twenty-four hour variation of enzyme activity was found 
in a purified extract, and a twenty-four hour variation was shown in a 
crude homogenate it must be concluded that this variation in the 
activity of the enzyme is due to other factors. The addition of 
varying concentrations of pyridoxal phosphate did not cancel out the 
twenty-four hour variation so the availability of this co-factor does 
not appear to regulate the variation of enzyme activity. Equally, 
the availability of precursor did not appear to affect the activity of 
the enzyme since pretreatment with p-chlorophenylalanine did not 
significantly alter the rates of synthesis at 01.00 h. and 13.00 h. 
when measured in a crude homogenate (Figure 48). As a consequence 
of this last finding it appears that 5-hydroxytryptophan decarboxylase 
is probably unsaturated with its substrate.
The twenty-four hour variation of 5-hydroxytryptophan decarboxylase 
is therefore controlled by other factors, possibly by competition of the 
5-hydroxytryptophan substrate with other amino acids e.g. DOPA.
As stated in Chapter Three of this thesis, maximal concentrations 
of 5-hydroxytryptamine and its precursors have been found at 01.00 h. 
and 13.00 h. It was therefore felt justified to take these two clock 
hours to determine many of the variables which might affect the 
concentration of 5-hydroxytryptamine in the rat brain. Unfortunately, 
in the case of 5-hydroxytryptophan decarboxylase it can now be seen 
(Figure 49) that highest activity was measured at 17.00 h. and lowest 
activity at 09.00 h. The twenty-four hour variation was not 
significantly different from the calculated sine curve (Figure 50), 
and the highest activity was significantly different from the lowest 



























Figure 4 8 . The activity of 5-hydroxytryptophan decarboxylase
at 01.00 h. ( © ---  ©) and 13.00 h. (0   0)
following pretreatment of rats with p-CPA (316 mg/kg, 
p.o^  . Whole brain homogenate incubated at pH 8.0 for 
1 h. at 37°C. Results are the mean of eight 
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Figure 49. The twenty-four hour rhythm of 5-hydroxytryptophan 
decarboxylase activity (i SEM) in the rat brain. 
Solid black bars indicate the hours of darkness.
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Figure 50. The twenty-four hour rhythm of 5-hydroxytryptophan 
decarboxylase activity compared with the calculated 
sine curve.
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the activity at 13,00 h, was significantly different ( p < 0,001) 
from the activity at 01,00 h.
The results obtained from these experiments indicate that 
5-hydroxytryptophan decarboxylase activity or the availability of 
the enzyme to decarboxylate 5-hydroxytryptophan could play an 
important part in the production of the twenty-four hour rhythm 
of 5-hydroxytryptamine synthesis.
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C H A P T E R  E I G H T
The activity of monoamine oxidase and the effects of monoamine oxidase 




Monoamine oxidase (EC.1.4.3.4) (MA.O) has been widely reported to 
be important in the regulation of the effective concentrations of 
biologically active amines in the CNS (Davison, 1958; Page 1958;
Axelrod 1959). All monoamines are susceptible to this enzyme and 
catecholamines and 5-hydroxytryptamine are therefore readily 
metabolised by MAO in neuronal tissues (Brodie, Spector and 
Shore 1959). MAO is an insoluble enzyme located mainly in the 
outer membrane of the mitochondria (Schnaitman, Erwin and 
Greenftwalt 1967). Rodriguez and De Robertis (1962) reported 70.2%
MAO activity in the mitochondrial fraction, 17.5% in the nuclear 
fraction and 12.5% in the microsomal fraction. The half life of the 
enzyme in the brain is approximately eleven days, and this half life 
bears no relation to the turnover rates of the monoamines (Goridis and 
Neff 1971)o The activity of MAO is unaffected by raphe lesions which 
deplete 5-hydroxytryptamine concentrations (Marsden* Broch and 
Guldberg 1972).
Johnston (1968) suggested that there was more than one MAO in the 
brain. Gorkin (1969) came to a similar conclusion using liver extracts 
containing MAO. Huszti and Borsy (1968) suggested different forms of 
the enzyme inactivated 5-hydroxytryptamine and dimethoxyphenylethylamine,
Youdim, Collins and Sandler (1969) isolated four forms of MAO from 
rat brain, and also showed that hârmaline and other p -carbpline 
monoamine oxidase inhibitors (MAOIJ increased 5-hydroxytryptamine 
concentrations in the rat brain without affecting noradrenaline and 
dopamine concentrations, thus providing further evidence for more 
than one enzyme, although the possibility exists that there are 
differing substrate specificities for different molecular forms of 
the same enzyme. Yang, Goridis and Neff (1972) agreed that there may
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be multiple forms of MAO and also reported that some forms of the 
enzyme appear to be located in specific tissues.
The rate of deamination of 5-hydroxytryptamine is increased 
by L-DOPA (Karobath, Diaz and Huttunen 1972) and decreased by MAGI. 
MAOI are generally classified as hydrazine derivatives and non­
hydrazine derivatives but have the common function of inhibiting 
the activity of MAO. The non hydrazine derivatives also increase 
the rate of conversion of 5-hydroxytryptophan to 5-hydroxytryptamine 
(Weber 1966). The characteristic behavioural pattern following the 
injection of MAOI plus tryptophan or 5-hydroxytryptophan (front paw 
clonus, piloerection, exophthalmia and body tremors) are related to 
the degree of MAO inhibition and not to 5-hydroxytryptamine 
concentrations (Weber 1966). The inhibition of MAO by pargyline 
is probably due to the MAOI combining irreversibly with the flavin 
co-factor of the enzyme, (Oreland, Kinemuchi and Yoo 1973) and it is 
possible that other MAOI act in a similar manner.
The specific activity of MAO reaches adult levels by two weeks 
post partum in all regions of the brain except in the cerebellum, 
and it is therefore apparent that all the components of the 
indoleamine pathway do not mature synchronously.
The twenty-four hour variation of MAO activity has not been 
widely investigated. Snyder, Axelrod and Zweig (1967) could not 
find such a variation in enzyme activity in the pineal gland.
However, Hery, Rouer and Glowinski (1972) found a more pronounced 
oxidative deamination of newly synthetised 5-hydroxytryptamine in 
the hypothalamus and brain stem during darkness, but indicated that 
this was due to an increased release of the amine and not to changes 
in enzyme activity.
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Since MAO catalyses the breakdown of gll monoamines, changes in 
the ratios of enzyme concentrations.following MAGI will alter animal 
behaviour» Valzelli and Garattini (1968) have summed up this 
situation»
"Considering that 5-hydroxytryptamine, noradrenaline and dopamine 
may exert an opposite or synergic effect on given receptors it is 
suggested that certain pharmacological effects of MAGI's may be 
associated not only with the increased level of brain amines, but 
also with new ratios which are established between the various amines 
in specific parts of the brain."
In this Chapter the activity of monoamine oxidase in the rat brain 
has been measured at two clock hours, and the effects of three monoamine 
oxidase inhibitors on the accumulation and synthesis rates of 




Male Sprague Dawley rats (120 - 140g) were maintained under the 
constant environmental conditions described in Chapter Two for ten days 
before each experiment.
8 o2 o1 Assay of Monoamine oxidase (MAO) ( monoamine:02 oxidoreductase 
(deaminating) EC. 1.4.3.4.) activity.
Acclimatised male Sprague Dawley rats, in groups of seven or eight, 
were killed by decapitation at either 01.00 h. or 13.00 h. The pineal 
gland was discarded and the brain rapidly removed, weighed and homogenised 
in ice-cold 0.25M sucrose (10 ml./g) and centrifuged twice at l,500g. at 
0°C for ten minutes to precipitate excess debris. The supernatant was 
removed and centrifuged at 18,000g. at 0°C for twenty minutes to obtain 
a crude mitochondrial fraction. The pellet was resuspended in 5 ml.
0.05M phosphate buffer pH 7.4 and centrifuged at 18,000g. at 0°C for 
twenty minutes. The pellet was resuspended in 1.7 ml. 0.05M
phosphate buffer and the activity of the MAO was determined as follows:
14 -5
0.2 ml. DL- C-5-hydroxytryptamine (57 mCi/m.mole) (2 x 10 M)
+ 0.1 ml. non-radioactive DL-5-hydroxytryptamine ( 1 x 10 ^M) was added
to the homogenate obtained above and was incubated at 37°C for one hour
in a shaking water bath. The reaction was stopped by boiling for five
minutes at 100°C. ^^C-5-hydroxyindole-3-acetic acid was isolated by
the chromatographic method described in Chapter Five, with the exception
that only one-way paper chromatography was employed, using the
propan-2-ol:ammonia:water solvent system. The areas containing the 
14
C-5-hydroxyindole-3-acetic acid were cut out, eluted with 10 ml.water 
and evaporated to dryness under reduced pressure at 55°C, and made up
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to loO ml. with water. 0.5 ml. was added to 5 ml. Unisolve and 
taken for liquid scintillation counting. The rate of formation 
of 5-hydroxyindole-3-acetic acid was calculated from the results 
obtained.
8.2.2 The Effects of Monoamine Oxidase Inhibitors (MAOI)
on the twenty-four hour rhythm of 5-hydroxytryptamine 
in the rat brain.
Male Sprague Dawley rats were maintained under constant 
environmental conditions for ten days before each experiment as 
described in Chapter Two. Rats were kept in groups of seven or 
eight.
In the first experiment, rats were injected intraperitoneally 
with pargyline (150 mg/kg) or saline (0.9%) and were killed by 
decapitation four hours later such that one group of pargyline treated 
and one group of saline treated was killed at 01.00 h. and one group 
of each was killed at 13.00 h. The concentration of 5-hydroxytrypt^ 
amine in each group was determined by the method described in Chapter 
Three.
In the second experiment, rats were injected intraperitoneally 
with tranylcypromine (20 mg/kg) or saline (0.9%) and the procedure 
carried out as before using animals killed at 01.00 h. and 13.00 h.
In the third experiment rats were allowed free access to a 
solution of isocarboxazid (100 jig/ml.tap water), which replaced the 
normal drinking water, for either four or eight days. Drinking 
activity was monitored by the method described in Chapter Eleven.
In the first instance groups of rats were killed, after four days.
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at four-hourly intervals throughout twenty-four hours to determine 
the twenty-four hour variation of the effects of MAOI on 
5-hydroxytryptamine concentrations. In the second instance groups 
of rats were killed after 4 days or 8 days at 01.00 h. and 13,00 h. 
only in order to determine the long term effects of MAOI on the 
twenty-four hour rhythm of 5-hydroxytryptamine concentrations in 
the rat brain.
8.3 RESULTS AND DISCUSSION
The rate of formation of 5-hydroxyindole-3-acetic acid from 
5-hydroxytryptamine was 624 - 11 mp.moles/h ^ at 01.00 h. and 
597 i 13 mp.moles/h ^ at 13.00 h. (Table 6). Each estimate was 
made as the rate formed per brain, since there was no significant 
difference between brain weights at these clock hours. There was 
no significant difference between the rates of 5-hydroxyindole-3- 
acetic acid formation at 01.00 h. and 13.00 h , , and. it was therefore 
concluded that there was no twenty-four hour variation of monoamine 
oxidase activity.
The concentration of 5-hydroxytryptamine in rats injected with 
saline (0.9%) were 249 t 16 mjig/g^ at 01.00 h. and 444 i 11 mjxg/g^ 
at 13.00 h. (Table 7) 0  These concentrations were significantly 
different at the p <  0.001 level by students t test. As expected 
there was therefore a twenty-four hour variation on 5-hydroxytrypt- 
amine concentration in control groups. Rats killed 4h. following 
the injection of pargyline (150 mg/kg i.p.) showed 5-hydroxytrypt­
amine concentrations to be increased by 56% (388 i 27 mpg/g ^) at
01.00 h. and 87% (827 - 40) at 13.00 h. These increases were 
statistically significant (p< 0.001) and the concentrations measured
Clock hour n
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mpo moles 5-hydroxyindole-3-acetic acid 
formed/h/brain
01.00 14 624 t 11
13.00 15 597 ± 13










249 Î 16*** 444 ± 11*** -
Pargyline 
(150 mg/kg)
388 ± 27***^ 56 827 ± 40***f 87
Tranylcypromine 
(20 mg/kg) 469 ± 3%**ff
89 921 ± 27**^^ 108
Table 7 o The synthesis of 5-hydroxytryptamine at 01,00 h.
and 13,00 h, following inhibition of monoamine oxidase 
with pargyline and tranylcypromine. Animals were killed 
after four hours,
*** p <  0,001 OloOOho, compared with 13.00 h.
f p <  0,001 pargyline compared with control
ff p <  0,001 tranylcypromine compared with control.
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at OloOO ho were significantly different from those at 13.00 h.
(p <0o001) .
5-hydroxytryptamine concentrations in animals injected with 
tranylcypromine (20 mg/kg i.p.) were also increased when compared 
with control values; 89% (469 t 36 mpg/g at 01.00 h. and 108% 
(921 t 27) at 13.00 h. These values were significantly different 
from control values (p< 0.001) and the values measured at 01.00 h. 
were significantly different (p< 0.001) from values measured at
13.00 ho
The net increase in 5-hydroxytryptamine concentrations was 
greater at 13.00 h. than at 01.00 h. in both pargyline-treated 
and tranylcypromine-treated rats, and the synthesis rate of the 
amine was therefore greater at 13.00 h. when compared with OliOO h. 
It is thus apparent that there is a twenty-four hour variation in 
the rates of synthesis of 5-hydroxytryptamine when measured 
in vivo by this method of MAO inhibition, with the higher rate 
at 13.00 h. and the lower rate at 01.00 h.
Isocarboxazid administered in the drinking water (100 pg/ml). 
increased 5-hydroxytryptamine concentrations in the rat brain 
throughout the twenty-four hours (Figure 51). Water consumption 
was approximately 25 ml./rat/day with 95% of the drug being 
consumed during the dark period. Each rat therefore consumed 
approximately 2.5 mg. isocarboxazid per day. There was no 
significant variation in 5-hydrpxytryptamine concentrations with 
clock hour in isocarboxazid-treated rats (Figure 51).
Concentrations of the amine were therefore stable throughout the 
tweiity-four hours, and this must presumably be due to the synthesis 
of 5-hydroxytryptamine being greater than the rate of release and 




























Figure 51. The effects of isocarboxazid (□ —  O 4 days)
( B □ 8 days) ( A  A  control) administered
in the drinking water (100 pg/ml) on the twenty- 
four hour variation of 5-hydroxytryptamine 
concentrations (t SEM) in the rat brain (measured 
at 01.00 h. and 13.00 h. only). Numbers of 
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Clock hour
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Figure 52. The effects of isocarboxazid (100 |jig/ml. in the
drinking water for 4 days) ( □ ---□) on the
twenty-four hour variation of 5-hydroxytryptamine 
concentrations (_ SEM) in the rat brain. Control
( A  A), The number of animals used are shown
in parentheses.
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There was no significant difference in 5-hydroxytryptamine 
concentrations between rats receiving isocarboxazid for four days 
and for eight days (Figure 52). A maximum concentration of the 
amine therefore appears to have been reached, possibly by feedback 
mechanisms inhibiting the synthesis of the amine, thus preventing 
further increases of 5-hydroxytryptamine concentrations in the 
rat braino
The twenty-four hour rhythm of 5-hydroxytryptamine concentrations 
was abolished by the use of isocarboxazid in the drinking water after 
four and eight days, it was therefore apparent that the presence of 
monoamine oxidase is essential to maintain the rhythm of 5-hydroxy­
tryptamine concentrations in the rat brain. The mechanism by which 
monoamine oxidase exerts this controlling influence must be indirect 
since the activity of the enzyme itself did not vary with clock hour.
It must therefore depend on the availability of substrate to exert 
an effect. The availability of substrate for degradation is 
dependent upon the activity of 5-hydroxytryptamine-containing neurones, 
and the activity of these neurones can be determined by the measurement 
of 5-hydroxyindole-3-acetic acid concentrations in the rat brain 
(5-hydroxyindole-3-acetic acid concentrations have been determined 
over a twenty-four hour period, and the results are presented in the 
following Chapter).
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C H A P T E R  N I N E
The twenty-four hour rhythm of 5-hydroxyindole-3-acetic acid 
concentrations in the rat brain
173
9ol INTRODUCTION
5-hydroxyindole-3-acetic acid is formed from 5-hydroxytryptamine 
by oxidative deamination involving monoamine oxidase and aldehyde 
dehydrogenase. The acid has been identified in the cerebrospinal 
fluid (CSF) of the dog (Twarog and Page 1953) and the rat (Ashcroft 
and Sharman 1960) and in the brain of the rat (Sharman 1960). The 
acid does not easily enter the brain (Moir and Eccleston 1968) but 
concentrations rapidly increase following injection of tryptophan 
(Schubert 1974) or 5-hydroxytryptophan (Roos 1962) or following 
stimulation of the raphe nuclei. (Eccleston, Padjen and Randic 1969).
The distribution of 5-hydroxyindole-3-acetic acid in the brain is 
the same as the distribution of 5-hydroxytryptamine and the acid is 
therefore probably formed at the same site in the tissue (Roos 1962). 
Indeed the concentration of 5-hydroxyindole-3-acetic acid in the CSF 
reflects the metabolism of 5-hydroxytryptamine in the brain (Bowers 
1970; Roos, Anden and Werdinius 1964; Moir, Ashcroft, Crawford,
Eccleston and Guldberg 1970) , and similarly changes in the brain 
concentration of the acid reflect the turnover of brain 5-hydroxy­
tryptamine (Per ez-Cruet, Tagliamonte, Tagliamonte and Cessa 1972,
Bliss, Thatcher and Ailion 1972). On the other hand changes in the 
concentration of the acid itself do not influence the turnover of 
the amine (Neff and Tozer 1968).
5-hydroxyindole-3-acetic acid is the major excretory product 
of 5-hydroxytryptamine metabolism (Chapter One) and must therefore 
be removed from the brain to the circulation. The efflux of the 
acid from the brain has components due to diffusion, a saturable transport 
mechanism and bulk flow (Ashcroft, Dow and Moir 1968; Sampath and 
Neff (1974). The transport mechanism is apparently situated in the
174
choroid plexuses of the fourth ventricle although only 10% of the 
total 5-hydroxyindole-3-acetic acid is removed through the CSF 
(Meek and Neff 1973). Evidence for the use of bulk flow to remove 
metabolites has been presented by Guldberg, Ashcroft and Crawford 
(1966). These workers demonstrated a marked gradient of 5-hydroxyindole- 
3-aIcetic acid concentrations from the lateral ventricles tô the cisterna 
magna of the dog. However, Sampath and Neff (1974) concluded that most 
of the acid found in the brain is transported directly into the 
circulation and only a small fraction enters the CSF. The choroid 
plexuses were not the only sites of acid transport in the brain.
Nearly all studies to determine rates of metabolism of 
5-hydroxytryptamine by measuring 5-hydroxyindole-3-acetic acid 
concentrations have employed the drug probenecid which inhibits the 
removal of the acid from the CNS (Korf, Van Praag and Sebens 1971).
Since the rate of accumulation of 5-hydroxyindole-3-acetic acid 
following the injection of probenecid is almost identical with the rate 
of formation of 5-hydroxytryptamine it has been implied that 
5-hydroxyindole-3-acetic acid is transferred directly from brain tissue 
to the plasma under normal conditions (Neff, Tozer and Brodie 1967).
The twenty-four hour variation of 5^hydroxyindole-3-acetic acid 
concentrations has not been extensively investigated. However, Morgan, 
Yndo and Mcfadin (1974) found significant daily changes in the 
concentrations of the acid in the brain of mice, although these daily 
changes did not correlate with the concentrations of 5-hydroxytryptamine 
that were measured. Quay (1964 (a) ) found a twenty-four hour variation 
of 5-hydroxyindole-3-acetic acid concentrations in the pineal glands of 
female rats and this variation, which generally resembled that of 
5-hydroxytryptamine in the pineal gland, had the following characteristics;
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The time of maximum content of the acid was significantly later 
than that of the amine. The drop to a nocturnal minimum was 
more rapid. The nocturnal basal level was maintained for at 
least five hours before the start of the subsequent morning rise. 
As a result of these findings, Quay (1964(a) ) concluded that the 
later rise and the maximum point of 5-hydroxyindole-3-acetic acid 
concentrations in the 5-hydrOxyindole-3-acetic acid rhythm when 
compared with the 5-hydroxytryptamine rhythm could indicate that 
the former is derived from the latter.
In this Chapter the twenty-four hour variation of 
5-hydroxyindole-3-acetic acid concentrations has been determined.
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9.2 METHODS
Male Sprague Dawley rats (120 -140g) were maintained under the 
constant environmental conditions described in Chapter Two for ten 
days before each experiment.
9.2.1 Assay of 5-hydroxyindole-3-acetic acid (Giacalone and 
Valzelli 1966)
Rats were killed by decapitation, the pineal glands discarded 
and the brains immediately removed, weighed and homogenised in 3.0 ml. 
O.IN HCl containing 0.5% L-ascorbic acid,using a glass tube and teflon 
pestle as described previously. The homogenate was deproteinised using 
0.5 ml. 10% (^/v) ZnSO^.THgO and 0.3 ml. N/1. NaOH. The mixture was 
centrifuged at 4,000 r.p.m. for ten minutes in a bench centrifuge. The 
supernatant was filtered through glass wool and 0.5 ml. 2% (*Yv) EDTA,
0.5 ml. 6% C^/v) L-ascorbic acid and 0.65 ml. N/1. HCl were added to 
the filtrate. The homogeniser tube and pestle were washed with 3.0 ml.
O.IN. HCl containing 0.5% (w/v) L-ascorbic acid. The washings were 
added to the precipitate obtained previously and the precipitate was 
resuspended. 0.5 ml. 10% (^/v) ZnSO^ 75^,0 and 0.3 ml. N/1. NaOH were 
added and the mixture was centrifuged at 4000 r.p.m. in a bench 
centrifuge. The supernatant was filtered through glass wool and the 
filtrate was added to the first filtrate obtained. 3.0g. NaCl and 5 ml. 
butyl acetate were added to the combined filtrates, the mixture was 
shaken for five minutes, and centrifuged for two minutes at 5000 g*
4.5 ml. organic phase was added to 4.0 ml. O.IN. HCl containing 0.5% ( Wv) 
L-ascorbic acid saturated with NaCl, The mixture was shaken for five
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minutes and centrifuged for two minutes at 5000g. 4.0 ml. organic phase
was added to 1.3 ml. O.IM. phosphate buffer pH 7,0 containing 0.1% (#/v) 
L-ascorbic acid. The mixture was shaken for five minutes and centrifuged 
for two minutes at 5000g. 1.0 ml, aqueous phase was made 3N with
concentrated HCl and the fluorescence of the product was measured at 
excitation wavelength 295 mp, emission wavelength 540 mp (wavelengths 
uncorrected) in an Aminco-Bowman spectrophotofluorometer. The
fluorescence spectrum of the isolated product was compared with pure 
5-hydroxyindole-3-acetic acid (Sigma) to validate the assay procedure.
Internal and external standards and phosphate buffer blanks were 
measured during each assay in order to calculate a more accurate estimate 
of 5-hydroxyindole-3-acetic acid concentrations in the rat brain.
9,2=2 The Twenty-four hour variation of 5-hydroxyindole-3-acetic 
acid concentrations in the rat brain.
Rats were killed in groups of seven or eight at four-hourly 
intervals commencing at 09,00 h, and 5-hydroxyindole-3-acetic acid 
was assayed as described, in order to measure the twenty-four hour 
variation of 5-hydroxyindole-3—acetic acid in the rat brain. The 
significance of the variation was determined by Fourier analysis 
and the test.
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9.3. RESULTS AND DISCUSSION
The fluorescence spectrum for the isolated product was identical 
with that of pure 5-hydroxyindole-3-acetic acid (Sigma) (Figure 53),
When tryptophan, 5-hydroxytryptophan and 5-hydroxyindole-3-acetic acid 
were carried through the extraction and assay procedure they did not 
produce fluorescence greater than that observed with a phosphate buffer 
blank. The product measured in the assay was therefore assumed to be 
5-hydroxyindole-3-acetic acid.
A twenty-four hour rhythm of 5-hydroxyindole-3-acetic acid
concentrations has been shown (Figure 54) with highest concentrations
(644.2 - 10.4 mpg/g ^) at 17.00 h. and lowest concentrations 
+ -1
(426.9 _ 19.5 mpg/g ) at 01.00 h. Highest concentrations were 
therefore reached four hours after those of 5-hydroxytryptamine 
although this peak still occurred during the light period.
Concentrations of the acid decreased rapidly during the early hours 
of darkness to reach a minimum at 01.00 h. Although the hour of 
lowest concentrations was the same when acid and amine were compared, 
the rate of decline was much greater for the acid.
The twenty-four hour variation of 5-hydroxyindole-3-acetic acid 
concentration was not significantly different from the calculated sine 
curve (Figure 55) and highest concentrations were significantly different 
from lowest concentrations when compared by the Students* t test
(p< 0.001).
Since it has already been shown (Chapter Eight) that the activity 
of monoamine oxidase did not vary with clock hour, it was concluded that 
the concentrations of 5-hydroxyindole-3-acetic acid measured were a 
consequence of the amounts of 5-hydroxytryptamine released from 
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Figure 5 3 . The Fluorescence spectrum of extracted 5-hydroxyindole-
3-acetic acid (a) compared with that of the pure compound (b): 
(A —  ■■ A) . Excitation 295 mp, scan emission; (Q - ®)
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Figure 54. The twenty-four hour variation of 5-hydroxyindole- 
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Figure 55. The twenty-four hour variation of 5-hydroxyindole- 
3- acetic acid concentrations in the rat brain 
compared with the calculated sine curve.
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5-hydroxyindole-3-acetic acid concentrations were therefore considered 
to be a reflection of the activity of 5-hydroxytryptamine-containing 
neurones» The activity of these neurones was therefore highest during 
the light period and lowest during the dark period»
It has been suggested (Hery, Rouer and Glowinski 1972) that the 
twenty-four hour rhythm of 5-hydroxytryptamine concentrations may be 
controlled in part by an increased release of the amine during the 
dark period» This has clearly not been found to be the case since 
the concentrations of 5-hydroxyindole-3-acetic acid were lowest during 
this period»
So far in this thesis the synthesis and breakdown mechanisms 
relating to 5-hydroxytryptamine have been investigated in an attempt to 
identify controlling factors in the production of the twenty-four hour 
rhythm of 5-hydroxytryptamine» On several occasions catecholamines have 
been implicated in the production of this rhythm. The effects of 
catecholamine synthesis inhibitors on the twenty-four hour rhythm of 
5-hydroxytryptamine were therefore investigated and the results are 
presented in the following Chapter»
183.
C H A P T E R  T E N
The Effects of Inhibitors of catecholamine synthesis on the 
twenty-four hour variation of 5-hydroxytryptamine concentrations
in the rat brain.
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10.1 INTRODUCTION
The concentrations of noradrenaline in the brain of rats and cats 
exhibit a twenty-four hour or circadian rhythm with highest concentrations 
normally found during the dark period (Graziani and Montanaro 1967;
Friedman and Walker 1968; Manshardt and Wurtman 1968; Reis and 
Wurtman 1968; Davies 1971). The rhythm of noradrenaline concentrations 
is therefore opposite in phase to the rhythm of 5-hydroxytryptamine 
concentrations.
Scheving, Harrison, Gordon and Pauly (1968) were unable to detect 
a rhythm of either dopamine or noradrenaline concentrations in the rat 
brain, and suggested that catecholamines are characterised by reproducible 
"higher frequency ultradian" rhythms. However previous work in our own 
laboratories (Davies 1971) has shown a rhythm of dopamine concentrations 
with two peaks (08.00 h and 1600 h) and therefore three periods of low 
concentrations (00.00 h, 12.00 h and 20.00 h ) . Concentrations of
dopamine were therefore generally higher during the light period and 
approximately in phase with 5-hydroxytryptamine concentrations.
Reis, Weinbren and Corvelli (1968) and Reis, Corvelli and Conners 
(1969) found that the noradrenaline rhythm was endogenous or free running, 
and that the 5-hydroxytryptamine rhythm was independent of the noradrenaline 
rhythm in the brain regions of the cat that were studied.
If all these results are considered together it becomes apparent 
that, unlike the rhythm of 5-hydroxytryptamine concentrations, the 
twenty-four hour rhythms of catecholamine concentrations vary according 
to brain region. As a result, when whole brain, or parts of brain 
containing more than one brain region are taken for assay, ultradian 
rhythms may be seen. However noradrenaline rhythms normally show 
highest concentrations during the dark period.
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It is worth reiterating at this stage that some evidence is 
available that catecholamines can play a part in controlling 
5-hydroxytryptamine concentrations in the brain of the rat. Thus 
the concentrations of 5-hydroxytryptamine in the pineal gland are 
regulated by sympathetic innervation (Zweig and Azelrod 1969) , and 
the maturation of the twenty-four hour rhythm of 5-hydroxytryptamine 
in the brain occurs only following the maturation of noradrenaline 
concentrations (Asano 1971).
The effects of inhibitors of catecholamine synthesis or 
destruction of catecholamine-containing neurones on the twenty-four 
hour rhythm of 5-hydroxytryptamine concentrations have not been 
widely investigated. However Hery, Rouer and Glowinski (1973) 
investigated the effects of 6-hydroxydopamine(6-OHDA) on the rhythm 
in the rat hypothalamus and found that the decrease in 5-hydroxytrypt­
amine concentrations associated with the dark period did not occur 
following the intraventricular injection of 6-OHDA. These workers 
concluded that the diurnal variation in 5-hydroxytryptamine synthesis 
seemed to be controlled in part by central catecholamine-containing 
neurones since it was unlikely that 6-OHDA was toxic to 5-hydroxytrypt- 
amine-containing neurones. Noradrenaline concentrations were markedly 
decreased when 5-hydroxytryptamine concentrations were estimated three 
weeks after 6-OHDA injection.
In this Chapter I have investigated the effects of a tyrosine 
hydroxylase inhibitor ( -methyl-p-tyrosine) (Levitt, Spector, Sjoerdsma 
and Udenfriend 1965), a dopamine-p-hydroxylase inhibitor (FLA-63) (Anden 
and Fuxe 1971), and the effects of 6-OHDA on the twenty-four hour rhythm 
of 5-hydroxytryptamine concentrations in the rat brain.
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It was intended that such an experimental design would allow the 
effects of noradrenaline and dopamine on the rhythm to be determined 




Male Sprague Dawley rats (120 - 140g) were maintained under the 
constant environmental conditions described in Chapter Two for ten days 
before each experiment.
10.2.1 The Effects of FLA-63 (bis(4-methyl-l-homopiperazinylthiocarbonyl)
disulphide) on the twenty-four hour variation of 5-hydroxytryptamine 
concentrations in the rat brain.
Two groups of seven rats were injected intraperitoneally with FLA-63 
(25 mg/kg. made up in N/1.HCl), and a further two groups of seven rats were 
injected intraperitoneally with N/1.HCl. These latter groups served as 
controls. The four groups were killed by decapitation, three and a half 
hours after injection so that one group of FLA-63 treated and one group of 
controls were killed at 01.00 h . , and the remaining \groups were killed at
13.00 h. The pineal glands were discarded and the brains were 
immediately removed, frozen in liquid nitrogen, and stored at -14°C. 
5-hydroxytryptamine was assayed by the method of Snyder, Axelrod and 
Zweig (1965) as described in Chapter Three.
The experiment was repeated exactly as described except that 
FLA-63 (25 mg/kg.) was injected orally.
10.2.2 The Effects of oC-methyl-p-tyrosine ,( ct-MPT) on the twenty-four 
hour variation of 5-hydroxytryptamine concentrations in the rat 
brains,
Two groups of ten rats were injected intraperitoneally with (K-MPT- 
methyl ester (250 mg/kg. 2ml/kg.). A further two groups of ten rats were 
injected intraperitoneally with 0.9% saline (2 ml/kg.), and these groups
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served as controls. The four groups were killed, by decapitation, four 
hours after injection so that one group of ®t-MPT treated and one group 
of control rats were killed at 01.00 h. and the remaining groups at
13.00 h. The pineal glands were discarded and the brains were 
immediately removed, frozen in liquid nitrogen and stored at -14°C. 
5-hydroxytryptamine was assayed by the method described in Chapter 
Three.
In a second experiment two groups of ten rats were injected 
intraperitoneally with ot-MPT methyl ester (250 mg/kg. 2m/kg) eighteen 
hours and again four hours before decapitation. Two control groups 
of ten rats were injected intraperitoneally with 0.9% saline (2ml/kg), 
at the same times- The brains were removed at 01.00 h. and 13.00 h. 
as described previously and the 5-hydroxytryptamine content of the 
brain was assayede
10.2.3 The Effects of 6-hydroxydopamine on the twenty-four hour
variation of 5-hydroxytryptamine concentrations in the rat brain.
Male Sprague Dawley rats (60-80g) were maintained for ten days under 
the constant environmental conditions described in Chapter Two, so that the 
body weight of the rats was 130 - 150g. at the time of the start of 
experiment. In two groups of eight rats 6-hydroxydopamine (250 pg/rat in 
a volume of 10 pi), was injected into the lateral ventricle of the brain. 
Two groups of eight rats were similarly injected with 0.9% saline. The
operations were carried out under ether anaesthesia. The rats were 
returned to the environmental cabinets for a further eighteen days, when 
they were killed by decapitation so that one group of 6-hydroxytfyptamine 
treated and one group of control rats were killed at 01.00 h. and the
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remaining groups at 13.00 h. The brains were removed and 
5-hydroxytryptamine was assayed by the methods described previously
10.3 RESULTS AND DISCUSSION
FLA-63 (25 mg/kg.) injected intraperitoneally was lethal to 
three rats from the groups killed at 01.00 h. and to two rats from 
the group killed at 13.00 h. No rats died as a result of the 
intraperitoneal injection of N/1 HCl (in control groups. Rats in 
the experimental groups therefore died aa a result of FLA-63. The 
results from the remaining rats are shown in Figure 56. There was 
no significant difference in brain 5-hydroxytryptamine concentrations 
between control and FLA-63-treated rats at 01.00 h. However, the 
concentration of the amine in FLA-63-treated rats was decreased by 
42% when compared with control values at 13.00 h.
FLA-63 (25 mg/kg.) injected orally did not significantly alter 
5-hydroxytryptamine concentrations at either 01.00 h. or 13.00 h.
(Figure 57). However it cannot be concluded that FLA-63 has no 
effect in altering 5-hydroxytryptamine concentrations, since levels 
were decreased at 13.00 h. following intraperitoneal injection of the 
drug. Neither can it be concluded that this latter effect is due to 
the direct effects of the drug, since these effects were measured in 
animals whose cage mates had died as a result of FLA-63. Other factors 
such as stress and fear must be taken into account. These experiments 
were not repeated since lower doses of the drug have little effect on 
catecholamine concentrations (Anden and Fuxe 1971) and higher doses 
could only increase lethality. Since FLA-63 was unsatisfactory, and 
no better inhibitor of dopamine-p-hydroxylase is available, the 
experiments reported in this Chapter were unable to differentiate between 
the effects bf noradrenaline and dopamine on the twenty-four hour rhythm 
































Figure 56 The effects of FLA-63 (25 mg/kg.i.p. 0 0)
on the concentrations of 5-hydroxytryptamine 
(- SEM) in the rat brain measured at 01.00 h. 
































Figure 57. The effects of FLA-63 (25 mg/kg p.o.A A )
on the concentrations of 5-hydroxytryptamine 
(- SEM) in the rat brain measured at 01.00 h 
and 13.00 h. ( A  A) Control ( a  H).
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ot-methyl-p-tyrosine (250 |tig/kgo I/P) did not significantly 
alter 5-hydroxytryptamine concentrations at 13.00 h. when compared 
with saline injected controls (Figure 58). However, 5-hydroxy- 
tryptamine concentrations were significantly greater (p< 0.01) 
at 01.00 ho in -MPT-treated rats when compared with controls^
It would therefore appear that the rate of decline of 5-hydroxy­
tryptamine concentrations during the initial part of the dark 
period has been decreased following the inhibition of catecholamine 
synthesis withot-MPT.
In order to determine whether a similar response could be 
obtained at 13.00 h . , two doses of ot-MPT (250 mg/kg.I/P) were 
injected, the first 18 h. and the second 4 h. before the rats were 
killed (Figure 59). 5-hydroxytryptamine concentrations were 
significantly greater (p <  0.001) at both 01.00 h. and 13.00 h«
The increase was 128% at 01.00 h. and 56% at 13.00 h. It would 
therefore appear that when the concentrations of catecholamines 
(dopamine and noradrenaline) are depleted in the rat brain by et-MPT 
the twenty-four hour rhythm of 5-hydroxytryptamine concentrations 
is abolished since concentrations at 01.00 h. and 13.00 h. were not 
significantly different.
The effects of the intraventricular injection of 6-OHDA on 
5-^hydroxytryptamine concentrations in the rat brain can be seen in 
Figure 60. Concentrations of the amine were significantly greater (72%) 
(p< 0.001) at 01.00 h . , and (20%} (p<0.01) at 13.00 h. eighteen days 
after 6-OHDA injection when compared with control rats.
The concentrations of 5-hydroxytryptamine were not significantly 
different at these two clock hours following 6-OHDA injections. It 
would therefore seem likely that central cateçholamine-contâining 
neurones play a part in the control of 5-hydroxytryptamine concentrations 




























Figure 58. The effects of <-MPT (250 mg/kg i.p.A A)
administered 4 h. before the rats were killed, 
on the concentrations of 5-hydroxytryptamine 
(- SEM) in the rat brain measured at 01.00 h. 



























Figure 59. The effects of o( -MPT (250 mg/kg.i.p.A A)
administered 18 h. and 4 h. before the rats 
were killed, on the concentrations of 
5-hydroxytryptamine (t SEM) in the rat brain

























Figure 60. The effects of 6-OHDA (250 pg i.c.v.A A)
on the concentration of 5-hydroxytryptamine 
(t SEM) in the rat brain measured at 01.00 h 
and 13.00 h. ( A  A) (Control 0  S ).
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to 5-hydroxytryptamine containing neurones (see Introduction). 
However the alterations in 5-hydroxytryptamine concentrations 
noted here could be caused either by an increased sensitivity 
of noradrenaline receptors or by behavioural changes in the rats.
If the effects of ot -MPT and 6-OHDA are compared, it is 
apparent that the catecholamines may play an important part in 
the control of the synthesis of 5-hydroxytryptamine, and since 
these effects are most marked at 01.00 h. (Figures 59,60) it is 
possible that lowered concentrations of the catecholamines could 
represent a decreased inhibition of 5-hydroxytryptamine synthesis 
Further implications of this supposition will be discussed in 
Chapter Twelve.
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C H A P T E R  E L E V E N
Locomotor activity and 5-hydroxytryptamine 
concentrations in the rat brain.
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11.1 INTRODUCTION
Locomotor activity has been speculatively correlated with 
5-hydroxytryptamine concentrations in the rat brain (Grahame-Smith 
1971), and the twenty-four hour rhythm in locomotor activity has 
been widely reported (Richter 1922; Hunt and Schlosberg 1939;
Peacock, Hodge and Thomas 1966; Hutchins and Rogers 1970).
The rat is a nocturnal animal which exhibits a high degree of 
spontaneous activity commencing shortly after the onset of 
darkness, and almost all locomotor activity occurs during the 
dark period. Locomotor activity depends on a large number of factors 
including age of the animal, hunger, thirst and the presence of external 
stimuli such as noise and temperature. Richter (1922) reported six to 
ten bursts of activity during the dark period@ however there is a large 
difference in the amount of activity, even between littermates 
(Reed 1947).
In this Chapter the effects of various drugs known to alter 
concentrations of 5-hydroxytryptamine in the rat brain, have been 
compared, by their effects on the locomotor activity of the rat.
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11.2 METHODS AND MATERIALS
Male Sprague Dawley rats (80 - lOOg) were maintained under 
constant environmental conditions in a light-proofed and sound-proofed 
room lit by a 150 watt electric lamp connected to a time switch such 
that the light came on at 06.00 h. and switched off at 18.00 h. The 
room was thermostatically controlled and maintained at 23 t 3°C.
Each rat was housed individually in a "Squirrel cage"
(E.Ko Bowman Ltd . , London) with access to food and water ad libitum.
Each "Squirrel cage" consisted of an activity wheel (16 in. x 5 in.) 
connected to a nesting box (8 in. x 10 in.) by an open portal. Each 
"Squirrel cage" was fitted with a device for recording the drinking 
activity of the animal (for full details see Navaratnam 1974). Locomotor 
activity was measured by the closing of an electrical contact with each 
revolution of the activity wheel, and electrical pulses were counted 
and stored in an Elmeg DM0 12 multi-channel digital printing aggregate 
unit and visualised on the Elmeg 2DG V 12 channel digital print-out unit 
(both instruments were manufactured by Elektro-Mechanik GmbH, Germany). 
Under this procedure each rat was not isolated from external stimuli
i.e. each animal, although not within sight of its neighbours, was 
subjected to the auditory stimuli produced by the revolutions of 
neighbouring activity wheels. However, by randomising the drug 
treatment given to animals in each cage, it was hoped that any such 
extraneous effects would be nullified. The drinking monitor and the 
recording devices for measuring locomotor activity were assembled outside 
the experimental room in order to keep auditory stimuli to a minimum.
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Groups of nine rats were housed in the experimental room and were left 
undisturbed until each exhibited a synchronised locomotor activity rhythm, 
(usually after 12-15 days). Drugs were then administered either in the 
drinking water or intraperitoneally, and the effect of the drugs on 
locomotor activity was monitored until control levels were reached or until 
six days following drug administration whichever was the sooner.
The effects of the following drugs were determined;- tryptophan, 
5-hydroxytryptophan, p-chlorophenylalanine, isocarboxazid, ot-methyl-p- 
tyrosine, and tap water or saline as a control. The effects of these 
drugs on locomotor activity were compared with their effects on the 
concentration of 5-hydroxytryptamine in the rat brain described in 
previous chapters in this thesis.
11.2.1 Expression of Results
In only two treatments (isocarboxazid and p-chlorophenylalanine) 
were the results sufficiently uniform to calculate a mean result from 
the data obtained. The results from these two treatments are therefore 
expressed as the mean effect of drug treatment on locomotor activity per 
clock hour, and the graphs shown (Figures 62 and 63) are drawn from the 
day of maximum effect of the drugs (day 3 for p-chlorophenylalanine and 
day 5 for isocarboxazid). Locomotor activity has been scaled as follows:
Scale 1. 0 - 49 0 p 0 m  o.
2. 50 - 199 IT op 0in0
3. 200 - 499 IT 0 p cin 0
4. 500 - 999 r opoiiio
5. 1000 - 1499 TT o p 0 HI 0
6. 1500 - 2000 IT 0 p G in 0
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In other experiments results were too variable to express on 
this basis. The gross locomotor activity was therefore expressed 
per twenty-four hours and plotted for each animal three days before 
and six days after the start of drug treatment. Each animal 
therefore acted as its own control and results are expressed as the 
percentage change in locomotor activity with the activity on the 
first day of treatment representing 100%.
11.3 RESULTS AND DISCUSSION
In the first experiment a monoamine oxidase inhibitor, isocarboxazid, 
was given to rats in the drinking water at a concentration of 100 pg/ml. 
Control rats received normal tap water. The total locomotor activity 
per hour was plotted against clock hour (Figure 61). Rats which drank 
tap water demonstrated a biphasic locomotor activity rhythm, with 
minimal activity during the light period and a subsequent increase at 
the onset of darkness. This level was maintained throughout the dark 
period. In rats drinking the isocarboxazid solution a similar rhythm 
was displayed but the level of activity during the dark period was 
increased by more than 100%. No increase in locomotor activity was 
recorded during the light period.
When these results were compared with the effects of isocarboxazid 
on brain 5-hydroxytryptamine concentrations (Chapter Eight, Figures 51,52) 
it was apparent that the increased concentrations of 5-hydroxytryptamine , 
during the light period could be inversely correlated with the decreased 
locomotor activity during this period, while decreased concentrations 
of the amine may be inversely correlated with the marked increase in 










Figure 6 1 . The effects of isocarboxazid (100 pg/ml.
administered in the drinking water) on the
locomotor activity of the rat (  isocarboxazid;
------ control).
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In the second experiment rats were injected orally with either 
p-chlorophenylalanine (316 mg/kg) or saline (0.9%). The saline 
injected rats demonstrated a similar pattern of loqomotor activity 
to the control rats in the previous experiment. In p-CPA injected 
rats the rhythm of locomotor activity was completely disrupted 
(Figure 62),with activity throughout the twenty-four hours at 
similar levels to control rats during the dark period. Maximum 
disruption was demonstrated three and four days after the injection 
of p-CPA and this disruption may therefore be related to the decrease 
of 5-hydroxytryptamine concentrations found at a similar time 
(Chapter Five). A  further inverse correlation between locomotor 
activity and 5-hydroxytryptamine concentrations has therefore been 
shown.
Figure 63 demonstrates the drinking activity of a group of 
nine rats housed in squirrel cages, and is typical of the activity 
recorded throughout these experiments. In the first three columns 
rats had been injected with saline, in the second three with p-CPA 
and the final three received isocarboxazid in the drinking water.
It was apparent that virtually all the drinking activity occurred 
during the dark period and very little occurred during the light 
period even following disruption of the locomotor activity rhythm 
following p-CPA injection.
The effects of the two precursors of 5-hydroxytryptamine 
synthesis (tryptophan and 5 -hydroxytryptophan) on the locomotor 
activity rhythm of the rat are shown in Figures 64 and 65. Each 
point represents the gross activity of one animal per twenty-four 
hours. The effects were somewhat variable from animal to animal, 




















Figure 6 2 . The effects of p-CPA (316 mg/kg.p.o) on the




























1 - 3  Tap water
4 - 6  p-CPA p.o.
7 - 9  Isoboxazid drinking water
Figure 63. A record of the drinking activity of rats
over a 36 h. period. Each stroke represents 


















Time (days) before and after the drug
Figure 64. The effects of tryptophan (1 mg/ml.
administered in the drinking water) 






























Time (days) before and after drug
Figure 6 5 . The effects of 5-hydroxytryptophan
(Img/ml administered in the drinking 
water) on the locomotor activity of 
the rat.
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general depression of locomotor activity was seen throughout the experiment.
Both drugs were given in the drinking water at a concentration of 1 mg/ml.
There were six animals in each group.
From evidence available, it is almost certain that tryptophan and 
5-hydroxytryptophan are rapidly metabolised in the body, and only a small 
amount of that ingested will be taken up by the CNS. It must also be 
borne in mind that the rats only consumed these compounds during the 
dark period. When these facts are considered together it seems likely 
that a high degree of variability in the effects on locomotor activity 
is bound to exist between animals, since the amount of tryptophan or 
5-hydroxytryptophan ingested at any given time during the dark period 
is unlikely to be the same in any of the animals. Drugs which have 
longer lasting effects (p-CPA, isocarboxazid) are more likely to 
produce consistent results between animals.
From these experiments it can be seen that drugs which elevate 
only brain 5-hydroxytryptamine concentrations (tryptophan and 5-hydroxy­
tryptophan) also decrease locomotor activity, while drugs which elevate 
all amine concentrations (isocarboxazid) increase activity. It was
therefore interesting to measure the effects of a drug which depletes
catecholamine concentrations but increases 5-hydroxytryptamine concentrations 
i.e. -MPT (Chapter Ten, Figure 59),^-MPT was injected intraperitoneally 
(250 mg/kg) on two consecutive days at 13.00 h. and the results recorded 
(Figure 66). The results were again very variable but it appeared that 
locomotor activity was initially reduced and subsequently increased 
although this latter effect may have been due to the effects of the 
drug wearing off (a rebound effect). It is proposed that the initial 
reduction of locomotor activity is a result of the increased 




























Time (days) before and after drug
Figure 6 6 . The effects of dk-MPT (250 mg/kg i.p 
injected on two consecutive days at
13.00 h.) on the locomotor activity 
of the rat.
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It seems likely from these experiments that 5-hydroxytryptamine 
concentrations play a part in controlling locomotor activity, with 
the major action being a decrease in activity as 5-hydroxytryptamine 
concentrations increase»
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Discussions directly related to the results obtained during the 
course of this work, and the relationship between these results and 
those of other workers have been presented in the relevant Chapters 
in this thesis and will not be reiterated here. However the conclusions 
which can be drawn from these results will be collected together to 
present an argument which will suggest the identity of the regulating 
factors in the twenty-four hour rhythm of 5-hydroxytryptamine 
concentrations in the rat brain. This hypothesis will hinge on the 
fact that a twenty-four hour rhythm of 5-hydroxytryptophan decarboxylase 
activity has been detected and that an interaction between catecholamines 
and 5-hydroxytryptamine has been demonstrated.
From the results reported in this thesis and from those reported by 
other workers (Chapter Three) there would appear to be no doubt that 
the concentrations of 5-hydroxytryptamine found in the rat brain vary 
with the time of day. This variation is normally entrained to produce 
a twenty-four hour rhythm, with highest concentrations during the light 
period (13.00 h.) when the rats are least active, and lowest concentrations 
during the dark period (01.00 h.) when the rats are most active. Highest 
concentrations exceeded lowest concentrations by 40% (Chapter Three)«
Having established this, it is necessary to decide which of the many 
possible mechanisms do actually play a part in controlling the rhythm.
The possible means of attaining maximum concentrations of 5-hydroxytrypt­
amine in the rat brain at 13.00 h. can be summarised as follows:
1) A reduced release of 5-hydroxytryptamine from 01.00 h. to
13.00 h. subsequently increasing after this period.
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2) A reduced rate of intracellular metabolism as concentrations 
of the amine increase, and an increased rate as the 
concentrations of S-hydroxytryptamine decrease.
3) An enhanced synthesis of the amine from 01.00 h. to 13.00 h. 
subsequently decreasing after this period.
Of these possibilities the first has already been questioned 
(Chapter Nine) since the concentrations of 5-hydroxyindole-3-acetic acid 
in the rat brain vary with clock hour such that highest concentrations 
were recorded at the same clock hour as the highest concentrations of 
5-hydroxytryptamine. In addition, the activity of monoamine oxidase does 
not vary throughout the twenty-four hours (Chapter Eight). It therefore 
follows that 5-hydroxyindole^3-acetic acid is formed as a result of the 
5-hydroxytryptamine released from nerve terminals. The increase of 
5-hydroxytryptamine concentrations from 01.00 h. to 13.00 h. cannot 
therefore be controlled by a reduced release of 5-hydroxytryptamine 
during this period.
The fact that monoamine oxidase activity does not vary with clock 
hour (Chapter Eight) also rules out the second possibility. The 
suggestion of feedback control of the synthesis of 5-hydroxytryptamine 
can also be ruled out at the physiological concentrations involved, 
since concentrations of 5-hydroxytryptamine were maintained at elevated 
levels in the presence of monoamine oxidase,inhibitors (Chapter Eight, 
Figure 51).
If one considers the third possibility i.e. variations in the 
synthesis of 5-hydroxytryptamine with clock hour, then it is apparent 
that a large number of factors could be involved. Evidence for this 
possibility may be summarised as follows:
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1) 5-hydroxytryptamine concentrations did not increase during 
the light period following the inhibition of tryptophan-5- 
hydroxylase with p-CPA (Chapter Five),
2) The uptake of tryptophan into a synaptosomal preparation was 
greater at 13.00 h. than at 01.00 h. (Chapter Four).
3) The : activity of 5-hydroxytryptophan decarboxylase was higher 
at 13.00 h. and 17.00 h. than during the dark period 
(Chapter Seven).
4) The synthesis of 5-hydroxytryptamine was greater at 13.00 h. 
than at 01.00 h. following the inhibition of monoamine oxidase 
with either pargyline or tranylcypromine (Chapter Eight).
Other factors in the synthesis of 5-hydroxytryptamine are not 
integral to the main argument, but must also be considered, and are 
listed as follows:
1) Tryptophan concentrations in the brain parallel the
concentrations of the amino acid in the serum, whether or 
not this is bound to albumin (Chapter Four, Figure 24).
No evidence has been produced in this thesis to determine 
which tryptophan fraction, if either, controls the 
concentrations of tryptophan in the brain. However, the 
discovery of a 180 degree phase difference between the 
twenty-four hour rhythms of brain tryptophan concentrations 
and brain 5-hydroxytryptamine concentrations strongly suggests 
that endogenous tryptophan concentrations do not control the 
twenty-four hour rhythm of 5-hydroxytryptamine concentrations 
in the rat brain. Indeed it is further suggested that the 
concentrations of 5-hydroxytryptamine in the brain must be
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buffered from the possible effects of fluctuating tryptophan 
concentrations.
This latter assumption may not be viable since it is not 
known how much endogenous tryptophan in the brain is 
available for uptake into neurones or nerve cell bodies.
In fact a knowledge of the localisation of the tryptophan 
available for uptake would greatly clarify the situation. 
However, on the present evidence produced, endogenous 
concentrations of tryptophan in the brain are not considered 
to play a part in the production of the twenty-four hour 
rhythm of 5-hydroxytryptamine concentrations in the rat 
brain.
2) The uptake of ^^C-tryptophan into brain region homogenates 
did not vary with clock hour (Chapter Four, Figures 30,31), 
although a higher rate of uptake was recorded at 13.00 h. 
in an isolated synaptosomal preparation (Figure 29). Thus 
a higher initial accumulations of amino acid precursor 
occurred at the same clock hour as highest concentrations 
of 5-hydroxytryptamine in the brain. Not only is this 
important in that higher initial accumulation of precursor 
could lead to a higher rate of synthesis, but might also 
provide the mechanism by which the effects of the variation 
in endogenous tryptophan concentrations are nullified.
3) Tryptophan-5-hydroxylase activity does not vary with clock 
hour (Chapter Five), and it is therefore unlikely that the 
activity of this enzyme participates in the production of 
the twenty-four hour rhythm in 5-hydroxytryptamine 
concentrations. However it is recalled that tryptophan-5- 
hydroxylase exists in both a soluble and particulate form
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(Knapp and Mandell 1972) with the former predominating 
in cell bodies and axons and the latter in nerve terminals. 
Since a twenty-four hour variation of tryptophan uptake 
was indicated in an isolated nerve ending preparation but 
not in a crude homogenate it is not inconceivable that the 
particulate form of the enzyme may produce more 
5-hydroxytryptophan at 13.00 h. than at 01.00 h. If such 
a variation does occur it was not detected by the methods 
employed in this thesis and has not been reported in the 
literature.
4) The uptake of 5-hydroxytryptophan into nerve ending
homogenates does not vary with clock hour (Chapter Six,
Figures 41,42), and cannot therefore be considered to have 
a role in the production of the twenty-four hour rhythm of 
5-hydroxytryptamine. In addition it has been shown that 
the availability of 5-hydroxytryptophan for conversion to 
5-hydroxytryptamine does not play a part in the production 
of the rhythm (Chapter Seven) since inhibition of tryptophan-5- 
hydroxylase, and therefore inhibition of the availability of 
5-hydroxytryptophan from brain tryptophan, by p-CPA did not 
alter the rates at which 5-hydroxytryptophan decarboxylase 
was able to convert 5-hydroxytryptophan to 5-hydroxytryptamine 
in vitro (Figures 43,48).
It is clear that of all the parameters measured, only the variation 
of 5-hydroxytryptophan decarboxylase activity with clock hour (Chapter 
Seven) can convincingly fill the role of a regulating factor in the 
production of the twenty-four hour rhythm of 5-hydroxytryptamine 
concentrations.
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The rate of conversion of 5-hydroxytryptophan to 5-hydroxytryptamine 
varied with clock hour such that the rate at 13.00 h. was significantly 
greater than that at 01.00 h. (Figure 43). This difference is sufficient 
to account for the variation in 5-hydroxytryptamine concentrations at 
these clock hours, and it is therefore suggested that this factor plays 
a major role in the production of the twenty-four hour rhythm of 
5-hydroxytryptamine concentrations in the rat brain.
The variation in the ability of 5-hydroxytryptophan decarboxylase 
to convert 5-hydroxytryptophan to 5-hydroxytryptamine is not due to 
rhythmic activity of the enzyme itself since the activity of the enzyme 
was similar at 01.00 h. and 13.00 h. when measured in a purified enzyme 
extract (Chapter Seven, Figure 47), nor is the variation due to the 
availability of pyridoxal phosphate or to the enzyme being saturated 
with substrate (Figure 46). The number of factors remaining which 
could alter the rate of production of 5-hydroxytryptamine are small.
Other co-factors e.g. metal ions are a possible variable, but it
seems unlikely that such components could be maintained in concentrations
which would have to be so delicately balanced to produce these effects.
A Second possibility is competition for the enzyme by different substrates 
since a large number of amino acids can be taken up by 5-hydroxytryptamine 
containing neurones. Of particular interest is the competition between
dihydroxyphenylalanine (DOPA) and 5-hydroxytryptophan (Chapter O ne), since 
it has been shown that 5-hydroxytryptamine concentrations decline as 
noradrenaline concentrations increase in the brain (or vice versa)
(Chapter Ten), and noradrenaline concentrations exhibit a marked 
circadian rhythm which is 180° out of phase with the twenty-four hour 
rhythm of 5-hydroxytryptamine concentrations.
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It has been reported that L-DOPA decreases the synthesis and increases 
the deamination of 5-hydroxytryptamine (Karobath, Diaz and Huttunen 1972), 
and that DOPA and 5-hydroxytryptophan may compete for the same enzymic 
site (Yuwiler, Geller and Eiduson 1960). Thèse authors also found that 
DOPA combines irreversibly at 5-hydroxytryptophan sites while acting 
elsewhere but that 5-hydroxytryptophan cannot combine irreversibly at 
DOPA sites. It is therefore apparent that aromatic-L-amino acid 
decarboxylase shows some degree of preference for the conversion of DOPA 
over 5-hydroxytryptophano
Since noradrenaline concentrations exhibit a twenty-four hour 
rhythm with highest concentrations during the dark period (Chapter Ten) 
and both tyrosine and phenylalanine concentrations exhibit circadian 
rhythms with highest concentrations at the same time (Fernstrom, Larin 
and Wurtman 1973), it seems likely that DOPA concentrations also exhibit 
a rhythm in this phase, particularly since noradrenaline concentrations 
are controlled by end-product inhibition of tyrosine hydroxylase (Lin,
Neff, Ngai and Costa 1969). It therefore seems probable that the 
balance between the two competing substrates (DOPA and 5-hydroxytryptophan) 
will swing in favour of DOPA during the dark period.
As a consequence the conversion of 5-hydroxytryptophan to 
5-hydroxytryptamine will decrease as the synthesis of noradrenaline 
increases.
The problem then arises as to how DOPA concentrations are decreased 
so that 5-hydroxytryptamine synthesis increases. It is suggested that 
the rate of synthesis of noradrenaline is dependent on the activity of 
noradrenaline containing neurones ie. when these neurones are inactive 
the amine accumulates so that end product inhibition of tyrosine 
hydroxylase occurs and the synthesis of noradrenaline (and consequently 
the concentration of DOPA) decreases until such a time as the neurones
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are reactivated. Some evidence has been obtained to support this 
hypothesis. In Chapter Eight it has been shown that 5-hydroxytryptamine 
concentrations continue to increase following monoamine oxidase inhibition, 
and it has been reported that 5-hydroxytryptamine concentrations increase 
to a much greater extent than noradrenaline concentrations following 
inhibition of this enzyme (Lin, Neff, Ngai and Costa 1969). In addition 
it has been reported that non-hydrazine monoamine oxidase inhibitors 
increase the rate of synthesis of 5-hydroxytryptophan to 5-hydroxytryptamine 
(Weber 1966). Further evidence has been presented in Chapter Ten, where 
it was shown that the injection of doses of * -MPT and 6-OHDA which reduce 
catecholamine concentrations to low levels (Spector, Sjoerdsma and 
Udenfriend 1965, and Hery, Rouer and Glowinski 1973 respectively) also 
increased the concentrations of 5-hydroxytryptamine in the brain.
(Figures 59, 60), to abnormally high levels. In addition the twenty-four 
hour rhythm of 5-hydroxytryptamine in the brain was abolished by the 
injection of both monoamine oxidase inhibitors and inhibitors of 
catecholamine synthesis. These results are in agreement with the 
suggestion that the control of the twenty-four hour rhythm of 
5-hydroxytryptamine concentrations is at least in part regulated by the 
ratio of the concentrations of DOPA to 5-hydroxytryptophan, and that the 
lower concentrations of 5-hydroxytryptamine recorded in rats during the 
dark period are a result of the decreased synthesis of the amine at this 
time.
A comparison of the twenty-four hour rhythms of 5-hydroxytryptamine 
concentrations, 5-hydroxytryptophan decarboxylase activity and 
5-hydroxyindole-3-acetic acid concentrations (Figure 67) shows that 
the results produced in this thesis support the proposed hypothesis, 
but such a comparison also indicates that 5-hydroxytryptophan decarboxylase 





























































When these rhythms are compared (Figure 67) it can be seen that 
the rhythm of 5-hydroxyindole-3-acetic acid is directly dependent on the 
other two. Also the shoulder which is seen in the 5-hydroxytryptamine 
rhythm at 17,00 h, can be correlated with the activity of 
5-hydroxytryptophan decarboxylase, which is maximal at this time.
The increase in concentrations of 5-hydroxytryptamine from 09.00 h. 
until 13.00 he is explained by the increased activity of 
5-hydroxytryptophan decarboxylase by the méchanism presented 
previously. The decrease from 13.00 h. to 01.00 h. can also be 
explained by decarboxylase activity as described before. However, 
this part of the rhythm is probably influenced to a significant 
extent by the reduced activity of 5-hydroxytryptamine-containing 
neurones, as reflected in the 5-hydroxyindole-3-acetic acid concentrations 
at these times. However, a second mechanism must be proposed for the 
increase of 5-hydroxytryptamine concentrations from 01.00 h. to 09.O O h . 
since decarboxylase activity remains at a minimum during this period.
It is significant perhaps that the concentrations of circulating and 
brain tryptophan are highest at 01,00 h. and it is therefore 
conceivable that the availability of the amino acid may in fact play 
a part in the initial increase in 5-hydroxytryptamine concentrations by 
methods which have not been.detected in this work (mechanisms involving 
cyclic AMP may play a part). It is apparent however that tryptophan 
availability alone is insufficient to produce the twenty-four hour 
variation of 5-hydroxytryptamine in the rat brain.
Several factors which may participate in the control of the synthesis 
of 5-hydroxytryptamine in the CNS have not been investigated in this work. 
First, as already mentioned above, one of the most interesting and perhaps 
the most important omission is the role of cyclic AMP on the transport of 
tryptophan to 5-hydroxytryptamine-containing neurones. Some evidence is
222.
available that concentrations of the nucleotide increase in situations 
where the synthesis of 5-hydroxytryptamine is stimulated (Cramer, Ng, 
and Chase 1972), and it has also been demonstrated that noradrenaline 
modulates cyclic AMP concentrations in the glial cells surrounding 
5-hydroxytryptamine-containing neurones. The inference can therefore 
be drawn that cyclic AMP may contribute to changes in 5-hydroxytryptamine 
synthesis and to the interneuronal regulation of 5-hydroxytryptamine- 
containing neurones (Clowinski, Hamon and Hery 1973). Secondly, it 
has been reported that, in an experimental situation, the intraneuronal 
levels of 5-hydroxytryptamine appear to control the rate of synthesis 
of the amine in the spinal cord (Schubert 1973). However, this remains 
to be more fully elucidated.
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Suggestions for further work
1) It would be of interest to correlate the interacting 
mechanisms of the twenty-four hour rhythms of catecholamines 
and 5-hydroxytryptamine in specific brain regions of the rat 
brain with reference to the availability of the amine precursors.
2) The effects of cyclic AMP concentrations on precursor
availability have not been widely explored. It would be 
interesting to tackle this problem on the system presented in (1)
3) It is necessary to clarify the situation with regard to the 
activity of 5-hydroxytryptamine-containing neurones and 
5-hydroxytryptamine concentrations, since the results reported 
here do not always agree with those reported by other workers.
4) Tryptophan-5-hydroxylase exists in both soluble and particulate 
forms (Knapp and Mandell 1972).It could prove of interest to 
determine whether these forms could have a cumulative effect
on the production of 5-hydroxytryptamine at nerve endings, and 
whether there could be any variation with clock hour in the 
axonal rate of flow of the enzyme. "
In more general terms it is evident that it is possible to use the
twenty-four hour rhythms of noradrenaline and 5-hydroxytryptamine (which 
appear to be delicately balanced in opposition) to investigate interactions 
and the effects of drugs on these amines in the brain. These experiments 
may also have helped to elucidate some of the mechanisms involved in the 
control of 5-hydroxytryptamine synthesis.
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